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1.1. The importance of ovine pneumonic pasteurellosis.
In recent years the sheep sector of the U.K. farming industry
has continued to expand (Table 1.1). Amongst the infectious
diseases affecting livestock, respiratory diseases are of major
importance. They cause considerable economic loss with 8 percent
(%) of all sheep deaths in 1982 being due to respiratory disease
(ADAS 1982). Losses from respiratory disease, are however, due
not only to deaths, but also to debilitation through chronic
respiratory disease, generally recognised as unthriftiness.
Further evidence for the importance of pneumonia has been gained
from slaughter-house surveys in which 5 to 80% (an average of 20%)
of lungs were found to be pneumonic on any one day (Sharp, 1977).
Pneumonic pasteurellosis, caused by the Pasteurella species P.
haemolvtica or P. multocida, has been identified as the most
common form of fatal respiratory disease in sheep accounting for
70% of diagnosed pneumonias (MAFF.1980).
P. haemolvtica is the most common Pasteurella species isolated
from cases of ovine pasteurellosis in Britain (Gilmour, 1980), and
is also a frequent isolate from cattle in Britain (Quirie et al.,
1986) and in northern America (Carter, 1973; McKercher, 1978) where
it is associated with a form of bovine pasteurellosis termed
shipping fever complex (Lillie, 1974). Ovine pasteurellosis has
also been reported in many other parts of the world including East
Africa (Pegram et al., 1979) New Zealand (Salisbury, 1957) Norway
(Mohn and Utkler, 1974) and South Africa (Cameron, 1966).
Table 1.1 Sheep and lambs total (U.K.)a
Year 1982 1983 1984 1985
numbers 33,067,192 34,069,367 34,801,982 35,627,653
a
reprinted from Agricultural Statistics. 1986. MAFF, DAFS,
DANI, Welsh Office. Published by HMSO.
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With the continued expansion of the sheep industry and further
livestock intensification the incidence of disease in general and
pasteurellosis in particular might be expected to rise. Antibiotic
treatment as a therapeutic measure against pasteurellosis is
impractical as it requires excessive livestock handling and is
prohibitively expensive to sheep farmers. As both a prophylactic
and a therapeutic measure antibiotic treatment also poses an
undesirable risk in the selection of antibiotic-resistant mutants.
This problem has become apparent in the U.S.A., where inappropriate
use of antibiotics by cattle farmers has produced P. haemolvtica
strains carrying plasmid-borne resistance factors (Zimmerman and
Hirsh, 1980).
The most appropriate means of controlling ovine pasteurellosis
would therefore seem to be by vaccination. However, despite the
widespread use of the currently available vaccines doubts about
their efficacy have been expressed (Gilmour, 1980; Gilmour et
al. , 1983) and deaths of both ewes and lambs in vaccinated flocks
have been reported (ADAS. 1984). This has prompted further
research to improve and develop new vaccines against ovine
pasteurellosis and this thesis forms part of the work of this
proj ect.
A review of the current knowlege available on the antigens of P.
haemolvtica. the experimental models of pasteurellosis, the
mechanisms of immunity by which the mammalian host responds to
vaccination and infection and their modulation by P. haemolvtica
was considered to be helpful in determining the research to be
undertaken in this thesis.
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1.2. P. haemolytica: a Gram-negative organism,
a) Classification of the Genus Pasteurella.
Bacteria in the genus Pasteurella are Gram-negative
(Gracilicutes), facultatively anaerobic rods belonging to the
family Pasteurellaceae (Bergey, 1984).
P. haemolvtica is a cocco-bacillus which is haemolytic on
sheep-blood agar, grows on MacConkey agar and does not produce
indole. These characteristics differentiate it from P. multocida.
Isolates of P. haemolvtica can be divided into two biotypes (A
and T) on the basis of morphological and biochemical
characteristics (Smith, 1961). Biotype A strains ferment
arabinose but usually not trehalose, whereas all biotype T strains
ferment trehalose. On agar plate cultures, biotype A colonies are
an even grey colour while those of the biotype T are generally
larger and more mucoid, with a brownish centre. Taxonomic studies
by Smith and Thai (1965) and investigations of nucleic acid
homology by Biberstein and Francis (1968) demonstrated marked
diffferences between A and T biotypes which led them to suggest
that these biotypes are, in fact, different species.
Within the A and T biotypes 15 different serotypes (Fraser et
al., 1982a) have been identified by an indirect haemagglutination
(IHA) test (Biberstein et al., 1960), the specificity of which is
now known to reside within the capsular antigens (Adlam et al.,
1984). Serotypes 1, 2, 5, 6, 7, 8, 9, 11, 12, 13 and 14 belong
to the A biotype while serotypes 3, 4, 10 and 15 are T biotype.
Additionally, there are isolates that are untypable by the IHA test
and so far these have all been of the A biotype (Donachie et al.,
1984a).
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The A and T biotypes are associated with different types of
ovine pasteurellosis. The A biotype principally causes an enzootic
pneumonia in all ages of sheep, although lambs under two months of
age may develop a septicaemic form of disease. The T biotypes cause
a distinct form of systemic disease which is a cause of death in
older sheep and was first described by Stamp et al. in 1955.
In surveys, serotype A2 has been found to be the most common
isolate from cases of ovine pasteurellosis (Thompson et al., 1977;
Fraser et al., 1982b). In contrast, the serotype Al is the
predominant isolate in bovine pneumonic pasteurellosis (Wessman and
Hilker, 1968; Fox et al., 1971; Mwangota et al., 1978; Allan et
al., 1985). Differences in the prevalence of serotypes in disease
has led to suggestions that variations in virulence may occur
between serotypes, but Gilmour et al., (1986) failed to show any
clear differences in pathogenicity between serotypes Al, A2, A7 and
A9 in sheep.
b) The immunochemistry of the cell surface and extracellular
antigens of Gram-negative bacteria.
The Gram-negative cell-wall consists of a distinct
outer-membrane which lies external to a thin layer of
peptidoglycan. Together with the underlying cytoplasmic membrane
these layers form the Gram-negative cell envelope. The structure
of this envelope (Fig.1.1) has been described in most detail for
the Enterobacteriaceae and has been reviewed by Costerton, (1974)
and Rogers et al., (1981).
The cytoplasmic membrane: this trilaminar membrane encloses the
cytoplasmic contents. Its structure is similar to that of other
biological membranes (Martin and MacLeod, 1971) in that it consists
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of a phospholipid bilayer amongst which is dispersed intramembrane
and transmembrane proteins. The bacterial cytoplasmic membrane is
the site of synthesis and transport of cell wall materials which
are assembled outwith the cytoplasmic membrane and it also bears
receptor proteins involved in protein uptake (Costerton et al.,
1974).
The peptidoglycan layer: this lies exterior to the cytoplasmic
membrane and is an inelastic surround which is important in
maintaining the shape of the bacteria and withstanding the osmotic
pressures of the cytoplasm which might otherwise cause lysis.
The peptidoglycan (fig 1.1) is a thin layer in the Gram-negative
bacterial wall when compared to that found in the Gram-positive
wall . Peptidoglycan consists basically of three parts 1) a glycan
backbone, composed of a p 1-4-linked disaccharide repeating unit of
N-acetylglucosamine and fi 1-4 N-acetylmuramic acid; 2) a linear
tetrapeptide which usually includes diaminopimelic acid. The
tetrapeptide is attached to the lactyl group of the muramic acid.
3) there is also a peptide cross-linkage which connects adjacent
tetrapeptide chains. Together these linkages form a single
basket-like molecule of peptidoglycan which encompasses the whole
cell. Each of the regions is subject to compositional variations
which lead to antigenic diversity, but the nature of the
cross -linkage is the most variable feature of the structure
(Schleifer and Stackebrandt, 1983). The peptidoglycan layer is
attached via a low molecular mass lipoprotein (7.2 kDa in
Escherichia coli) to a trilaminar outer membrane (Braun , 1973) .
The outer-membrane: this consists of a bilayer which was first
discovered by electron microscopy (Birch-Anderson et al., 1953;
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Murray, 1957). A number of surface-labelling studies have
shown that the internal leaf of the outer membrane is phospholipid
in nature whilst the external leaf appears to consist largely of
lipopolysaccharide (LPS) (reviewed by Nikaido and Vaara, 1985) . A
general structure for LPS, proposed by Luderitz et al. , (1971),
shows it as a branching "0" antigen-specific side chain (somatic
antigen), a core region and a lipid A portion (Fig 1.2). The
0-antigen, because of the variety of structural forms, has
serological specificity and rough and smooth type LPS mutants have
been described for many Gram-negative species. The smooth type
bears long, branching 0-antigen chains and the rough-type mutants
lack the branching 0-antigen. The core region contains sugars
unique to prokaryotes, in particular an aldoheptose and a 3-keto
deoxyoctonic acid (KDO), the latter linking the core region to
lipid A. The lipid A portion is hydrophobic and thought to be
embedded in the inner area of the outer leaflet of the trilaminar
outer membrane, whilst the 0-antigen polysaccharide region is
hydrophilic and is presented on the outer surface of the outer
membrane (Fig 1.1).
Fifty percent of the outer membrane consists of proteins, some
of which (the porins) control the diffusion of solutes across the
membrane. The outer membrane, however, is not a site of active
transport but rather acts as a molecular sieve (Costerton,1979).
Some outer membrane proteins (OMP) such as the OMP A protein of
E.coli are external phage receptors (Palva, 1979). while others
such as the iron restricted proteins (IRP) are involved in iron
scavenging mechanisms and are inducible under certain conditions
such as those occurring in vivo (Hancock et al., 1976).
Fig. 1.1. A schematic diagram of the Gram-negative cell
envelope.
LPS = Lipopolysaccharide, P = Protein,
LP = Lipoprotein, PL = Phospholipid
Fig. 1.2. A schematic diagram of the lipopolysaccharide
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Both the LPS and OMPs of the outer membrane are potential
antigens and virulence factors of immunological and pathological
importance. The lipid A region of LPS is particularly accredited
with causing many pathophysiological effects (Majde and Person,
1981) and LPS was termed endotoxin to distinguish it from the
exotoxin of Vibrio cholera by Pfeiffer in 1892. However, the
physical state, namely the degree of aggregation of purified LPS,
has a profound effect on its biological activity (Luderitz et al.,
1982), and this may compromise toxicity studies undertaken with the
purified molecule.
Bacterial glycocalyx: external to the envelope components, many
Gram-negative bacteria posesss exopolysaccharide capsular layers,
which are included under the blanket term of a glycocalyx
(Costerton et al., 1981). Capsules can be visualised by light
microscopy, by negative staining with indian ink (Duguid, 1951) or
the congo red-acid fuchsin method (Maneval, 1941). Capsules can
also be stained with ruthenium red (Howard and Gourley, 1974) or
cationic ferritin (Weiss et al., 1979) for examination by electron
microscopy. Exopolysaccharides can be divided into homo- and
hetero- polysacchrides. Homopolysaccharides are composed of
single-sugar, long-chain molecules such as cellulose, levan and
glucan polymers. The sialic acid (N-acetylneuraminic acid) based
polymer found in the E. coli K1 (McGuire and Binkley, 1964) and
Neisseria. meningitidis group B (Bhattacharjee et al., 1975)
capsules is also a homopolysaccharide.
Heteropolysaccharides such as those found in Klebsiella species
are composed of two or more monosaccharides and frequently contain
uronic acids. P. multocida group A has a hyaluronic acid based
10
capsule which is a linear disaccharide of D-glucuronic acid- J3 (1-
3) N-acetyl-D-glucosamine and which may be involved in avoidance of
phagocytosis (Maheswaran and Thies, 1979).
Capsular antigens serve as important serotyping antigens for
some Gram-negative organisms such as Shigella. Pasteurella.
Neisseria. Klebsiella species and E. coli and may play an
important role in pathogenicity.
Other factors such as fimbriae, sex pili and flagella protrude
from the the cell wall and play important roles in attachment,
plasmid transfer and motility respectively. Flagella are open
protein-lattice structures specialised at the proximal end into a
hook and inserted into specialised sites in the cell-wall and
cytoplasmic membrane (McGroarty et al. , 1973). Fimbriae and pili
are used synonymously to describe those filamentous appendages
which insert into the cell-wall (Ottow, 1975). A distinction based
on function has however since been proposed by Jones and Isaacson
(1983) in which fimbriae are defined as those appendages involved
in bacterial adhesion and colonisation and pili are filaments which
are involved in gene transfer.
Flagella are used in serogrouping of some bacterial species such
as Salmonella species and E. coli. They are also associated with
colonisation and pathogenicity allowing some pathogens such as V.
cholerae to respond chemotactically to nutrient gradients (Freter
et al., 1981) and others such as Bordetella avium to progress in
the opposite direction to mucocilliary clearance (Arp and Cheville,
1984).
The presence of fimbrial types has been closely associated with
host specific pathogenicity of enterotoxigenic E. coli strains.
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Fimbriae bearing the K88, K99 or colonisation factor antigens (CFA)
are associated with adherence and proliferation (colonisation) in
the intestine of pigs, cattle and man respectively (Gaastra and de
Graaf, 1982).
Extracellular bacterial products: Gram-negative bacteria release
many extracellular products into their external environment. These
products include exotoxins, endotoxin, proteases and enzymes, many
of which are virulence factors and can be used to specifically
identify virulent strains of bacteria. In contrast to endotoxin
which is a heat-stable LPS, exotoxins are usually heat-labile
proteins. Protein toxins such as the E. coli heat-labile and
heat-stable enterotoxins (LT and ST), cholera toxin, pseudomonas
exotoxin A, shiga toxin and pertussis toxin are sub-unit toxins
which consist of two types of protein chain. E. coli LT and ST
have been found to be encoded by plasmids. However, more recently
an LT-II toxin which is encoded by chromosomal genes has been
identified (Green et al. , 1983).
E. coli LT and cholera toxin are antigenically similar and may
have evolved by plasmid transfer. They activate intracellular
adenylate cyclase, which promotes water efflux from gut epithelial
cells causing diarrhoea. Pseudomonas exotoxin A and shiga toxin
also act intracellularly by inhibiting protein synthesis (reviewed
by Eidels et al., 1983 and Middlebrook and Dorland, 1984).
Enzymes released by Gram-negative organisms include proteases.
N. meningitidis. N. gonorrhoea and E. coli produce proteases
that specifically split IgA (Plaut et al., 1975) which may help
these organisms to evade mucosal immunity. Most proteases such as
those of Pseudomonas aeruginosa are, however, probably involved in
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aiding the bacterium to obtain nitrogenous nutrients (Morihara,
1964).
Haemolytic substances can be divided into heat-labile proteins
including pbospborylases and the heat-stable haemolytic lipid or
lipoid substances. P. aeruginosa. for instance, produces two
haemolysins, one a protein baemolysin which is a phospholipase C
(Esselmann and Liu, 1961), whilst the other is a glycolipid
composed of two molecules of each of rhamnose and JB-hydroxydecanoic
acid (Jarvis and Johnston, 1949).
With the discovery of many exotoxins produced by Gram-negative
bacteria it was no longer possible to consider that endotoxin alone
was responsible for pathogenicity, but rather that a number of
cellular and extracellular products were involved .
c) The immunochemistry of the cell-surface and extracellular
antigens of P. haemolvtica.
A phenol/water extract (PWE) (Westphal, 1952) of P. haemolvtica
serotypes A1, A2 and A6 cell-wall was prepared by Donachie et al.
(1984b) and found to contain both KDO and heptoses, indicating the
presence of LPS. A sugar analysis by gas chromatography identified
the presence of mannose, galactose, glucose, two unusual heptose
sugars, glucosamine and galactosamine. Gel-filtration
chromatography of partially acid-hydrolysed Al PWE suggested that
the LPS was of the rough type, consisting of only a short
O-antigen. The PWE was also found to contain a serotype-specific
antigen which was detectable by the IHA test. However, on crossed
Immunoelectrophoresis (CIE), two precipitating antigens were
identified, of which, only one was serotype specific. Adlam et al.
(1985a) have since investigated highly purified capsular extracts
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of P. haemolvtica and concluded that serotype specificity resides
within this capsular antigen.
Perry and Babiuk (1984) investigated the composition of the P.
haemolvtica serotype T4 LPS and concluded that it is a smooth type
LPS with an unbranched, linear O-polysaccharide repeating unit of
D-galactose. The core consists of rhamnose, galactose, glucose,
two forms of glycero-D-mannoheptose, KDO and phosphate, while the
lipid A fraction contains myristic and ^5-hydroxymyristic acids,
2-amino-2-deoxy-D-glucose and phosphate. The structure of the LPS
from the A and T serotypes so far investigated therefore suggests
that the LPSs of the A biotype serotypes are of a rough type
while those of the T biotype serotypes may be smooth.
P. haemolvtica LPS has been demonstrated to have dermonecrotic
effects, haemodynamic effects, including the induction of a
biphasic leucocyte response (Keiss, 1964),cause lung lesions in
sheep similar to those seen in cases of pneumonia (Brogden et al.,
1984) and produce marked changes in carbohydrate metabolism of
sheep (Bruss et al., 1983).
The capsular polysaccharide of P. haemolvtica Al has a
structure similar to that of the enterobacterial common antigen
(Adlam et al., 1984) and is a polymer of N-acetyl-
D-mannosaminuronic acid linked 1,4 to N-acetyl-D-glucosamine. The
capsules of the T4 and T15 serotypes (Adlam et al., 1985a and Adlam
et al., 1985b respectively) have also been identified and are both
techoic acids. The T15 capsule is identical to the K62 capsular
polysaccharide of E. coli (Jann and Schmidt, 1980) and the N.
meningitidis group H polymer (Van der Kaaden et al., 1984). The T4
capsule differs only in that a phosphate is attached to the C4 of
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galactose instead of the C6 as in the T15 polymer. This difference
is, however, sufficient to give these capsules different antigenic
specificities.
Neither flagella nor fimbriae have yet been identified in P.
haemolvtica and the role of attachment in the pathogenicity of this
respiratory pathogen is uncertain.
Taxonomic studies by Smith and Thai (1965) and investigations of
nucleic acid homology (Biberstein and Francis , 1968) revealed
marked differences between the A and T biotypes of P. haemolvtica
and led the latter authors to suggest that the biotypes were
different species. Sutherland and Donachie (1985) however showed
that ovine isolates of both biotypes produce a cytotoxin which is
peculiar to P. haemolvtica and is therefore a shared
characteristic which supports the continued classification of these
two biotypes within the one species. The cytotoxin has not yet been
purified and its composition is therefore undetermined. It is,
however, known to be a specific leucotoxin and its activity can be
abrogated by treatment with trypsin (Baluyut et al. , 1981;
Sutherland and Redmond, 1986) , periodate and amylase (Chang e_t
al. , 1986) , suggesting that the cytotoxin has both protein and
carbohydrate moieties. Since this cytotoxin is leucotoxic it has a
potentially important role in pathogenesis.
The haemolytic activity of P. haemolvtica is an important
characteristic which distinguishes it from P. multocida, another
species which causes pneumonia in sheep and cattle. Whether P.
haemolvtica actually produces a true extracellular haemolysin has
not however been proven and its role in pathogenesis is uncertain.
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1.3. A description of the diseases of sheep caused by
P. haemolvtica.
a) Pneumonia.
The first description of ovine pneumonic pasteurellosis was
probably given by Montgomerie et al., (1938), who described the
disease as an ovine enzootic pneumonia. Biotype A strains are
responsible for pneumonic pasteurellosis in sheep of all ages, but
in lambs under two months of age a septicaemic form of the disease
is common (Gilmour, 1980). Many healthy sheep are carriers of P.
haemolvtica and in one survey, biotype A strains were the
predominant isolates (94%) from the nasopharynx while 65% of
isolates from the tonsils were of the T biotype Gilmour et al.
1974). Studies by Al-Sultan (1982) showed that colonisation occurs
soon after birth, and Shreeve and Thompson (1970) found that young
lambs reared with their dams acquired an increasing number of
serotypes as they grew older whereas lambs removed from their dams
harboured few typable strains. This may suggest that early
colonisation may occur by intimate contact with the suckling ewe.
Not all carriers however develop pasteurellosis, and evidence
for predisposing or concurrent factors such as environmental stress
(Harris, 1974) or infections caused by chlamydia (Dungworth and
Cordy, 1962; Biberstein et al., 1967), Parainfluenza type 3 (PI3)
virus (Hore et al., 1968; Davies et al. 1980; Sharp et al. 1978),
adenovirus (Belak et al. 1976; Davies et al. 1980 ), sheep
pulmonary adenomatosis (Sharp and Martin, 1983) and mycoplasma
(Jones et al., 1978; Gilmour et al., 1979) in its aetiology have
been reported as a result of both field and experimental studies.
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In Britain, most outbreaks of pneumonia occur between April and
July, with a peak appearance in May and June (Gilmour, 1980). In
affected flocks deaths can occur within 24 to 48 hours of the start
of an outbreak but mortality seldom exceeds 10% (Gilmour, 1980).
Other animals may show high temperatures (up to 42°C), tachypnoea
or dyspnoea, coughing and nasal and ocular discharges may be
obvious. Recovering animals may develop chronic lung lesions and
may be unthrifty thereafter.
Major pathological findings at necropsy include consolidated
pneumonic lesions usually of the apical lobes, pericarditis and
pleurisy, including a greenish gelatinous exudate and often large
volumes of straw coloured pleuritic fluid. Histologically, the
major features are alveolar necrosis, interlobular septae are
oedematous and lymphoid cell infiltration. A pathognomonic feature
of consolidated lesions is the presence of spindle-shaped pyknotic
cells called "oat-cells" which form swirls in inter-septal spaces
and are generally considered to be degenerate mononuclear cells
(Dungal, 1931; Downey, 1957; Stamp and Nisbet,1963 ), although
some workers have suggested that in bovine pasteurellosis they may
be dead neutrophils (Slocombe et al., 1985). Large numbers of P.
haemolvtica can generally be recovered from lesions and exudates
and in more chronic cases of the disease Mycoplasma ovipneumoniae
is also often isolated concurrently (Jones et al., 1978).
b) Systemic disease.
The systemic form of ovine pasteurellosis was first described by
Stamp et al. (1955) in Scotland and was later described in the USA
(Biberstein and Kennedy, 1959) . The disease is distinct from the
pneumonic form in that it involves the T serotypes of P.
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haemolvtica. it causes death only in weaned lambs and is associated
with the movement of sheep onto fresh pasture or turnips and rape
(Stamp et al. 1955; Suarez-Guemez, 1985). Prodromal signs are
rarely observed, and mortality can be as high as 20% in a flock.
Afflicted live animals are generally moribund and have a frothy
oral discharge. In this disease lung lesions are always present,
the entire lungs being distended and the air passages filled with
frothy fluid. Lesions can also be found in the liver, spleen,
alimentary tract, oesophagus and sometimes the kidneys. Large
numbers of organisms are usually recovered from these sites and
fewer numbers may also be isolated from the blood.
1.4. Experimental systems and models of infection with
P. haemolvtica.
a) Pneumonia.
In order to test the efficacy of experimental vaccines against
pneumonic pasteurellosis it was necessary to develop an
experimental system in sheep, or a model in laboratory animals in
which to reproduce the natural disease. Problems associated with
the experimental infection of conventionally-raised sheep were 1)
P. haemolvtica is an ubiquitous commensal of the upper respiratory
tract (Gilmour et al., 1974) 2) normal animals usually have serum
antibodies to P. haemolvtica derived from either prior exposure to
P. haemolvtica or perhaps other bacteria containing cross-reactive
antigens. These factors may explain the general resistance of sheep
to experimental infection that has been observed previously (N.
Gilmour, personal communication).
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However, Biberstein et al. (1967) using pulmonary intubation
produced a non-lethal disease in 43% of conventionally-reared
animals which was similar in its pathology to the natural disease.
The proportion of animals susceptible to this infection was
increased with a predisposing chlamydial infection, indicating the
possible importance of synergistic microbial infections in
pneumonic pasteurellosis. Jones et al. (1978) also successfully
infected conventional lambs with P. haemolvtica after
pre-disposition with mycoplasma infection. The pneumonia produced,
however, was not the classical enzootic pneumonia described for the
majority of field cases of pneumonic pasteurellosis (Montgomerie et
al., 1938) but had the characteristic pathology of a chronic
pneumonia and was termed "atypical pneumonia" (Gilmour et al.,
1979).
Gilmour et al. (1975), using hysterectomy-derived, colostrum
deprived lambs which were fed on sterilised milk and concentrates
and designated specific pathogen free (SPF) lambs produced
pneumonia in 40% of infected lambs. This was later increased to
90% when lambs were predisposed with PI3 virus seven days before an
aerosol of P. haemolvtica (Sharp et al., 1978). This has since
become the accepted method for consistent experimental reproduction
of ovine pneumonic pasteurellosis at the Moredun research institute
The use of SPF lambs for experimental infection and vaccine
studies is however costly and dependent upon the seasonal
availability of lambs. Because of this many attempts have been
made to develop small animal models of P. haemolvica infection.
However it has been found that P. haemolvtica is non-pathogenic in
various laboratory animals including cats, dogs, hens, pigeons,
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rabbits and guinea pigs (Dungal, 1931; Lovell and Hughes, 1935;
Beveridge, 1937 and Montgomerie et al. , 1938). P. haemolvtica is
also of low pathogenicity in mice, but Smith (1958) developed an
intraperitoneal (IP) model of infection which used mucin to
increase virulence. This simple model only recorded death or
survival and was improved upon by Evans and Wells (1979) , who
enumerated bacteria in the liver of infected animals. The latter
model was used successfully to demonstrate significant protection
in vaccinated mice. However, one objection to the mouse model and
one which Evans herself alluded to (Evans, 1979) was that it had
no resemblance to the mode of natural infection,and that the
immunological response elicited in the peritoneum was likely to
differ from that generated in the lung.
Differences in the immunological response of the mouse to P.
haemolvtica compared to the sheep have also assumed much more
importance with the finding that a cytotoxin produced by P.
haemolvtica. which is specifically lethal for leucocytes of
ruminants (Benson et al., 1978; Sutherland et al., 1983 Richards
et al. , 1982), is not toxic for mouse leucocytes (A.D. Sutherland,
unpublished findings). In view of these shortcomings, the use of a
mouse model for ovine pasteurellosis was not attempted in this
thesis.
b) Systemic pasteurellosis.
Reproduction of systemic pasteurellosis in sheep with T biotype
P. haemolvtica has not yet been entirely successful . Inoculation
9 9 -1
of 1 x 10 colony forming units per ml (cfu ml ) of type T
organisms caused death in adult sheep (Smith, 1960) but this number
of organisms was only marginally lower than the number of killed
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organisms required to cause death suggesting that death was caused
by endotoxaemia alone.
Suarez-Guemez et al. (1985) produced systemic T biotype disease
in sheep treated with hydrocortisone and in which dietary
alterations had induced acidosis. Hydrocortisone is
immunosuppressive and the value of this system for studying
vaccination is therefore dubious. Attempts to predispose animals to
disease by inducing acidosis alone failed (N. Gilmour, Personal
communication), perhaps indicating the necessity for
immunosuppression in this system. The absence of a reliable and
acceptable method for the reproduction of systemic pasteurellosis
currently hampers progress in vaccination and pathogenesis studies.
1.5. Vaccination against P. haemolvtica serotype A in lambs.
Doubts about the efficacy of commercial vaccines against
pneumonic pasteurellosis have been expressed (Gilmour et al., 1979;
Gilmour, 1983; ADAS., 1984) and have prompted several suggestions
as to why these vaccines may be ineffective. For example,
infections in flocks may be due to serotypes not included in the
vaccines, the antigens in these vaccines may not be appropriate
for protection or they may not be presented in the best manner or
with the most efficient adjuvant.
With many developments culminating in a successful experimental
infection system for reproducing pneumonic pasteurellosis in SPF
lambs (Sharp et al., 1978) the efficacy of vaccines to combat this
disease could be tested. In 1983, Gilmour et al. showed that
serotype specific protection could be obtained against pneumonic
pasteurellosis in SPF lambs using sodium salicylate extract (SSE)
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vaccines. These SSE vaccines gave significant homologous
protection against serotypes Al, A6 and A9 but were poorly
protective against the A2 serotype which required the addition of
heat killed organisms to SSE vaccines to give reasonable
protection. Also, there was no heterologous protection observed
with SSE vaccines ( Gilmour et al., 1979).
The poor protection against the A2 infection by SSE vaccines was
worthy of particular note since this serotype has been shown in two
surveys to be the most prevalent isolated from field cases of the
disease (Thompson et al., 1977; Fraser et al., 1982b). Because of
this poor protection against serotype A2 and a lack of heterologous
protection, research on vaccines has continued to search for
improvements in these areas.
One central hypothesis to the development of new effective
vaccines against the A2 serotype was that previous vaccines did not
contain the correct protective antigens and that if these could be
identified and incorporated into vaccines, protection against A2
infection would be possible. In order to prove that it was
possible to protect against A2 infection, Donachie et al. (1986a)
treated lambs experimentally infected with P. haemolvtica with
antibiotics as soon as they showed signs of disease. These
"convalescent" lambs were then exposed to a second challenge of PI3
virus and P. haemolvtica A2 (Sharp et al., 1978). These lambs
were highly immune to the second challenge, thus proving that
immunity to serotype A2 was possible. Additionally, serological
analysis indicated that some humoral imune mechanisms correlated
with protection while cell-mediated immunity (CMI) was not
stimulated. These findings were in contrast to those of Wells et
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al. (1979), who concluded that since passive transfer of immune
serum failed to give protection against P. haemolvtica infection
CMI was probably of more importance than humoral immunity. An
alternative conclusion in view of the findings of Donachie et al.
(1986a) might support the idea that for antibodies to be protective
they must be raised against the correct antigens.
1.6. The interaction of effector mechanisms of immunity with
P. haemolvtica.
a) Mechanisms of immunity in the lung.
Non-specific innate barriers (Table 1.2) provide the initial
resistance of the host to microbial invasion of the mucosal
surfaces including the lung. However, the ability of specific
effector-mechanisms of immunity to combat the establishment of
infection by microbial pathogens is of more importance in terms of
vaccine strategy since these, once primed, can retain
immunological "memory" which responds when infection is
encountered. Immunity to extracellular bacterial pathogens such as
P. haemolvtica is generally recognised as being mediated by
humoral immunity whereas protection from intracellular pathogens
such as Listeria monocytogenes and Salmonella typhimurium is more
dependent upon CMI and especially on the T-lymphocyte activation of
macrophages (Sharma and Remington,1980). Since P. haemolvtica is
an extracellular pathogen, only the mechanisms of immunity related
to infection by extracellular pathogens will be considered here.
In recent years the lung has been recognised as having a
distinct mucosal immune system which may be independent in part
from the systemic immune system. This mucosal immune system was
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termed the bronchus-associated lymphoid tissue (BALT) in line with
the term gut-associated lymphoid tissue (GALT) (Bienenstock et al.,
1973). These mucosal immune systems provide local CMI, and locally
synthesised secretory IgA (slgA), IgG and IgM contribute to local
humoral immunity (Tomasai and Bienenstock, 1968; Tomasai, 1976).
IgG is the predominant class of immunoglobulin in the lower regions
of the sheep lung (Gorin et al., 1979) while IgA dominates the
upper respiratory tract (Watson and Lascelles, 1971). Transudation
of immunoglobulin and other factors from serum may also contribute
to local immunity. Wells et al. (1977a) found that
radio-labelled IgGl and IgG2 were transported from serum to sheep
nasal secretions. Passively acquired IgG to PI3 virus was
detectable in nasal secretions of colostrum fed lambs (Smith,
1975; Smith et al., 1976) and passive transfer of immune serum
protected swine against mycoplasmal pneumonia (Lam and Switzer,
1971) and cattle against bovine pleuropneumonia (Masiga e_t a_l. ,
1975) . Wells et al. (1977b) suggested that passively acquired
maternal IgG represented an important humoral defence at the
mucosal surfaces prior to active production of IgA and IgM .
In the lower lung the alveolar macrophage is considered
initially to be the major means of particle clearance and
facilitates the inactivation of infectious microorganisms (Reynolds
and Newball, 1976) and generally it is thought that the phagocytic
macrophage can eliminate small amounts of bacteria which enter the
lung. However, during active infection or inflammation
polymorphonuclear leucocytes (PMNL) and monocytes (MO) may be
recruited to the lung to augment the phagocytic potential of the
resident macrophage pool (Davies and Penwarden, 1981).
25
Attraction of PMNL and MO to the lung occurs by the release of
chemotaxins or chemotaxinogens. Chemotaxins stimulate chemotaxis
directly and may be host derived factors such as the C5 des arg
complement fragment (Fernandez et: al.,1978) and prostaglandin E or
bacterial products (Keller and Sorkin, 1967; Ward et al-> 1968;
Schiffmann et al., 1975). Chemotaxinogens indirectly cause
chemotaxis usually by complement activation. Bacterial
chemotaxinogens include LPS (Morrison and Ulevitch, 1978) and
peptidoglycan (Verbrugh et al., 1980).
PMNL are more active in phagocytosis of bacteria than are
mononuclear cells (Steigbigel et al., 1974) and once internalised,
bacteria can be attacked by hydrolytic enzymes (Spitznagel and
Schafer, 1985) and microbicidal oxygen intermediates (Beaman and
Beaman, 1984) leading to intracellular killing and degradation.
PMNL can also secrete degradative enzymes such as lysozyme, and
cationic proteins (Weiss et al., 1978) which can cause
extracellular killing (Pryzwansky et al., 1979).
Phagocytosis of particles, including bacteria, can be enhanced
by opsonins. The complement component C3b can attach directly to
bacterial surfaces or can combine with antibody bound to surface
antigens. Professional phagocytes have special receptors on their
surfaces for C3b which promote the more rapid and increased
attachment of the opsonised particle (Rabinovitch, 1975).
In the immune animal, immunoglobulins, the Fc region of which
can be recognised by receptors on the phagocyte membrane, also act
as opsonins. Silverstein et al. (1963) identified four classes of
immunoglobulins in the sheep by immunoelectrophoresis. These were,
IgGl (fast 7S# or 7Sjfl), IgG2 (slow 7S* or 7S2T2) , IgM (£2M or #1M)
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and IgA (^2A or &1A) . Since then a subclass of IgGl (IgGla)
(Curtain, 1969) and IgG3 (Babel and Lang, 1976) have been
described. The presence of IgD (Heimer et al., 1969) and IgE (Pan
et al. , 1968) has also been reported. Watson (1976) has found the
sheep IgG2 subclass of inraiunoglobulin to be a major opsonin, while
in the human, only IgGl and IgG3 are opsonic (Griffin et al.,
1977). IgA has been generally considered to be non-opsonic and also
unable to fix complement. IgM is also poorly opsonic but unlike
IgA it binds complement very efficiently and may promote
opsonisation via C3b receptors.
Glass e_t al. (1981) have also shown the presence of
"lectin-like" receptors on phagocyte membranes which can
specifically bind bacterial surface ligands to promote phagocytosis
independently of opsonins. Binding of S. albus to these
"lectin-like" receptors was inhibited by 10 mM D-galactose which
may have been an analogue of the bacterial surface ligand.
Complement can be directly bactericidal for many Gram-negative
bacterial species by virtue of the membrane attack complex (C5b to
C9). This complex can be activated via the alternative or the
classical complement pathways (Fig. 1.3.). The role of antibodies
in activating the classical pathway probably makes this the most
important method of stimulating bactericidal activity with regards
to actively-acquired immunity, since it can be manipulated by
vaccination with suitable antigens.
Little evidence is available to indicate that complement
mediated bactericidal activity operates at mucosal surfaces.
Physiological conditions in the gut and urinary tract are unlikely
to support complement and the activity of complement in the lung is
Fig. 1.3. Diagram of the classical and alternative
pathways of complement activation.
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largely undetermined. Jonas and Broad (1972) found a sheep lung
washing did not cause haemolysis of antibody-rabbit red blood cell
complexes. However, the lung washing could restore the haemolytic
activity of sera which were depleted of individual complement
components, suggesting that these factors were present in the lung
wash. Complement consists of a number of labile components and it
is perhaps possible that some of these did not survive the
processing of the lung washing. Burrells (1986) found that C3
acted as an acute-phase reactant when levels increased in the lungs
of sheep infected with PI3 virus and P. haemolvtica. It is
possible that complement factors, like immunoglobulins, are
transudated into the lung during active infection. The role of
complement as an acute-phase reactant has been reviewed by Atkinson
and Frank (1980).
Besides being opsonins and mediating bactericidal activity,
immunoglobulins can directly neutralise and inhibit the function of
bacterial antigens and virulence factors. Since it is not opsonic
and does not combine with complement, the major anti-bacterial
activity of slgA appears to be inhibition at the mucosal surface
(Williams and Gibbons, 1972). Agglutination, inhibition of
motility and of toxins are also attributed to immunoglobulin
function at the mucosal surface.
b) Perturbation of ovine immune mechanisms by P. haemolvtica.
Amongst pathogenic bacteria there are a plethora of cellular and
extracellular pathogenic determinants which can cause perturbation
of host defence mechanisms. These pathogenic determinants have
been the subject of many monographs, reviews, colloquia and books
(Smith, 1977; Steele et al., 1977; O'Grady and Smith, 1980;
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Easmon et al., 1983 and Falcone et al., 1984) which show that each
pathogenic species is equipped with pathogenic determinants and
that strain virulence is usually associated with the expression of
one or more of these determinants in which case they are termed
strain virulence factors (Smith, 1977).
Serotypes of P. haemolvtica express a number of virulence
factors which may be involved in a) stimulation b) avoidance /
inhibition or c) destruction of host effector mechanisms of
immunity. These factors include 1) capsule, 2) LPS, 3) cytotoxin,
4) haemolysin, 5) protease(s) and 6) neuraminidase. It is
uncertain, however, what role if any each of these factors may play
in pathogenesis and of what value they may be as vaccine antigens.
Capsule: the presence of a hyaluronic acid capsule has been
associated with avoidance of phagocytosis by P. multocida type A
strains opsonised with immune and non-immune sera (Maheswaran and
Thies, 1979; Anderson et al., 1984). However, the presence of
antibodies directed against the capsular antigens of strains of
other bacteria such as Streptococcus pneumoniae (Giebink et al.,
1977) and E. coli (Van Dijk et. al. , 1979) has been associated with
an increase in phagocytosis due to opsonisation. As early as 1945,
Macleod et al. found that capsular vaccines were protective
against capsulate serotypes I, II, IV and VII of the pneumococcus
and natural protection has been associated with opsonic antibodies
directed against capsular antigens (Bateman and Rowley, 1969)
suggesting that phagocytosis involving anti-capsular antibodies is
important in protection.
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Extrapolation from these studies indicates that while the
antigenically specific capsules of P. haemolvtica serotypes may be
involved in the avoidance of phagocytosis in the non-immune animal,
they may also be capable of stimulating protective opsonic
antibodies if included in vaccines.
SSE vaccines were found to be protective against homologous P.
haemolvtica Al, A6 and A9 infections but not against heterologous
challenge (Gilmour et aj.., 1983). Protection appeared to be
associated with anti-capsular antibodies, in that IHA titres were
raised by vaccination with the Al vacccine which gave homologous
protection, but an A2 SSE vaccine which was poorly protective did
not stimulate IHA titres. Correlation of IHA titre with the
response to challenge by individual animals was however not
successful. It can be speculated that the Al SSE vaccine may have
increased opsonophagocytosis by stimulating anti-capsular
antibodies. This would also have accounted for the serotype
specific protection observed.
The serotype A2 capsule is poorly immunogenic in mice (Evans and
Wells, 1979), rabbits and sheep (Gilmour et al., 1979) and this may
account for the poor protection given by serotype A2 SSE vacines.
However, "convalescent" lambs produced by Donachie et al. (1986a)
were immune to a subsequent homologous A2 infection and immunity
was associated with opsonic antibodies detected in their sera and
lung washings.
Capsules have also been implicated in inhibition of phagocytosis
and complement-mediated bacterial killing by masking somatic
antigens. For example, although staphylococcal capsules do not
prevent binding of opsonins to cell-surface antigens (Peterson et
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al. , 1978), they do however prevent increased phagocytosis by
inhibiting the interaction of opsonins with phagocyte receptors
(Wilkinson et al., 1979). MacDonald et al. (1983) however showed
that a bovine isolate of serotype Al P. haemolvtica was
susceptible to the bactericidal effects of the classical complement
pathway, but no attempts were made to correlate this activity with
protection against disease.
LPS: biotype A serotypes are believed to possess rough type LPS
by their elution characteristics on gel-filtration columns
(Donachie et al., 1984b). In contrast, the T4 serotype has a smooth
type LPS (Perry and Babiuk, 1984). P. haemolvtica LPS has been
shown to have many of the pathophysiological effects of endotoxin
(Keiss, 1964; Rimsay et al., 1981). Brogden et al. (1984) found
that P. haemolvtica Al LPS, when injected into the sheep lung
elicited a biphasic leucocyte response typical of endotoxin. LPS
instillation also induced an influx of neutrophils into the lung,
suggesting that P. haemolvtica LPS may be a chemotaxinogen.
Because of these findings, LPS has been considered to be important
in the pathogenesis of pneumonic pasteurellosis. Protection
against pasteurellosis might therefore include the production of
antibodies which can inhibit endotoxin. LPS has also been found to
be an important antigen in complement mediated bactericidal
activity against Gram-negative bacteria (Glynn and Ward, 1970;
Tramont et al. , 1974) . Donachie et al. (1984b) found that PWE
vaccines containing LPS could protect mice against experimental P.
haemolvtica challenge.
Cytotoxin: this is probably the most important virulence factor
of P. haemolvtica. The P. haemolvtica cytotoxin is a bacterial
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cell-free toxin (an exotoxin) that specifically kills leucocytes of
sheep (Sutherland et al. 1983; Sutherland, 1985), cattle (Benson
et al. , 1978; Maheswaran et al., 1980; Walker et al., 1980;
Markham and Wilkie, 1980; Berggren et al., 1981; Shewen and
Wilkie, 1982a) and goats (Chang et al., 1982; Richards et al.,
1982) but not those of non-ruminants (Sutherland et al., 1983). The
apparent specificity of P. haemolvtica cytotoxin for ruminant
leucocytes suggests the requirement for a specific receptor for the
mediation of toxicity. That the cell types affected are of the
naturally infected hosts of P. haemolvtica lends further support
to the idea that this leucocidin is an important pathogenic
determinant of this organism.
A notable feature of experimental pneumonic pasteurellosis in
sheep is the consistent recovery of high numbers of P. haemolvtica
from the lungs of animals in the early phases of disease (Sharp et
al., 1978; Rushton et al., 1979; Davies and Penwarden, 1981).
Proliferation of P. haemolvtica may be a consequence of functional
impairment of alveolar macrophages by the cytotoxin. Even at
sub-lethal doses the cytotoxin has been shown to inhibit the
production of chemotactic factors by bovine alveolar macrophages
(Markham et al., 1982). The importance of neutrophil chemotactic
response in pasteurellosis is suggested by the findings of Davies
and Penwarden (1981), who noted that the clearance of P.
haemolvtica from the lungs of infected sheep was coincident with
the influx of PMNL. Neutrophils are more avid in phagocytosis of
bacteria than macrophages and bovine neutrophils have been found to
be less susceptible to cytotoxin than macrophages (Markham et al.,
1982). These may be essential attributes which allow recruited
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PMNL to clear P. haemolvtica from the infected lungs of sheep and
cattle.
Cytotoxic activity can be neutralised by antibodies produced in
calves by vaccination with live P. haemolvtica (Baluyut et al.,
1981), and several necropsy studies have correlated resistance to
bovine pasteurellosis with antibody titres to cytotoxin (Shewen and
Wilkie, 1982b; 1983a; Cho et al., 1984; Gentry et al., 1985a).
Shewen and Wilkie (1983b) also showed cross-neutralisation of the
cytotoxin produced by twelve serotypes of P. haemolvtica with
rabbit antisera raised against them. This extracellular toxin is
unlikely to have been present in previous cell-extract vaccines
used experimentally and commercially against ovine pneumonic
pasteurellosis, and therefore has the potential to be a novel
antigen with possible cross-protective capacity.
Haemolysis: attempts have been made to determine whether P.
haemolvtica cytotoxin is responsible for the haemolysis displayed
by this organism on sheep blood agar. Culture supernatants with
leucocidal activity were not, however, haemolytic for sheep or
cattle red blood cells (Baluyut et al., 1981). This work
therefore questioned whether P. haemolvtica produces an
extracellular haemolysin.
Lui (1959) demonstrated that haemolysis produced by V. cholera
on blood agar was not due to a true haemolysin but rather to lysis
of red blood cells by alkaline conditions brought about by colony
growth. Paradoxically, production of a true haemolysin was shown
to occur at pH 7.0. It is possible that haemolysis by P.
haemolvtica is also attributable to the effects of bacterial
fermentation . However, a role for haemolysis in pathogenesis has
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been suggested by the finding that injection of haemoglobin with P.
haemolvtica enhances infection in mice (Chengappa et al., 1983;
Al-Sultan and Aitken, 1984). This increased disease presumably by
making iron more readily available for bacterial growth. On the
basis of these studies, further work to identify the cause of
haemolysis by P. haemolvtica and the posssible role this attribute
has in pathogenesis and immunity seems merited.
Protease: P. haemolvtica produces an extracellular neutral
protease (Otulakowski et al., 1983) which attacks
sialoglycopeptides. These authors speculated that this protease
may contribute to virulence by either unmasking receptors for
cytotoxin on macrophage membranes or by cleaving a possible proform
of the cytotoxin.
Neuraminidase: Tabatabai and Frank (1981) first described the
presence of a neuraminidase in the supernatant of P. haemolvtica Al
cultures which was inhibited by antibodies raised against it in
rabbits. Neuraminidase production has since been observed in the
majority of other serotypes (Frank and Tabatabai, 1981;
Otulakowski et al., 1983), but only the latter authors found
neuraminidase to be produced by the A2 serotype.
All of the above virulence factors may be important antigens
against which various mechanisms of immunity may contribute to the
elimination of infection. Consequently, in the formulation of
effective vaccines it may be important to include a number of these
antigens. In a multifactorial vaccine approach, many mechanisms
of immunity may be stimulated which may work in synergy or
individually if circumstances dictate to erradicate infection.
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1.7. Aims of the thesis.
This thesis formed part of a project to determine the antigens
and mechanisms of immunity involved in protection against ovine
pneumonic pasteurellosis caused by serotype A2 P. haemolvtica. The
aim of the work was to identify and characterise antigens and
virulence factors of P. haemolvtica which can modulate host
mechanisms of immunity and are therefore of potential importance in
vaccine formulations. At the outset, the hypothesis was formed
that the production*of cytotoxin neutralising (CN) antibodies by
vaccination may contribute to protection against ovine pneumonic
pasteurellosis. CN antibodies may help to prevent disease at the
earliest stages of infection by increasing bacterial clearance,
due to reduced phagocytic cell death (which may also prevent
adverse inflammatory responses), and increasing lymphocyte
responsiveness. It was however considered that cell-surface
antigens would be required in effective vaccines to induce
bacterial clearance by enhanced opsonophagocytosis or by
stimulating antibody-activated complement-mediated bacterial
killing.
It was considered that factors of particular importance were:
1) characterisation of P. haemolvtica cytotoxin and an assessment
of the value of a cytotoxin preparation as a vaccine antigen 2) an
assessment of the role of serum CN antibodies and
opsonophagocytosis in immunity 3) the susceptibility of P.
haemolvtica serotypes to serum killing. The role of this effector





Unless otherwise stated, the following P. haemolvtica serotype
strains were used throughout this thesis: serotype Al, strain
V1763; serotype A2, strain T884; serotype T3, T635; serotype T4,
R317; serotype A5, T683; serotype A6, D0133; serotype A7, D0800;
serotype A8, C53; serotype A9, D0775; serotype T10, D0770;
serotype All, D0759h; serotype A12, N498; serotype A13, D0804;
serotype A14, 22.7.87; serotype T15, D0685; serotype A16,
26.10.87. Strains were stored at -70°C in nutrient broth (Oxoid) in
0.5 ml volumes and thawed as required.
2.2. Production of P. haemolvtica cytotoxin.
Cytotoxin was expressed in supernatant fluids of dialysis sac
cultures and prepared as described by Sutherland (1985). Dialysed
and lyophilised supernatant fluid, termed crude cytotoxin, was
prepared as described by Sutherland and Redmond (1986).
See flow chart at the end of Section 2.
2.3. Preparation of P. haemolvtica A2 SSE and LPS.
The SSE and LPS were prepared from P. haemolvtica organisms as
described by Donachie et al. (1984b).
See flow charts at the end of Section 2.
2.4. Polyacrylamide gel electrophoresis (PAGE).
2.4.1. Sodium dodecyl sulphate (SDS)-PAGE.
The SDS-PAGE was performed on 10% gels by the method of Laemmli,
(1970) using a slab-gel apparatus (Bio-Rad, U.K.) and a power pack
(Pharmacia Ltd, Milton Keynes. U.K.). Samples were run at 13 mA
37
limiting current per gel until the dye-front reached the bottom
of the gel . After electrophoresis gels were stained with either
silver or Coomassie blue dye by the methods of Morrisey (1981).
2.4.2. Detection of proteases by PAGE.
Proteases were detected in P. haemolvtica serotype A1 and A2
crude cytotoxin preparations by a modification of the method of
Heussen and Dowdle (1980) for detecting enzyme activities in
SDS-PAGE gels containig suitable substrates. Samples (1 mg) of
crude cytotoxin were resuspended in: a) SDS-PAGE solubilising
buffer which did not contain 2-mercaptoethanol. The samples were
not heated before loading onto gels b) normal SDS-PAGE solubilising
buffer and the samples were heated at 100°C before loading. Samples
were loaded onto 10% SDS-PAGE gels containing 0.1% azocasein
(Sigma, U.K.) which was incorporated into gels as a substrate.
Casein was found to be a digestible substrate for protease
activities in crude cytotoxin preparations by Otulakowski et al.
(1983). Samples were run at 13 mA per gel as described above. When
electrophoresis was completed gels were washed in 2.5% aqueous
Triton X100 (Sigma) for 1 hour at room temperature. Gels were then
rinsed in distilled water three times and incubated in 0.1 M
glycine pH 8.3 buffer for 48 hours at room temperature. Proteases
were shown by negative staining in which digested areas of
substrate were detected in gels stained in Coomassie blue dye
(Morrisey, 1981).
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2.4.3. Detection of LPS in proteinase K digests by SDS-PAGE.
Proteinase K (Sigma) digests of P.haemolytica whole cells (5 mg
ml ■*") were prepared by the method of Hancock and Poxton (1988) and
the structure of the LPS of various serotypes of P.haemolvtica was
examined by running digests on SDS-PAGE. Gels (10%) were prepared
on a midget-gel apparatus (LKB, Sweden.) and loaded with 10 /rl of
each digest. Gels were run at a constant voltage (100 V) until the
dye-front reached the bottom of the gel. Gels were stained with
silver by the method of Tsai and Frasch (1982) to visualise LPS.
2.5. The protocol for inducing "convalescence" in SPF lambs.
The protocol for inducing "convalescence" in SPF lambs was
described by Donachie et al. (1986a). Table 2.1 outlines the
experimental protocol used to induce "convalescence" in group 1 SPF
lambs while the other (group 2) lambs remained untreated. These
groups were then experimentally challenged with parainfluenza type
3 (PI^) virus followed by homologous P. haemolvtica A2 strain as
indicated in Table 2.1.
Fig. 2.1. SDS-PAGE of affinity chromatography purified
IgG (arrows) from a "convalescent" lamb serum,
lane 1, 10 pi of IgG; lane 2, molecular mass
standards.
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Table 2.1. Experimental protocol to produce "convalescence" in SPF
lambs (see text p 38).























2.6. Purification of IgG from "convalescent" immune serum.
Sheep IgG was purified from a "convalescent" lamb serum by
affinity-column chromatography. The column was a pig anti-sheep IgG
(Fab£) ligand bound to Sepharose 4B (Pharmacia, U.K.) and was
donated by Mr. A. Dawson. A volume (10 ml) of "convalescent" lamb
serum (at 2.27 g IgG L ^) was loaded onto the column. Loading of
the serum and elution of the IgG was done as described in the
affinity chromatography handbook (Pharmacia). The desorbed IgG
fractions (60 ml total volume) were pooled and dialysed overnight
against 0.05 M Tris/HCl buffer pH 7.0. The IgG fraction was then
concentrated and exchanged with phosphate-buffered saline pH 7.2
(PBS) on a collodion bag apparatus (Sartorius, U.K.) and finally
adjusted to an IgG concentration equivalent to that in the original
whole serum (2.27 g 1 ^). The IgG was shown to be purified by
running a sample (10 pi) on SDS-PAGE (12.5% gel) along with 5 pi of
molecular mass markers composed of Sigma type G8511 and M3889 plus
BDH type 44261 2F markers, reconstituted as recommended. The IgG
was identified as consisting of a 53 kDa heavy chain and a 26 kDa
light chain (Fig 2.1.).
2.7. Immunoblotting of P. haemolvtica antigens.
Dot blotting of P. haemolvtica antigen preparations was
performed by adding 2.0 ul volumes of the antigen preparation to
strips of BA 83 nitrocellulose paper (Schleicher and Schuell,
Dassel, W. Germany) and allowing the antigen to air-dry. Western
blotting of antigens resolved on SDS-PAGE gels was performed by the
method of Burnette (1981) as modified by Herring and Sharp (1984).
After the antigens were bound to nitrocellulose, the
nitrocellulose was blocked in 50% FBS in wash buffer (PBS pH 7.2
containing 0.5% Tween 20 (Sigma), 0.037% EDTA and 2.5% Na Cl) for 1
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hour at 37oC and then washed three times quickly in wash buffer
followed by three 10 min washes in wash buffer. The blocked
nitrocellulose was then incubated at 37oC for 1 hour in wash buffer
containing a 1 in 200 dilution of donkey anti-sheep IgG conjugated
with horse radish peroxidase (HRP) (Scottish Antiserum Production
Unit, Law hospital, Carluke). The nitrocellulose was again washed
three times quickly and three times for 10 mins in wash buffer.
Blots were developed by adding the substrate (5 mg of
diaminobenzidine) (Sigma) together with 20 ^ul of ^ m"'*
substrate buffer (0.1M Tris/HCl pH 7.4) and developing for 5 mins.
Development was stopped by running the blot under tap water.
2.8. Statistical analysis.
All analysis was done using the "Minitab" statistical
computer-programme package (Minitab, State College, Pennsylvania.
USA.). Significance testing between grouped data was done by the
two-sample T-test unless otherwise stated. Correlations between
data were calculated using the Spearman rank correlation
coefficient test.
* In Section 4, before the addition of anti-sheep IgG conjugate,
specific T10 sera were added to the blot at a 1 in 50 dilution in
wash buffer. The blot was incubated in the sera at 37°C for 1
hour, washed three times quickly and three times for 10 mins in
wash buffer. In Section 5, the addition of exogenous specific
antibody to the blot was omitted.
Flow chart of the production of P. haemolvtica crude cytotoxin by
dialysis sac culture
Defrost 0.5 ml aliquot of P. haemolvtica from -70°C
and inoculate into 50 ml of nutrient broth (NB).
Incubate 37 C overnight (static)
<7
Pellet bacteria (5,000 g for 30 mins), wash xl in
phosphate buffered saline pH 7.2 (PBS)
<7
Resuspend bacterial pellet in 400 ml of PBS and
inoculate 20 ml volumes into the lumen of sterile
dialysis sacs (9 inch) sealed at one end and
suspended in 500 ml of NB. Incubate on a shaker at
100 rpm at 37 C for the required period.
Collect sac contents and pellet bacteria (5,000 g
for 30 mins). Filter sterilise supernatant fluid
through a 0.45 jjM membrane. Place supernatant fluid
in a dilaysis sac and dialyse exhaustively (several
changes over 36 hours) against distilled water at
4°C.
<7-
Lyophilise dialysate (crude cytotoxin) and weigh.
Flow chart of the production of P. haemolvtica cell wall sodium
salicylate extract (SSE).
Defrost 0.5 ml aliquot of P. haemolvtica from
-70 C. Inoculate into 50 ml of nutrient broth (NB).
Incubate 37 C overnight (static).
Inoculate 30 ml of culture into 3 1 of NB, incubate
37 C for 6 hours on an orbital shaker at 100 rpm.
Pellet bacteria at 5,000 g for 30 mins and resuspend
in 300 ml of 1M sodium salicylate. Shake suspension
at 37°C for 3 hours.
<7
Pellet bacteria (30,000 g for 30 mins at 4 C) and
dialyse supernatant fluid against phosphate buffered
saline pH 7.2 (PBS) fo 48 hours.
Concentrate dialysate to 30 ml by ultrafiltration on
a YM 100 membrane (Amicon)
Dialyse retentate against distilled water for 48
hours at 4°C and lyophilise.
Flow chart of the production of P. haemolvtica lipopolysaccharide
(LPS).
Defrost 0.5 ml aliquot of P. haemolvtica from
-70 C. Inoculate into 50 ml of nutrient broth (NB).
Incubate 37 C overnight (static).
Inoculate 30 ml of culture into 3 1 of NB, incubate
37 C for 18 hours on an orbital shaker at 100 rpm.
Pellet bacteria at 5,000 g for 30 mins and resuspend
in 50 ml of distilled water (DW).
o
Warm bacteria suspension to 68 C and add to 50 ml of
90% aqueous phenol at 68 C. Maintain at 68 C for 10
mins.
Remove the mixture and cool on ice until phase
separation occurs. Centrifuge at 5,000 g for 30
mins at 4 C.
__
Collect upper (aqueous) phase and dialyse for 36




Detection and—Some Characterisation of P_. haemolvtica A2
Cytotoxin and Cytotoxin Neutralising Antibody.
Live organisms of all the known serotypes (1 to 15) of P.
haemolvtica have been shown to be cytotoxic for ovine macrophages
(Sutherland and Donachie, 1985). Culture supernatant fluid from
serotype Al was also found to be lethal for ovine macrophages
(Sutherland et al. , 1983) , PMNL and lymphocytes obtained from
peripheral blood, and gastric duct derived lymphocytes (Sutherland,
1985) , but not tissue culture cells or leucocytes from other
non-ruminant species (Shewen and Wilkie, 1982a; Sutherland et al.
1983)
Toxicity is therefore attributable to an extracellular factor
which has specificity for ruminant leucocytes including those of
cattle (Shewen and Wilkie, 1982a) and goats (chang et al., 1982;
Richards et al. 1982) as well as sheep. As such , the cytotoxin is
apparently active only against leucocytes of the natural hosts of
P. haemolvtica. This restricted activity may be a reason for the
host- range specificity of this pathogen, and since it is lethal
for cells involved in immunity, the toxin is likely to be an
important pathogenic determinant.
Because of its virulence attributes the cytotoxin, if
antigenic, may also have potential as a vaccine component. Since
protection against serotype A2 infection has remained particularily
elusive, emphasis was accorded here to the production and
characterisation of cytotoxin by this serotype with a view to using
this antigen in a novel vaccine preparation. However, since most
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of the current knowledge of the P. haemolytica cytotoxin has been
derived from serotype A1 cultures and some of the physical and
chemical characteristics of the toxin have been described (Baluyut
et al. 1981; Sutherland and Redmond, 1986), the Al serotype
toxin was used as a standard with which the serotype A2 toxin was
compared.
A crude cytotoxin preparation from serotype Al P. haemolvtica
was previously derived from nutrient broth dialysis-sac culture
supernatant fluid (Sutherland and Redmond, 1986) . The advantages
of this technique were that it was cheaper than culture in RPMI
medium supplemented with foetal bovine serum (FBS), which was used
by others (Markham and Wilkie, 1980; Baluyut et al. 1981), and
that after dialysis, bacterial products (crude cytotoxin) were free
from contaminating broth components. This technique was therefore
used in these studies for the production of serotype A2 crude
cytotoxin.
Cytotoxicity was first detected by Benson et al. (1978) , who
reported morphological changes in bovine macrophage monolayers
inoculated with live P. haemolvtica organisms. The lethality of
the extracellular cytotoxin for ruminant leucocytes was later
examined either by using a trypan blue exclusion assay (Baluyut et
al. 1981 ; Sutherland et al. 1983) or by a method involving the
release of chromium-51 isotope from labelled bovine leucocytes
(Markham and Wilkie, 1980) which was modified to a microtitre
plate format by Shewen and Wilkie, (1983a). Since the technique
involving chromium-51 labelling was more sensitive than the trypan
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blue exclusion assay it was adapted here for the detection of
cytotoxicity using ovine bronchoalveolar macrophages (BAM) as
target cells.
3.1. Detection of P. haemolvtica serotpe A1 and A2 cytotoxin in
dialysis-sac culture supernatant fluids obtained after 6, 18
and 24 hours.
Dialysis sac culture (1 ml, produced as described in Materials
and Methods) was collected on three separate occasions at 6, 18 and
24 hours from cultures of P. haemolytica Al and A2. Samples were
centrifuged for 5 min on a microfuge (MSE, Fisons Instruments,
Crawley. UK.) at 13,000 g to pellet bacteria. The culture
supernatant fluid was filter-sterilised through a 0.45 jam filter
(Millipore,UK.) then stored at -70°C until assayed for toxicity.
Toxicity was assayed by mixing duplicate 200 jal volumes of culture
supernatant fluid with chromium-51 labelled ovine BAM in a
microtitre-plate.
Sheep BAM for the cytotoxicity assay were isolated as described
previously by Burrells (1986), then resuspended at 4 x 10^ viable
BAM ml ^ in RPMI 1640 medium (Imperial Laboratories, U.K.)
supplemented with 10% heat-inactivated foetal-bovine serum (Gibco,
U.K.), 1% glutamine, 3 mM HEPES buffer, 2% sodium bicarbonate and
adjusted to pH 7.4 with 1M Na OH (complete RPMI medium). BAM
counts and viability were assessed by trypan blue exclusion (0.4%
dye in PBS) in an improved Neubauer haemocytometer. Sodium chromate
(chromium 51-isotope) (Amersham, U.K.) was added to the BAM
suspension at 50 jaCi ml ^ and incubated at 37°C for 1 hour, after
which cells were sedimented and washed three times in Hanks'
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balanced salt solution (Hanks' BSS) by centrifugation at 100 g for
10 min at room temperature. The BAM suspension was finally
6 -1
resuspended in complete RPMI medium at 2 x 10 viable BAM ml
The toxicity of culture supernatant fluids for sheep BAM was
assessed by adding duplicate 200 pi volumes of each preparation to
wells of sterile, tissue-culture grade, flat-bottomed microtitre
plates (NUNC, Denmark). Then BAM (100 pi) were added to each well,
including spontaneous release control wells, containing 200 pi of
complete RPMI medium, and total release control wells, containing
200 pi of Triton X 100 detergent (Sigma). Plates were sealed with
sterile, plastic, adhesive film (Flow Laboratories. Irvine,
Scotland) and incubated at 37°C for 3 hours. BAM were then
sedimented by centrifugation of the plates at 100 g for 10 min at
4°C, after which 100 pi of supernatant fluid was removed from each
well for counting in a gamma-isotope counter (type auto-gamma 5650.
Canberra Packard. U.K.). The percent specific toxicity for each
supernatant was calculated from the formula:
percent specific cytotoxicity = 100 x counts in sample - counts
in spontaneous release control / counts in total release control -
counts in spontaneous release control.
The chromium-51 release assay was found to be faster, more
economical in materials and more sensitive than the trypan blue
exclusion assay used by this author previously (Sutherland et al.,
1983) and gave reproducible results from duplicate samples. Test
results (Table 3.1) showed that there was no significant difference
in the levels of toxicity given by three separate batches of
supernatant fluid prepared from each of the 6, 18 and 24 hour
cultures.
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Table 3.1. The percentage toxicity of three separate batches of
serotype A1 and A2 crude cytotoxin from 6, 18
and 24 hour cultures
(hours) preparations preparations
12 3 12 3
6 70 73 71 66 42 63
18 67 73 73 61 40 59
24 68 83 72 69 20 71
Percentage specific cytotoxicity = 100 x counts in sample
counts in spontaneous release control/counts in total control -
counts in spontaneous release control
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In view of these results, 18 hours was chosen as the standard
culture period for cytotoxin production since, it was, 1) the most
convenient for working with 2) it was considered that this
preparation may contain more cytotoxin antigen than earlier
cultures which, although it may not be biologically active, may be
antigenic and therefore of value in vaccine preparations.
3.2. Some characteristics of the antigens present in the crude
cytotoxin preparation.
A previous study (Sutherland and Redmond, 1986) found that a
serotype Al crude cytotoxin preparation consisted largely (90 %) of
polysaccharide while only a small percentage of protein was
present. The polysaccharide was not characterised, however, it
is possible that it consisted of capsular and lipopolysaccharide
antigens. Evidence for the presence of these antigens in serotype
A2 crude cytotoxin was therefore sought with the Al toxin being
included for comparison.
3.2.1. SDS-PAGE analysis (see Materials and Methods).
Lyophilised serotype Al and A2 crude cytotoxin and A2 SSE
cell-surface antigens (each prepared as described in the Materials
and Methods) were resuspended in phosphate buffered saline pH 7.2
(PBS) and mixed 1:1 with 2X SDS-PAGE solubilising buffer. A sample
of serotype Al (400 jug) and A2 (800 jag) crude cytotoxin
preparations, A2 SSE (10 jug) and 5 jal of SDS-6H molecular weight
standards prepared as described by the manufacturer (Sigma), were
loaded into wells of a 10% SDS-PAGE gel. The gel was silver
stained by the method of Morrisey (1981) and photographed.
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The SDS-PAGE profile (Fig 3.1) of the serotype A1 cytotoxin was
essentially the same as that previously described (Sutherland and
Redmond,1986). The profile of the polypeptide bands in the A2
serotype cytotoxin was also similar to that of the Al cytotoxin,
but there was quantitatively less of each band. Both serotype Al
and A2 toxins contained distinctly resolving antigen bands which
were of equivalent molecular mass to some antigens present in the
SSE. These were therefore considered to be OMPs, including the
major OMPs which are 51 kDa (arrow b) (Donachie et al. 1984b), and
29 kDa (arrow c) (Squire et al., 1984) in molecular mass. When gel
loading concentrations were considered, the outer membrane
antigens found in the toxin preparations appeared to be about 40
times less in quantity compared to the SSE. LPS was tentatively
identified in the cytotoxin preparations as a broad band running at
the gel dye-front (arrow d). High molecular mass polysaccharide
antigen (possibly capsule) was also seen as a diffuse indistinct
area of staining at the upper end of the gel.
Bands unique to the cytotoxin preparations (not in SSE) were
identifiable between 96 and 116 kDa and were more prominent in the
Al toxin preparation (arrow a). These bands were tentatively
identified as cytotoxin antigens since recent work by Lo et al.
(1986), with a recombinant serotype Al cytotoxin (leucotoxin)
expressed in E.coli, identified a 102 kDa band as the cytotoxin
protein, and Chang et al. (1987) identified a 105 kDa cytotoxin
antigen which degrades to 95 kDa during culture.
Fig. 3.1. Silver stained SDS-PAGE gel of:
lane 1, molecular mass standards (5 jil); lane
2, serotype A2 sodium salicylate extract of
cell-surface antigens; lane 3, A2 crude
cytotoxin, lane 4, serotype Al crude cytotoxin.
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3.2.2. Identification of protease activity in crude cytotoxin
preparations.
Otulakowski et al. (1983) found that protease activity was
present in Al crude cytotoxin preparations. These authors however
did not attempt to identify the antigens responsible for this
activity. Heussen and Dowdle (1980) have developed a method for
detecting plasminogen activators by incorporating the zymogen and
gelatin substrate in SDS-PAGE gels and negatively staining the
digested areas of gelatin around the resolved activator bands. This
method was used to attempt detection of proteases in crude
cytotoxin preparations. Otulakowski et al. (1983) had found that
the proteases could digest casein and so 0.1% azocasein was used as
a substrate for incorporation in gels. The method is fully
described in the Materials and Methods. The relative mobilities
(Rf values) of proteases were calculated by the method of Hames and
Rickwood (1984).
Areas of proteolytic activity were detectable in Coomassie blue
stained SDS-PAGE gels containing azocasein (Fig 3.2). The Al crude
cytotoxin had a large protease (Rf 0.05) which was located at the
top of the gel (arrow c) while the A2 toxin preparation had a less
distinct and smaller (Rf 0.99) protease which ran at the dye-front
(arrow b). Chymotrypsin A4 ( Boehringer Mannheim) was included in
the gel as a positive protease control (arrow a) and had a major
proteolytic band with an Rf value of 0.95. The smaller sized (Rf
0.99) protease in the A2 toxin preparation was found to be labile
to heating at 100°C for 5 mins in solubilising buffer containing
2-mercaptoethanol, whereas the larger sized protease (Rf 0.05)
Fig. 3.2. SDS-PAGE showing negatively-stained areas of
protease activity: lane 1 (arrow a),
chymotrypsin (50 jig); lane 2 (arrow b),
serotype A2 crude cytotoxin (1.0 mg); lane 3
(arrow c), serotype Al crude cytotoxin (1 mg).
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found in the A1 toxin preparation was not (results not shown).
This suggested that these proteases were unlikely to be related
isomers.
3.2.3. Detection of LPS in serotype A2 crude cytotoxin.
A modified limulus amoebocyte lysate (LAL) assay (G. Moon and
C. Hodgson, in preparation) was used to confirm the presence of
LPS, which was tentatively identified in the SDS-PAGE gel profile
of the crude A2 cytotoxin (part 3.2.1.). The assay was based on
the observation by Levin and Bang (1968) that the interaction of
LAL with endotoxin (LPS) produces a turbidity which increases with
reaction time. The kinetics of turbidity were followed
spectrophotometrically using a centrifugal analyser (IL Multistat
III plus, Instrumentation Laboratories).
Logarithmic dilutions (ranging from a concentration of 10,000
down to 1.0 pg ml ^) of a standard LPS preparation (E. coli 0113,
H10, K , Atlas Bioscan), and the crude cytotoxin sample 7.0 mg
ml \ were added manually (120 pi) to sample wells and 40 pi of LAL
(Pyrogell GT, Atlas Bioscan) was added to the reagent wells of the
analyser rotor. The LAL and LPS samples were allowed to
equilibriate at 37°C for 3 mins before optical density (OD)
readings were taken at 380 nm wavelength. When the OD of the
LAL/LPS mixtures reached an OD which remained steady over a period
of 20 to 30 sees this OD was taken as the baseline reading. From
this baseline, the time it took for each concentration of the
standard LPS preparation to give a rise in OD of 0.02 (the onset
time) was calculated. The onset time for each LPS concentration
was then plotted on log-log graph paper to produce a standard
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curve. The onset time for the crude cytotoxin sample was plotted
on the standard curve and the LPS concentration calculated by
extrapolation.
The assay detected LPS at 1 x 10^ endotoxin units mg ^ in
the crude A2 cytotoxin preparation, where 1 jig of the standard LPS
was equivalent to 10 endotoxin units.
3.2.4. Detection of serotype-specific capsular antigen in crude
cytotoxin.
Confirmation of the presence of the serotype-specific capsular
antigen in serotype A1 and A2 crude cytotoxin was sought by
titrating the cytotoxin in the IHA test (Biberstein et al., 1960)
against 1 in 20 dilutions of standard serotyping antisera raised in
rabbits at the Moredun Research Institute.
The serotype Al cytotoxin had capsular antigen which was
titratable down to 10.0 jag ml \ while the serotype A2 cytotoxin
had antigen which was titratable down to 40.0 jag ml The
capsular antigen in each cytotoxin did not cross-react with the
antiserum of the other serotype, thus confirming the specificity of
the capsular antigen.
3.3. Standardisation of activity in crude cytotoxin preparations
by titration.
In order to use cytotoxin preparations in a cytotoxin
neutralisation (CN) assay for comparing the CN titres of sera from
day-to-day and from different experiments it was first considered
necessary to standardise the cytotoxin preparations for activity.
Standardisation of the toxicity of each preparation by titration
54
was also intended to ensure the quality control and repeatability
of toxin production.
Crude cytotoxin preparations from serotypes Al and A2 (100 pi
volumes) were titrated in duplicate, in doubling dilutions, from 20
mg ml ^ down to 0.01 mg ml \ Each dilution was overlaid with 100
pi of medium to replace the test serum which would be added in the
CN assay. Finally, 100 pi of chromium 51 labelled BAM were added
to all assay wells and the assay carried out as described in part
3.1. The toxicity end-point for each toxin preparation was taken
to be at the lowest dilution which gave toxicity of 10% or greater,
and was expressed in mg ml ^.
Twelve batches of serotype Al crude cytotoxin were found to have
a mean toxicity end-point of 0.12 (+ 0.05) mg ml ^, while
twenty-one batches of serotype A2 crude cytotoxin had a mean
toxicity end-point of 8.1 (± 1.4 ) mg ml ^ (Table 3.2 ). Serotype
Al therefore produced significantly more (p<0.001) detectable toxin
than serotype A2.
Crude cytotoxin from a further four ovine serotype A 2 field
isolates (Fl, 2, 3 and 4) and one bovine serotype Al isolate (Fb 1)
gave toxicity end-points which were within the range of those given
by their respective standard strains (table 3.3). This indicated
that the lower toxicity of serotype A2 crude cytotoxin compared to
the Al toxin was a consistent attribute within the serotype and was
conserved amongst isolates.
Crude cytotoxin derived from four earlier log-phase (6 hour)
dialysis sac cultures of both serotype Al and A2 gave mean toxicity
end-points of 0.04 and 3.4 (± 0.94) mg ml ^ respectively (Table
3.4), which were not significantly different from the levels of
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Table 3.2. Toxicity end-points of batches of crude cytotoxin
from serotypes A1 and A2 18 hour cultures
Toxicity end-point (me ml ^") of:



























Table 3.3. Toxicity end-points for crude cytotoxin from
field isolates of P. haemolvtica
Toxicity end-points (mg ml "*") for field isolates
Serotype A2 Serotype Al
F1 F2 F3 F4 Fbl
5.0 20 20 10 0.3
Table 3.4. Toxicity end-points of crude cytotoxin from
serotypes Al and A2 6 hour cultures
Toxicity end-point (mg ml






(+ standard 0.04 3.4 (+ 0.94)
error)
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activity detected in the 18 hour homologous cultures. This
suggested that the difference observed in the levels of
extracellular cytotoxin found between the A1 and A2 serotypes was
not due to differences in the time of release of the toxin between
the serotypes.
3.4. Development and use of an assay to detect CN antibodies.
Shewen and Wilkie (1983a), Cho et al. (1984) and Gentry et al.
(1985a, 1985b) have correlated the presence of CN antibodies with
resistance of cattle to pneumonic pasteurellosis. The possibility
existed therefore that CN titres might be associated with immunity
in sheep protected against P. haemolvtica. To investigate this
possibility, sera and lung washings from "convalescent" lambs
(Donachie e_t al. , 1986a) were compared with those of naive SPF
lambs for CN activity. This study might be expected to provide
experimental evidence for the involvement of CN in immunity against
ovine pneumonic pasteurellosis.
Stimulation of CN antibodies in rabbits by vaccination with
serotype A2 crude cytotoxin was also attempted to give preliminary
information on whether this type of preparation may be useful as an
experimental vaccine component.
3.4.1. Detection of CN antibodies in the sera and lung washings of
"convalescent" SPF lambs.
The protocol for inducing "convalescence" in SPF lambs was
described by Donachie et al.(1986a) and is included in Materials
and Methods (table 2.1).
Sera tested for CN titre were taken from "convalescent" lambs
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(group 1) prior to the primary P. haemolvtica infection (day 0)
and from group 1 and group 2 (untreated control) lambs immediately
before the secondary infection (day 28). Lung washings were taken
at necropsy from all survivors. Titres of CN antibodies (Table 3.5)
in the sera and lung washings of experimental animals were assessed
by titrating samples in duplicate against crude cytotoxin
preparations which were used at a four-fold concentration of the
toxicity end-point (part 3.3). Volumes (100 pi) of each sample were
titrated in duplicate with complete RPMI medium in flat-bottomed
microtitre plates and then 100 pi of crude cytotoxin was added to
each dilution and left at room temperature for 10 mins to allow
antibody-toxin interaction to occur. BAM (100 pi) were then added
to each assay well and the assay was carried out as described for
the cytotoxicity assay in part 3.1. The CN titre of each sample
was taken as the highest dilution which neutralised cytotoxic
activity by >80% and was calculated from the formula:
CN titre = 100 x the percent specific toxicity of the cytotoxin
- the percent specific toxicity of the cytotoxin in the presence of
the test sample / the percent specific toxicity of the cytotoxin.
No serum CN titres were detectable against serotype A2 cytotoxin
in group 1 lambs (day 0) before "convalescence" was induced. CN
titres were however, detected in the sera of group 1 lambs on day
28 after the primary infection and these were significantly greater
(p<0.001) than those in group 2 lambs which had negligible CN
titres. Group 1 lambs also had CN titres in their lung washings
which were significantly greater (p<0.05) than the titres in the
three group 2 lambs which survived until necropsy.
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Table 3.5. Cytotoxin neutralisation (CN) titres in sera and
lung washings of convalescent and untreated SPF
lambs
CN Titres in:
Group animal serum lung washing
day 0 day 28 day 35
(pre 1st (post 1st (necropsy)
infection) infection)
Convalescent 1 0 32 16
lambs 2 0 NA 64
3 0 16 8
4 0 64 32
5 0 32 16
6 NA 64 NA
7 NA 16 16





1 NA 0 8
2 NA 1 8
3 NA NA 8
4 NA 1 NA
5 NA 0 NA
6 NA 0 NA
7 NA NA NA
mean (± 0.4 (± 0.25) 8.0
standard
error)
NA = not available for testing
NA (died) = sample not available because lamb died before day
of necropsy
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The three survivors in the group 2 lambs however, had CN titres
which may have been associated with their survival and was probably
due to a rapid primary response to the secondary infection.
However, it was not possible to compare the lung washings of those
group 2 lambs which died before necropsy.
Since all the convalescent animals were completely immune to
subsequent experimental challenge (Donachie et al. 1986a) serum and
lung washing CN titres were therefore associated with protection of
"convalescent" lambs against further experimentally induced
pasteurellosis.
3.4.2. Detection of CN antibodies in a rabbit vaccinated with a
serotype A2 crude cytotoxin preparation.
A cytotoxin-based vaccine was prepared by resuspending
lyophilised crude cytotoxin in sterile distilled water and
adsorbing with sufficient Alhydrogel (Miles) to give a final
concentration of 10 mg ml ^ cytotoxin in 0.27% Alhydrogel solution.
A rabbit, which had been pre-bled to ensure that it had no CN
antibodies was vaccinated twice subcutaneously (sc) with two doses
28 days apart and bled two weeks after the second vaccination. The
vaccine was found to have induced a CN titre of 1 in 4 in the CN
assay.
Discussion
Cytotoxicity against ovine BAM was readily measured in a
chromium-51 release assay. Production of serotype A2 cytotoxin in
dialysis sac cultures which were grown for 6,18 or 24 hours
resulted in preparations with equally detectable cytotoxic
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activity. This result was different from that of Baluyut et al.
(1981) who found toxic activity was detectable only in early log
phase (1 to 6 hour) cultures. However, those cultures were grown
in RPMI medium supplemented with 10% FBS and it is possible that
nutrients necessary for bacterial growth were exhausted after this
period. Indeed, Gentry et al. (1986) have suggested that FBS in
this type of culture serves mainly as a source of protein-bound
iron which is essential for toxin production. Dialysis sac culture
with nutrient broth for a period of 18 hours was chosen as a
convenient, cost-effective method of toxin production which
resulted in a product which was free of nutrient broth
constituents.
After titration of several batches of serotype Al and A2 crude
cytotoxin in the chromium-51 release assay it was concluded that
potent levels of toxin could be consistently produced by the
dialysis sac culture method. However, it was also found through
titration that serotype A2 produced significantly less detectable
cytotoxin than the serotype Al. This finding may have important
consequences for vaccine production. If it is assumed that the
lower activity is due to less cytotoxin antigen being produced
rather than the A2 toxin being innately less active, then the Al
serotype may provide a better source of cytotoxin antigen for
vaccines. It has been shown previously by Shewen and Wilkie,
(1983b) that cytotoxin produced by serotypes 1 to 12 were cross-
neutralisable with specific atiserum. If the cytotoxin were to
prove to be a protective antigen (an immunogen) then it may be
cross-protective amongst the P. haemolvtica serotypes.
SDS-PAGE analysis showed that the crude cytotoxin preparations
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contained in addition to cytotoxin many OMP, LPS and capsular
antigens. The presence of LPS was confirmed in an endotoxin assay
and the serotype-specific capsule was identified by the IHA test.
Two species of extracellular protease were demonstrated in the
crude cytotoxin preparations. One, with an Rf value of 0.05, was
found in the A1 toxin preparation and was heat stable while the
other, with an Rf of 0.99, was found in the A2 cytotoxin
preparation and was heat labile. Differences in lability probably
indicates that these proteases were of different species and not
isoenzymes.
Otulakowski et al. (1983) speculated that protease activity may
be involved in promoting the activity of the cytotoxin. It would
therefore be of interest to determine if the different proteases
found in the crude Al and A2 cytotoxins are responsible for the
differences in activity detected in these preparations. Also, the
A2 crude cytotoxin contained less detectable amounts of the 105 and
95 kDa cytotoxin proteins, detected by Chang et al. (1987), when
compared to the Al preparation. It may be that this also was a
cause for the lower toxin activity detectable in the A2 crude
cytotoxin.
Each of the antigens in the crude cytotoxin may be important
immunogens and their detection may have important consequences for
understanding any immunity raised by vaccines based on the crude
cytotoxin.
The first demonstration that lambs could be effectively
protected against P. haemolvtica A2 infection was given when
Donachie et al. (1986a) showed that "convalescent" lambs were
immune to subsequent homologous serotype A2 challenge. Some of the
mechanisms of immunity which may have been responsible for
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protection were examined by these authors, but CN antibody titres
were not measured. In these studies, the sera of "convalescent"
lambs had no serum CN titres prior to primary infection with P.
haemolvtica. However, after infection CN titres were detectable.
In contrast, untreated, susceptible animals had negligible titres.
Thus, CN titres would appear to be associated with immunity to
experimental ovine pasteurellosis.
All of the "convalescent" lambs had CN titres in their lung
washings at the time of necropsy, indicating that local CN antibody
was likely to have been involved in immunity. Three untreated
lambs which survived until necropsy also had CN titres in their
lung washings, but these were significantly lower and may have been
due to a rapidly mounted primary response to the challenge
infection. The ability of these animals to mount a rapid CN
response, although it did not entirely prevent the formation of
pneumonic lesions (Donachie et al. 1986a), may have been associated
with their ability to survive until the day of necropsy.
Unfortunately, lung washings from the untreated lambs which died
could not be taken and were therefore not available for comparison.
The serotype A2 crude cytotoxin preparation was shown to induce
a CN response after vaccination of a naive rabbit. The
demonstration of the ability of this vaccine to stimulate CN
titres, and the association of CN activity with immunity to P.
haemolvtica infection in lambs, indicates that the crude cytotoxin
may have potential as a novel vaccine for raising CN antibodies in




The Bactericidal Effects of Serum on P_. haemolvtica.
In studies relating to protection against bacterial disease, it
is important to define the mechanisms of immunity which operate
against the causative pathogenic organism. It is also desirable to
determine which bacterial antigens can stimlate these protective
mechanisms by vaccination.
P. haemolvtica serotype Al organisms were found by MacDonald £t
al. (1983) to be susceptible to killing by the classical
complement pathway when they were mixed with complement and immune
bovine serum. It is possible therefore, that bactericidal
mechanisms are similarily involved in the protection of sheep
against pasteurellosis and that this immune mechanism could be
stimulated by vaccines containing relevant antigens. In view of
this, a micro-titre plate assay was developed to detect antibodies
which stimulated the classical complement pathway and induced
killing of P. haemolvtica organisms. With a standard source of
complement in this assay, it was assumed that the percentage of
bacteria killed (%K) would be proportional to the bactericidal
capacity of antibodies in the sample. This was considered to be the
most important variable to study since levels of relevant
antibodies could be raised anamnestically after vaccination whereas
complement could not. The method was used to study bactericidal
activity in the sera of "convalescent" and naive SPF lambs which
were respectively either resistant or susceptible to experimental
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challenge with P. haemolvtica (Donachie et al., 1986a). Also an
attempt was made to identify bacterial antigens which were targets
for bactericidal antibodies.
4.1. Development and optimisation of a microtitre plate
bactericidal assay and characterisation of the
susceptibility of P. haemolvtica A2 to serum bactericidal
activity.
If P. haemolvtica A2 is susceptible to the classical but not the
alternative pathway of complement, as is the Al serotype (MacDonald
et al., 1983) , then bactericidal activity will only occur in the
presence of both specific antibody and complement. An assay was
therefore developed to detect and characterise bactericidal
activity against P. haemolvtica hi.
A sample (100 ul) of P. haemolvtica hi which was stored at
-70°C was thawed and inoculated into 10 ml of nutrient broth (NB).
After incubation at 37°C overnight, 200 pil of culture was
transferred to 10 ml of NB and incubated at 37°C for 3 hours to
obtain a log-phase culture, which was then centrifuged at 11,000 g
for 5 min at room temperature (Taylor, 1983). The resultant
bacterial pellet was washed once in modified barbitol buffer (MBB)
(Oxoid, U.K.) to remove residual NB, which has been shown to be
anti-complementary (Muschel and Treffers, 1956). The bacterial
inoculum was finally adjusted with MBB to the required number of
cfu ml . The actual bacterial number was confirmed by
retrospective plate counting on SBA.
Sera from naive SPF lambs or foetal calves were collected and
stored for use as complement sources. Each batch of serum was
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tested before use for the absence of bactericidal antibodies and
the presence of sufficient complement to cause 100% bactericidal
activity when used in conjunction with a standard positive control
serum.
The assay was performed in 96-well, tissue-culture grade,
flat-bottomed micro-titre plates (NUNC, Denmark) into which
reactants were simultaneously delivered to 12 wells with a multi¬
channel pipette. Triplicate assay wells received 20 pi of each
standard serum or test sample followed by 100 pi of bacterial
inoculum. Assay suspensions were incubated for 15 min at room
temperature to allow antibody-bacterium interaction to occur.
Standardised serum complement was then added in 80 pi volumes to
each assay well, except when evaluating the effect of antibody on
P. haemolytica A2 in the absence of complement, when 80 pi of
heat-inactivated FBS was addded.
Assay plates were covered with a sterile adhesive plastic film
(Flow laboratories, Irvine U.K.) and incubated at 37°C for the
required period. Generally, after incubation, 10 pi samples of each
triplicate suspension were removed with a multi-channel pipette and
inoculated onto SBA plates. When bacterial counts were too high for
direct plate counting, as when the assay was being evaluated,
sequential logarithmic dilutions of each suspension were made in
MBB diluent in microtitre plates before counting. After incubation
of SBA plates at 37°C overnight, the mean number of cfu ml was
calculated from each triplicate.
The mean percent of bacterial inoculum which was killed (%K) in
each suspension was calculated by the formula:
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%K = 100 x 1 - (the mean number of cfu ml ^ after incubation /
the mean number of cfu ml ^ before incubation). The %K for each
lung washing was adjusted by a correction factor (Donachie et al.,
1986a) to take account of the extent to which each sample had been
concentrated before assay.
A convalescent serum was initially selected as a standard
positive serum since it gave 100% killing in the presence of
complement. A FBS sample was selected as a standard negative
serum since it was not bactericidal in the presence of a complement
source.
When optimal assay conditions were developed with respect to
bacterial concentration and incubation period it was found that the
microtitre plate assay could be performed rapidly with little
variation in counts between sample triplicates. The standard
positive and negative sera gave repeatable results from day to day.
The standard positive serum killed 100% of a bacterial suspension
3 -1
containing 3.4 x 10 cfu ml , but only in the presence of
complement. No killing occurred when the complement was replaced
with heat-inactivated FBS. This bactericidal capacity rapidly
diminished with dilution of the standard positive serum, and was
abolished at 1 in 32 dilution (Fig.4.1). The standard negative
serum was not bactericidal at any dilution (Fig 4.1). The standard
positive serum was tested with various concentrations of P.
haemolvtica A2 (Fig 4.2). The killing activity of the serum
3
remained >85% for P. haemolvtica concentrations betwen 3.4 x 10
cfu ml ^ and 3.4 x 10^ cfu ml \ but thereafter decreased rapidly
with increasing bacterial concentration. A bacterial concentration
3-1 3-1
of 3 x 10 cfu ml (equivalent to an inoculum of 6 x 10 cfu ml )
was therefore selected as optimum.
Fig. 4.1 Titration of the bactericidal activity of a
"convalescent" (x x) and a naive (o o)
specific pathogen-free lamb serum
I
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Fig. 4.2. The bactericidal activity of a "convalescent"




Bacterial killing by the standard positive serum was apparent
after 2 min of incubation (97%K) and had increased to 100%K by 15
min. An incubation period of 30 min was therefore selected. Fresh
FBS was as effective a source of complement as naive SPF lamb
serum, but less convenient to obtain. Complement source sera were
used undiluted, since the bactericidal capacity of sera decreased
rapidly in the presence of a diluted complement source e.g. 100%
killing by one serum in the presence of an undiluted complement
source was reduced to 86% when the complement source was diluted 1
in 2. Heat inactivation of the complement source completely
abolished bactericidal activity, demonstrating that complement was
essential. The complement source was not bactericidal in the
presence of the standard negative serum, indicating that specific
antibody was also essential for bacterial killing. All further
assays employed the conditions which were found to be optimal for
determining bactericidal activity.
4.2. Bactericidal activity with purified IgG.
Confirmation that antibody was the essential component for
bactericidal activity in the standard positive serum was by the use
of immuno-affinity purified IgG which was purified from this serum
as described in Materials and Methods. IgG proved to be as
bactericidal (100%K) as the complete serum when used at the
equivalent concentration (2.27 g IgG L ^).
4.3. Detection of bacterial target-antigens for bactericidal
antibodies.
Aliquots of the standard positive serum were absorbed at 37°C
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for 20 min with 1 mg ml ^ of either SSE of P. haemolvtica A2 cell
wall or A2 LPS each of which was prepared as described in Materials
and Methods. After absorption, the serum was sterilised by
filtration. Absorption with LPS completely abolished bactericidal
activity, while the SSE reduced activity to 21% K.
4.4. The susceptibility of four ovine field isolates of
P. haemolvtica A2 to killing.
Four ovine, serotype A2, field isolates (F1 to F4) were tested
for their susceptibility to the bactericidal activity of the
standard positive serum to ascertain that the susceptibility of the
T884 strain was not unique. The standard negative serum was also
tested against each isolate to ensure that these isolates were not
susceptible to the alternative complement pathway. The T884 strain
was included in the assay as a positive control.
3
The inocula used in this assay ranged from 4.6 x 10 to 2.0 x
4 -1
10 cfu ml . All four isolates and the positive control strain
were completely killed by complement in the presence of the
standard positive serum. No killing was observed with the standard
negative serum.
4.5. Detection of bactericidal activity in the sera and lung
washings of "convalescent" SPF lambs.
If bactericidal activity is important in immunity to P.
haemolvtica then it is probable that immune animals should have
detectable bactericidal antibody levels.
Sera and lung washings from " convalescent" SPF lambs (group 1),
which were known to be immune to P. haemolvtica A2 infection
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(Donachie et al., 1986a), were compared with naive SPF lambs (group
2) for bactericidal activity against P. haemolvtica A2. The
experimental protocol for the treatment of these lambs is described
in the Materials and Methods. The bacterial inoculum used was 6.4
x 10"^ cfu ml ^.
Sera taken from the "convalescent" lambs on day 0
(pre-immunising infection) had no bactericidal activity, but those
collected on days 34 and 41 had group mean activities of 92.1 and
89.8%K, respectively (Table 4.1). Furthermore, all but one lung
washing obtained at necropsy (day 41) from these "convalescent"
lambs also contained bactericidal activity, although this was less
than in their sera (Table 4.1). Conversely, no bactericidal
activity was detected in sera of naive lambs on days 34 and 41 or
in lung washings taken from three of this group at necropsy nor
were these lambs protected against P. haemolvtica A2.
4.6. Studies on the susceptibility of a P. haemolvtica biotype T
serotype to bacterial killing mechanisms.
Biotype T colonies have a more mucoid colony morphology than A
biotype organisms (Gilmour, 1980). Perry and Babiuk (1984) have
demonstrated by SDS-PAGE analysis that at least one biotype T
serotype (T4) possesses a "smooth" type LPS structure. This type
of LPS may contribute to the mucoid appearance of T biotype
colonies. Variants of a number of Gram-negative bacterial species
possessing "smooth" type LPS have been found to be resistant to
complement-mediated bactericidal activity and this resistance is
often associated with the ability of variants to cause septicaemia
(Turk, 1959; Chedid et al., 1968; Rowley, 1968; Taylor, 1975 and
Madonna and Allen, 1981 ) .
9.
































Groupmean (±standard092.1(±5.4)89 87 91 .9( 3.1) error) SiBactericidalactivitywasnotdetect bleiserolungwash ngsfontroll m s ^Thebactericidalactivityoflungwashingst kentn cropsyasadjus edycorr c ion factortoreturnallsamplesunitvolumefthriginalharvest Bychallengewithlivorga isms,followedbypreventionfu m atingdis se antibiotictherapy NA -notavailable
74
The T biotype serotypes of P. haemolvtica cause a systemic
disease in young adult sheep (Thompson et al., 1977). Evidence for
"smooth" type LPS and associated resistance to bacterial killing
might therefore indicate that this is an important pathogenic
determinant in the aetiology of the systemic disease. The LPS
structure of all the T biotype serotypes was therefore examined by
SDS-PAGE and compared with those of the A biotypes.
4.6.1. SDS-PAGE analysis of the LPS structures of 15 serotypes
of P. haemolvtica.
LPS, prepared by the proteinase K digestion of whole cells
(Hancock and Poxton, 1988), was analysed by SDS-PAGE (Materials and
Methods). S. minnesota ("smooth" type LPS) and S. minnesota R595
("rough" type LPS) were included on gels as standards (Fig. 4.3).
The biotype T serotypes (3, 4, 10 and 15) were all found to have
a "smooth" type LPS profile, which showed as a typical ladder of
polysaccharide bands on the silver stained gels (Tsai and Frasch,
1982). In contrast, the A biotype serotypes 1, 2, 6, 7, 8, 9,
12, 13 and 14 had "rough" type LPS with only the heavily stained
core plus lipid A apparent at the bottom of the gels. The A
biotype serotypes 5 and 11 were intermediate, having a few faint
linear "0"-antigen bands. This study confirmed the finding of
Perry and Babiuk (1984) that the T4 serotype had "smooth" type LPS
and extended it to include the other T serotypes.
Fig. 4.3. SDS-PAGE of LPS from proteinase K digests of P.
haemolvtica whole cell preparations. Lanes 1
to 15, A and T biotype serotypes 1 to 15




4.6.2. Testing the susceptibility of serotype T10 organisms to
bactericidal activity.
Antisera to the serotype T10 were available from lambs which
were either made "convalescent" to this serotype or vaccinated with
homologous strain crude cytotoxin. Since these immunisation
schedules had been found to raise bactericidal activity against
serotype A2 organisms (see part 4.5 and section 7) these sera were
tested for their bactericidal activity against serotype T10
organisms.
The six anti-serotype T10 sera were raised in sheep. Two were
raised in SPF lambs by vaccination with a crude cytotoxin
preparation (as described for serotype A2 in section 7), and four
in normal adult sheep by live infection with serotype T10 organisms
(N. Gilmour, personal communication). The vaccinate sera were
taken 12 days after a second vaccination with crude cytotoxin.
"Convalescent" sera were taken seven days after a second live
infection with serotype T10. All sera were heat inactivated at
56°C for 30 min and stored at -20°C until used. These sera and the
standard negative serum were tested with complement in the
bactericidal assay against 100 y.1 of serotype T10 inoculum (7.0 x
3-1 3
10 cfu ml ). Serotype A2 (with an inoculum of 6.2 x 10 cfu
ml ^~) was included in the assay as a known susceptible strain and
was tested against the standard positive and negative sera.
Serotype T10 organisms were completely resistant to killing (0
%K) in the presence of all sera. The A2 organisms were susceptible
to the standard positive serum (100 %K) and resistant to the
standard negative serum (0 %K) which indicated that the complement
source and assay procedure were functional.
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4.6.3. Serological analysis of the anti-TIO immune sera.
Evidence to confirm that the anti-TIO sera were indeed immune
was sought by testing them for antibodies to cell-surface antigens
in an ELISA and by immunoblotting. The ELISA was performed by the
method of Fodor and Donachie (1988), except that the antigen was
serotype T10 LPS used at 100 jag ml-1 and dispensed in 100 jal per
well. Sera were diluted 1 in 100 for use in the ELISA.
Cell-walls of serotype T10 organisms, prepared by the method of
Shand et aT. (1985), were run on SDS-PAGE gels as described in
Materials and Methods. Cell wall antigens were transferred to
nitrocellulose for immunoblotting with the serotype T10 antisera by
the method of Herring and Sharp (1984). Sera were diluted 1 in 50
for immunoblotting.
In the ELISA, the six anti-TIO immune sera gave optical
densities (OD) at 495 nm wavelength ranging from 0.14 to 0.63,
whereas the standard negative serum gave an OD of 0 (Table 4.2).
The immune sera also reacted with cell-wall antigens by
immunoblotting, whereas the standard negative serum did not (Fig.
4.4). These results indicated that the immmunisation protocols had
successfully raised antibodies against T10 cell-surface antigens
including LPS.
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Table 4.2. Bactericidal and ELISA O.D. of anti-serotype T10 immune
sera.
cL b









Sera 1 and 2 were from specific-pathogen-free lambs vaccinated with a
serotype T10 crude cytotoxin preparation, sera 3 to 6 were from
conventionally raised sheep made "convalescent" to infection with
serotype T10, serum 7 was the standard negative (SPF lamb) serum.
^The maximum possible O.D. was 2.0
Fig. 4.4. Immunoblot of sera reacted against a cell wall
preparation of serotype T10 P. haemolvtica
Lane 1, is a naive SPF lamb (standard negative)
serum; lanes 2 and 3, are post-vaccination sera
from two SPF lambs vaccinated with a serotype
T10 crude cytotoxin preparation; lanes 4 to 7,
are sera from four "convalescent" lambs




The bactericidal assay gave little variation amongst replicates
and was comparable on a day-to-day basis. Titration of the immune
serum and bacterial inoculum indicated that assay results were
dependent upon both antigen and antibody titre. The most suitable
conditions for assay of SPF lamb sera or lung washings were 20 jil
3 -1
of undiluted serum and 3 x 10 cfu ml of serotype A2 P.
haemolvtica.
Serum complement was not bactericidal for P. haemolvtica A2 in
the absence of antibody, indicating that P. haemolvtica A2 could
not activate the alternative complement pathway. This result is in
agreement with the findings of MacDonald et al. (1983), who showed
that P. haemolvtica Al was not killed in the absence of a
functional classical complement pathway. Also, the standard
positive serum was not bactericidal unless in combination with
complement, indicating that bactericidal activity was due to an
antibody-complement complex.
Four field isolates of P. haemolvtica A2 were also found to be
susceptible to bactericidal activity indicating that the
susceptibility of the T884 strain was not unique.
Purification proved that IgG was the bactericidal component in
the standard positive serum. The bactericidal activities of IgA
and IgM against P. haemolvtica A2 were not investigated.
Previous studies have shown that IgM is more active than IgG in
bactericidal assays (Robbins et al., 1965; Bjornson and Michael
1970; Schulkind et al., 1972), although the activity of IgG has
been found in rabbit serum to increase during sequential
immunisation (Pike and Chandler, 1971). Also, IgG is
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predominantly produced in an anamnestic response and is the major
antibody class found in the lower respiratory tract of sheep (Gorin
et al. , 1979) . It is doubtful whether IgA can activate
bactericidal activity via the classical pathway (Sirotak et_ al.,
1976) and it has even been suggested that IgA may block
bactericidal activity against P. haemolvtica (MacDonald et al.,
1983). The immunoglobulin class meriting most attention,
following an anamnestic response to vaccination or after the
development of pneumonia, would therefore seem to be IgG.
The sera and all but one of the lung washings of "convalescent"
lambs were found to exhibit bactericidal activity against P.
haemolvtica A2. In contrast, samples from untreated control
animals, which were susceptible to the P. haemolvtica challenge,
had no bactericidal activity. The presence of bactericidal
antibodies in the sera and lung washings of the "convalescent"
lambs therefore correlated with resistance to P. haemolvtica.
Whether sufficient complement is available in the lung for
bactericidal activity to occur is uncertain, but Burrells (1986)
has shown that the C3 component of complement increases in the
sheep lung during PI3 virus/P. haemolvtica infection. The
possibility that complement behaves as an acute-phase reactant in
disease has been suggested previously (Atkinson and Frank, 1980).
As the recovery of lung washings involved dilution of the lung
fluids, bactericidal activities of sera and lung washings were not
directly comparable. Therefore, although the bactericidal
capacity of the lung washings was lower than their respective sera,
this may not necessarily reflect the situation in vivo. The lungs
of these "convalescent" lambs may have constituted an environment
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as bactericidal for P. haemolvtica as their blood. It is perhaps
more relevant to note that no bactericidal acttivity was detectable
in the lung washings of control lambs at necropsy.
In attempts to determine which antigen was the target for
antibodies involved in the bactericidal assay, absorption with LPS
was found to abolish the bactericidal activity of the standard
positive serum. Previous authors have described LPS as being the
antigen receptor for the bactericidal antibodies directed against
other Gram-negative bacteria (Glynn and Ward, 1970; Tramont et
al., 1974). An SSE preparation of P. haemolvtica A2 also reduced
the activity of bactericidal antibodies. This crude extract
contained small amounts of LPS, which may have been responsible for
the reduction in bactericidal activity, although other cell
surface antigens such as outer membrane proteins (Tramont et aT.,
1974) and phage receptors (Gabay, 1977), have been implicated as
targets for bactericidal antibodies. Separation of SSE into its
components may therefore reveal additional target antigens.
The bactericidal assay described here will be useful in the
understanding of the mechanisms of immunity against P. haemolvtica
A2 and in monitoring the ability of vaccines to produce
bactericidal activity both systemically and in the lung. This
assay may have similar applications for the study of bactericidal
activity against other Gram-negative bacteria and recent studies
with P. multocida (Wijewardana and Sutherland, in press) have
indicated this.
Bactericidal activity against the A2 serotype was induced in the
sera and lung washings of "convalescent" SPF lambs (Table 4.1) and
in SPF lambs vaccinated with a crude homologous preparation of P.
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haemolvtica cytotoxin (section 8). In contrast to the "rough" type
LPS of the serotype A2 , all the T biotype serotypes were found to
possess "smooth" type LPS. To investigate further whether
antibodies in immune sera would express bactericidal activity to a
T biotype organism (serotype T10), sera from animals which were
"convalescent" or vaccinated against this serotype were tested for
their bactericidal activity. However, these sera were not
bactericidal under the assay conditions described here despite the
presence in these sera of antibodies to LPS and other cell-surface
antigens as demonstrated by an anti-LPS ELISA and immunoblotting
respecively.
Together, these results suggest that the T10 serotype of P.
haemolvtica is, in contrast to the A2 serotype, resistant to the
bactericidal effects of antibody and complement. One possible
explanation for this distinction is that the LPS from the T10
serotype is of a "smooth" variety whilst the A2 serotype possess a
"rough" type of LPS (Fig. 4.3). The LPS of the other T serotypes
(3, 4 and 15) were also shown to be "smooth" (Fig. 4.3) therefore
also indicating their potential for serum resistance and this would
be worthy of further study. However, no immune sera against these
serotypes are available at present and this study was therefore not
carried out here.
The resistance of T10 serotype to bactericidal activity may
indicate why the T serotypes more readily causes a systemic form of
ovine pasteurellosis in young adult sheep than the A serotypes,
which are generally associated with the pneumonic forms of
disease.
Bactericidal activity raised by vaccination has been correlated
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with protection against pneumonia caused by the A2 serotype
(section 8). The apparent resistance of the T10 serotype to
bactericidal activity may therefore have significant bearing on the
formulation of vaccines against the systemic form of pasteurellosis
caused by the T serotypes.
85
SECTION 5
Qpsonin-Mediated Phagocytosis of P. haemolvtica Serotype A2,
It has been noted that P. haemolvtica serotype A1 is poorly
phagocytosed by bovine bronchoalveolar macrophages (BAM) (Benson et
al.. 1978; Markham and Wilkie, 1980). Opsonising antibodies
have, however, been shown to increase phagocytosis (Markham and
Wilkie, 1980; Maheswaran et al.. 1980). Uptake of late-log
phase (18 hour) organisms has also been observed to occur more
readily than with early log-phase (6 hour) cultures (Berggren et
al., 1981).
A significant increase in the uptake of chromium-51 isotope
labelled P. haemolvtica A2 was shown after opsonisation with sera
and lung washings from "convalescent" SPF lambs (Donachie et al.,
1986a). However, in agreement with the studies on phagocytosis of
P. haemolvtica Al by bovine macrophages, the degree of
phagocytosis in this study was also low. Despite this, there were
indications that opsonisation may be associated with protection of
sheep against pasteurellosis, and this mechanism of immunity would
therefore seem worthy of further investigation.
Several methods for studying phagocytosis have been developed
and these include plate counting of bacteria released from
sedimented phagocytes (Watson, 1976), counting visualised
internal particles by microscopy (Lee-Smith and Rommel, 1977) and
quantitation of isotope-labelled bacteria ( Verhoef et al..1977)
including P. haemolvtica (Maheswaran et al., 1980). Each of these
methods has however depended upon the removal of extracellular
bacteria, generally involving extensive washing of sedimented
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phagocytes by centrifugation, before pbagocytosed bacteria can be
counted. This practice is tedious, time consuming and can result
in cell loss or death which leads to counting errors.
A rapid, microtitre plate, opsonophagocytosis assay was
therefore developed to measure the uptake of isotope-labelled P.
haemolvtica by ovine BAM. The principle of this assay was that non
cell-associated bacteria would be removed from assay suspensions by
filtration through selectively sized filter membranes (5.0 jam pore
size) which would retain BAM and thus allow enumeration of
cell-associated (phagocytosed) bacteria. This method was then used
to screen sera for their opsonic potential and to characterise
opsonophagocytosis of P. haemolvtica A2.
Donachie et al. (1986a) used chromium 51-isotope labelled P.
haemolvtica for opsonophagocytosis assays whereas Maheswaran et al.
3 3
(1980) employed tritiated thymidine ( H). The advantages that H
has over chromium-51 is that chromium-51 is spontaneously released
from bacteria during the assay period and can be taken up by BAM
3
therefore giving erroneously high background counts, whereas H is
3
not spontaneously released. Also, H has a much longer half-life
and is therefore more cost-effective in use. Because of these
3
advantages, H was chosen as the isotope for use in the assay.
3
H-labelled P. haemolvtica A2 was prepared by inoculating 100
p.1 of P. haemolvtica A2 culture, which had been removed from
storage at -70°C, into 10 ml of NB containing 100 }iCi of
3
H-thymidine (Amersham U.K.). The broth was incubated for 18 hours
at 37°C and 1ml aliquots were then centrifuged at 11,000 g for 5
min on a microfuge. Pelleted bacteria were washed three times by
centrifugation in Hanks' BSS and finally resuspended in Hanks' BSS
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supplemented with 10% heat-inactivated FBS, 2% 30 mM Hepes buffer,
1% sodium bicarbonate and adjusted to pH 7.2 with 1 M Na OH (Hanks'
medium) to the desired concentration. Bacterial numbers were
determined by retrospective plate counting on SBA plates by the
method of Miles et al. (1938).
Sheep BAM were recovered from lungs obtained at Gorgie slaughter
house, Edinburgh. Cells were recovered by lung lavage as
described by Burrells (1986), followed by sedimentation at 100 g
for 20 min at room temperature. Cells were washed twice in Hanks'
BSS and resuspended in 5ml of Hanks' medium. An aliquot (10 pi) of
cells was added to 90 pi of trypan blue dye (Sigma, U.K.) and the
total cell count and BAM viability assessed by counting in an
improved Neubauer cell counting chamber. BAM suspensions were only
used if they were > 90% viable and represented greater than 80% of
the cell population as assessed by morphological criteria. BAM
6 -1
were finally adjusted to 2.5 x 10 viable cells ml by dilution in
Hanks' medium.
Sera to be tested for opsonins (immunoglobulins) were heat-
inactivated at 56°C for 30 min before use.
The opsonophagocytosis assay was performed in Millititer-SV
microtitre plates (Millipore, Bedford, U.S.A.) using the Titertek
vaccuum apparatus (Millipore) shown in Fig. 5.1 . The microtitre
plate filter membranes (5 pm pore size) were pre-wetted by the
addition of 10 pi of Hanks' medium to each assay well. Bacterial
suspension (100 pi) was added to each assay well except for three
blank control wells which received 100 pi of Hanks' medium.
Triplicate 100 pi volumes of bacterial suspension were also added
to 2 ml of Scintillator 299 (Packard Instrument Co. U.S.A.) in
Fig. 5.1
I
The Titertek microtitre plate apparatus used
for opsonophagocytosis assays, a, millititer
SV microtitre plate and carrier; b, vacuum
apparatus; c, filter punch.
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plastic counting vials for counting as total activity controls on a
beta-isotope counter (Canberra Packard, U.K.)- Volumes (20 pi) of
test sera, positive control (an SPF lamb "convalescent" serum) and
negative control (FBS) sera were then added to triplicate assay
wells, the plates sealed with sterile plastic film and incubated at
37°C for 30 min to allow opsonisation to occur. After
opsonisation, 80 pi of BAM suspension was added to each assay well
except the bacteria-only control wells, which received 80 pi of
Hanks' medium. Plates were again covered with sterile plastic film
and incubated at 37°C for the required period to allow phagocytosis
to occur.
Extracellular bacteria were removed from assays suspensions by
placing assay plates on the Titertek vacuum apparatus, removing
assay medium by suction and washing each well five times by suction
with 200 pi volumes of Hanks' BSS. The retained BAM containing
cell-associated bacteria were dried onto membrane filters by
placing the assay plates at 37°C in an incubator. Individual well-
membranes were then removed with a punch, added to 2 ml of
scintillant in plastic vials and activity counted on a beta-isotope
counter.
The percentage of bacterial inoculum phagocytosed in each sample
triplicate was calculated from the formula :
% phagocytosis — 100 x (the mean counts per min (CPM) in
triplicate test filters - the mean CPM in bacteria only filters /
the mean CPM in the total counts samples - the CPM in the bacteria
only filters) .
It was always confirmed that the CPM in the bacteria only
control filters was close to the CPM in the blank control filters
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before assay verification, since this ensured that the
extracellular bacteria had been removed from assay suspensions by
washing.
An opsonic index (OpI) of the percentage of bacteria which were
specifically opsonophagocytosed was calculated from the formula:
OpI = 100 x (CPMs - CPMc / CPMt).
Where, CPMs = the mean CPM for phagocytosed bacteria in the
sample, CPMc = the mean CPM for bacteria phagocytosed in the
presence of the standard negative control serum and CPMt = the mean
CPM in the total bacterial inoculum (100 pi volume). All CPM are
minus the mean CPM found in the bacteria only control filters.
5.1. Evidence for the retention of BAM on assay filter membranes.
The usefullness of this phagocytosis assay depended upon the
assumption that BAM would be retained on the assay plate filters.
Evidence for this was sought by adding chromium 51-isotope labelled
BAM to assay wells. BAM were labelled exactly as described in
section 3, suspended in Hanks' medium at 2.5 x 10^ viable BAM ml ^
and 80 pi volumes added to six assay wells containing 120 pi of
Hanks' medium. BAM suspension (400 pi) was also added to six 1 ml
polypropylene vials (NUNC, Denmark) containing 600 pi of Hanks'
medium which acted as spontaneous release controls. The assay
plate and tubes were incubated at 37°C for 30 min to emulate
phagocytosis and then the assay plate was placed on the Titertek
vacuum apparatus and washed five times in 200 pi of Hanks' BSS. The
initial assay medium and each subsequent wash were collected by
placing a microtitre plate in the vacuum apparatus below the assay
plate. The six spontaneous-release control tubes were centrifuged
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at 100 g for 5 min at room temperature to sediment the BAM. The
supernatant was removed and the BAM washed five times in 1 ml of
Hanks' medium. The supernatants and washings for each sample were
combined and added to plastic counting tubes. The BAM pellets from
the polypropylene tubes and the dried membranes from the assay
plate wells were also added to plastic counting vials and all
samples were counted in a gamma-isotope counter (Canberra Packard,
U.K.)
The mean CPM in the washings from the microtitre plate assay
wells was 2,083 and the mean CPM in the microtitre plate assay
filters was 10,003. Therefore 17.2% of the activity was present in
the supernatants. The mean CPM in the washings from the
spontaneous-release control tubes was 15,095 and the mean CPM in
the BAM pellets was 67,274, resulting in a mean spontaneous release
of 18.0% in the control tubes. This indicated that the amount of
isotope label which passed through the microtitre plate filter
membranes was equivalent only to the amount of isotope expected to
be spontaneously released. This therefore suggested that BAM were
retained by the assay filters, thus validating the assay procedure.
5.2 Optimisation of the opsonophagocytosis assay.
Opsonophagocytosis was optimised with respect to 1) bacterial
count in ratio to BAM numbers and 2) differing incubation periods.
The mean CPM in the P. haemolvtica A2 suspension (100 pi) was
1331, while the blanks and bacteria-only controls gave 111 and 112
mean CPM respectively.
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5.2.1. Optimisation of P. haemolvtica A2 to BAM ratio.
BAM at 2.5 x 10^ ml ^ were mixed with P. haemolvtica A2 in
ratios of 1 to 50 , 1 to 10, 1 to 5, 1 to 0.5 and 1 to 0.05. The
P. haemolvtica suspension had previously been opsonised, as
described, in the presence of either the standard positive serum or
the standard negative serum.
Results (table 5.1) showed that maximum phagocytosis occurred
when a BAM to bacteria ratio of 1 to 5 was employed. However, the
OpI was similar at ratios of 1 to 10 and 1 to 5. At both of these
ratios the % phagocytosis was significantly (p<0.001) higher in the
opsonised suspensions when compared with the unopsonised ones. At
ratios of 1 to 0.5 and 1 to 0.05 the CPM was approximately that of
the blanks and no phagocytosis was therefore apparent. At a ratio
of 1 to 50 opsonisation did not significantly increase the %
phagocytosis. A ratio of between 1 to 5 and 1 to 10 was therefore
selected as optimum.
5.2.2. Optimisation of assay incubation period.
Opsonophagocytosis in the presence of the standard positive
serum was measured at intervals of 10, 20, 30, 40 and 60 mins. The
% phagocytosis was 13, 23.1, 22.5, 21.5 and 23.3% respectively
for these intervals and the % phagocytosis therefore did not change
significantly beyond 20 min incubation. An assay period of 30 mins
was selected for further assays.
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Table 5.1. The percent phagocytosis of P. haemolvtica A2 in
assays containing differing bacteria to phagocyte
ratios
ODsonisine BAM: Mean (+ standard OpI
serum bacteria ratio error)
% Dhaeocvtosis
standard 1:50 7.0 (+ 0.18) 4.1
positive 1:10 24.9 (± 0.2) 19.5
1:5 32.1 (± 0.4) 20.0
1:0.5 0 0
1:0.05 0 0
standard 1:50 2.9 (± 0.26)
negative 1:10 5.4 (± 0.3)
1:5 12.1 (± 0.17)
1:0.5 0
1:0.05 0
BAM = bronchoalveolar macrophage
% phagocytosis (see text)
OpI - opsonic index (see text)
standard positive serum = serum from a "convalescent" SPF lamb
standard negative serum — foetal bovine serum
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5.3. Characterisation of the opsonin-mediated phagocytosis of
P. haemolvtica A2 by BAM.
Both complement components (C3b) and immunoglobulins (IgG
subclasses) have been found to increase the uptake of bacteria by
phagocytes (Verhoef et al., 1977). The role of complement as an
opsonin for P. haemolvtica A2 and its interaction with opsonic
antibody was therefore investigated. That opsonisation of P.
haemolvtica by the standard positive serum was due to the presence
of immunoglobulins was also confirmed with purified IgG from this
serum.
5.3.1. The role of complement as an opsonin for P. haemolvtica A2.
Complement (naive SPF lamb serum stored at -70°C, see section 4)
was added (20 jul) with either the standard positive serum or the
standard negative serum (20 jul) to phagocytosis suspensions as
described above, except that BAM were added as 60 jul volumes of a
6 -1
3.3 x 10 viable BAM ml . Assay suspensions therefore included 1)
20 jul of complement + 20 jul of standard positive serum, 2) 20 jul of
complement + 20 jul of standard negative serum, 3) 20 jul of standard
positive serum + 20 jul of standard negative serum and 4) 20 jul of
heat-inactivated (56°C for 30 min) complement + 20 jul of standard
negative serum.
Complement with the standard negative serum was found to cause a
significant (p<0.05) increase in phagocytosis (13.3%) of P.
haemolvtica A2 when compared to heat-inactivated complement (4.3%).
The standard positive serum induced 22.7% phagocytosis of the
bacterial inoculum and this was increased (but not significantly)
to 30.0% when complement was added.
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5.3.2. The opsonic activity of purified IgG for P. haemolvtica A2.
Purified IgG (2.27 mg ml "*") was shown to opsonise P. haemolvtica
A2 and significantly (p<0.05) increased phagocytosis to 21.2%
compared to 4.3% in the absence of antibody.
5.3.3. Absorption of opsonising serum with P. haemolvtica A2
antigen fractions.
Volumes (1 ml) of the standard positive serum were absorbed with
LPS, SSE or crude cytotoxin at 1 mg ml ^ for 30 min at 37°C. After
absorption the serum was sterilised by filtration (0.45 yam pore
sized membrane). The antigens used for absorption were prepared as
described in Materials and Methods.
Neither absorption with LPS nor crude cytotoxin significantly
altered the opsonic capacity of the standard positive serum, giving
23.3 and 26.4 % phagocytosis respectively. Absorption with SSE,
however, caused a small, but significant (p<0.001) decrease in
opsonic capacity which resulted in 18.4% phagocytosis compared to
24.9% in the presence of the unabsorbed serum.
Discussion
The microtitre plate opsonophagocytosis assay was rapid and gave
little variation between sample triplicates. Only low (but
statistically significant) levels of phagocytosis of P. haemolvtica
A2 were seen in the presence of opsonins, namely IgG and
complement. Low % phagocytosis have been observed previously for P.
haemolvtica A1 (Benson et al., 1978; Markham and Wilkie, 1980)
and the opsonic capacity of the standard positive serum found in
this work was similar to levels of phagocytosis found previously
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for "convalescent" lamb sera (Donachie et al., 1986a).
The optimal ratio of BAM to P. haemolvtica for the demonstration
of opsonophagocytosis appeared to be between 1 to 5 and 1 to 10. At
a higher ratio (1 to 50) phagocytosis did not increase
significantly in the presence of opsonins. Also, it was noted
that phagocytosis did not increase significantly beyond a period of
20 min incubation at a BAM to P. haemolvtica ratio of 1 to 10.
Taken together, these results suggest that phagocytosis of P.
haemolvtica in vitro is limited. One reason for this may be that
BAM are affected by the production of P. haemolvtica cytotoxin
during the incubation period; and the greater the number of
bacteria in the assay the more cytotoxin there would be expected to
be produced. Berggren et al. (1981) noted that at higher bacteria
to BAM ratios P. haemolvtica Al inhibited phagocytosis by bovine
BAM. Furthermore, Sutherland et al., (1983) found that live P.
haemolvtica Al organisms were toxic for ovine BAM. The convalescent
sera (which was used for opsonisation in this section) contained
cytotoxin neutralising (CN) antibodies, but these may not have been
sufficient to neutralise cytotoxin, which was presumably
continuously produced throughout the assay period. Additionally,
any surviving intracellular P. haemolvtica A2 may continue to
produce small amounts of cytotoxin inside the phagocyte, which
would not be neutralised by extracellular CN antibodies.
Despite the low levels of phagocytosis found in vitro,
significant increases were demonstrated after opsonisation of P.
haemolvtica with immune serum. The probable toxic effects of
cytotoxin in vitro may also not be so apparent during the early
stages of infection in vivo. when only low numbers of P.
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haemolvtica are likely to be present. At this time the BAM as the
resident phagocyte (Reynolds and Newball, 1976) may play an
essential role in the clearance of P. haemolvtica from the lung.
The ability of the immune animal to increase phagocytosis by
opsonisation may be a critical mechanism in avoiding establishment
of infection. Augmentation of the BAM population by infiltrating
PMNL may also contribute to clearance of P. haemolvtica from the
ovine lung (Davies and Penwarden, 1981). Because a significant
effect of opsonisation can be detected in vitro. further
characterisation of this mechanism of immunity was considered to be
justified.
Both complement (the C3b component) and antibody (particularly
the Igsubclass in sheep; Watson, 1976) have been shown to be
important opsonins of bacteria (Verhoef et al., 1977). Active serum
complement was found in this thesis to induce significant
opsonophagocytosis of P. haemolvtica A2. Although
complement-mediated opsonisation could not be shown to be
synergistic with antibody-mediated opsonisation, these opsonins
were not, at least, mutually exclusive in that opsonophagocytosis
was not impeded in the presence of both antibody and complement.
One possible explanation for this lack of synergy is that maximum
phagocytosis of P. haemolvtica may be around 30% in vitro because
of the effects of toxicity already discussed, and therefore
significant synergy in opsonisation with antibody plus complement
was not apparent because the limit of phagocytosis was nearly
reached by antibody alone. Affinity-column purified IgG from the
standard positive serum, at a concentration equivalent to that
found in the whole serum, was shown to opsonise P. haemolvtica A2
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at a similar level. This indicated that IgG was the major opsonin
in the standard positive serum.
Absorption of bactericidal activity (antibody) from convalescent
serum with LPS suggested that this was the target antigen for
antibodies involved in this activity (section 4). LPS did not,
however, significantly absorb opsonic activity from the standard
positive serum when used at 1 mg ml ^ final concentration.
Absorption with crude cytotoxin also failed to decrease
phagocytosis, and therefore a role for CN antibodies aiding
phagocytosis in vitro was not demonstrated. SSE of P. haemolvtica
A2 cells did, however, decrease the opsonic capacity of serum. A
major antigen in SSE is the serotype specific capsular antigen
(Donachie et al.. 1984b; Adlam et al. , 1985a). Anti-capsular
antibodies have been found to opsonise other bacteria such as S.
pneumoniae (Giebink et al., 1977) and strains of E. coli (Van Dijk
et al., 1979) and it may be speculated, therefore, that the
capsular antigen of P. haemolvtica A2 is a target antigen for
opsonic antibodies.
Recently, monoclonal antibodies (mAbs) against P. haemolvtica Al
capsule, and to a lesser degree mAbs to LPS, were shown to be
opsonins for mouse macrophages using the method described in this
section (C. Wilson, A.D. Sutherland, M. Quirie, L. Inglis and W.
Donachie. In preparation.). Production of monoclonal antibodies
against P. haemolvtica A2 antigens might therefore help to




The Susceptibility of In Vivo Grown P. haemolvtica to Effector
Mechanisms of Immunity,
That in vivo grown bacteria can differ phenotypically from
bacteria grown in vitro has been noted by others. Differences
include the in vivo expression of OMPs involved in iron acquisition
(Griffiths et al.. 1983; Sciortino et al.. 1983; Brown et al..
1984) and changes in LPS composition (Kelly £t aL. , 1989) .
Bacterial growth in vivo can also lead to phenotypic changes
resulting in resistance to bactericidal effects. Sensitive N.
gonorrhoea grown in guinea pig chambers became resistant to human
serum but reverted to the sensitive state on in vitro sub-culture
(Penn et al., 1976)
It was considered possible that P. haemolvtica may also undergo
phenotypic change in vivo. As a consequence, changes in relation
to expression of virulence factors and interaction with effector
mechanisms of immunity may occur. It was therefore decided to
investigate the interaction of P. haemolvtica grown in vivo with
bactericidal and opsonophagocytic mechanisms.
Day et al. (1980) studied the production of bacterial products
and changes in the surface structure of S. aureus after in vivo
growth in intraperitoneal chambers. This technique was therefore
adopted here for the in vivo growth of P. haemolvtica A2 in sheep.
The resultant organisms were examined for expression of in vivo
antigens and for susceptibility to bactericidal and phagocytic
immune mechansms.
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6.1. Preparation and implantation of peritoneal growth
chambers.
Chambers for the growth of P. haemolvtica A2 in vivo were
prepared from silicone tubing (19.0 mm internal diameter and 25.4
mm outer diameter) (Altec, Alton. England). Lengths of tubing
(approximately 50 mm) were closed at one end with a 25 mm diameter,
0.45 jam filter membrane (Millipore, U.K.) which was sealed in
place with medical-grade silicone type A adhesive (Dow Corning.
U.K.). The chambers were sterilised by autoclaving together with a
second filter membrane which was to be used to close the other end
of the chamber.
P. haemolvtica A2 chamber inoculum was prepared by centrifuging
bacteria from an 18 hour, 10 ml NB culture at 1,000 g for 30 min
and washing the pellet once in phosphate buffered saline pH 7.2
(PBS). The washed bacteria were resuspended in 50 ml of PBS, and
approximately 10 ml volumes were pipetted aseptically into the
chambers. With the aid of sterile forceps, the chambers were
sealed with the other sterile filter membrane. Retrospective plate
counting of the bacterial inoculum resulted in counts of 2.0 x 10^
and 5 x 10^ cfu ml ^ on two separate occasions.
Two chambers were each implanted aseptically into the peritoneal
cavity of anaesthetised sheep by Miss Lorna Hay and Dr. Gareth
Jones. The peritoneal opening was closed with surgical suture and
the animals allowed to recover. Seven days later the animals were
killed and the chambers recovered.
At necropsy the chambers were found to be completely enclosed by
a thick fibrinous capsule (Fig.6.1) from which they were removed
aseptically with a scalpel. Considerable areas of ecchymoses were
Fig. 6.1. Necropsy photograph of chamber-implants in the
peritoneum of a sheep. A fibrinous capsule
from which the chambers were removed is
arrowed.
Fig. 6.1. Necropsy photograph of chamber-implants in the
peritoneum of a sheep. A fibrinous capsule




noted on the peritoneal lining surrounding the chambers. The
chamber contents were recovered by standing the chambers on one end
and cutting away the upper filter with sterile scissors. The
contents of individual chambers were pooled on each occasion. No
white blood cells were found on microscopic examination of the
chamber contents, and this was taken as an indication that the
chambers had not ruptured in vivo. However, a small fibrinous
clot was found in each chamber which was removed with sterile
forceps. A plate count of the bacteria in the pooled
chamber-contents showed that 3.45 x 10^ and 2.0 x 10^ cfu ml ^ P.
haemolvtica A2 were present in pure culture on two separate
occasions.
Bacteria were recovered from volumes (10 ml) of the chamber
fluid by centrifugation at 1,000 g for 30 min at 4°C and the
supernatant fluid was stored at -70°C until required. Aliquots of
chamber contents (including bacteria) were also stored without
washing at -70°C for later analysis. Bacteria pelleted by
centrifugation were washed once in PBS and on resuspension in the
required diluent (see below) were tested for susceptibility to
bactericidal activity and phagocytosis without passage by growth in
vitro. Also, some pelleted bacteria were lyophilised and stored for
later analysis.
6.2. The susceptibility of in vivo grown P. haemolvtica A2 to
phagocytosis.
The susceptibility of in vivo grown organisms to phagocytosis by
BAM after opsonisation with "convalescent" SPF lamb serum could not
be assessed by the method described in section 5 since this
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required incorporation of H-thymidine into bacteria by growth in
vitro. Opsonopbagocytosis was therefore assessed by a plate
counting method and in vitro grown bacteria were tested in the same
manner for direct comparison.
In vivo grown bacteria were resuspended in Hanks' medium after
pelleting from peritoneal-chamber contents by centrifugation. In
vitro grown bacteria were prepared from an 18 hour culture in the
3
same manner as described in section 5, except H thymidine was
omitted from the culture. Bacterial counts in both inocula were
confirmed by retrospective plate counting.
The BAM suspension was prepared as described in section 5 and
sera used as opsonins were the standard positive and negative sera
described in section 5.
The opsonophagocytosis assay was performed on two separate
occasions. Volumes (500 pi) of in vivo or in vitro grown P.
haemolvtica A2 were mixed with 100 pi of the standard positive and
negative sera in duplicate 1 ml polypropylene vials (NUNC,
Denmark). Tubes were incubated at 37°C for 30 min on a roller
apparatus (Luckham Laboratories) to allow opsonisation to occur.
Then, 400 pi of BAM suspension was added to each suspension and the
tubes further incubated for 30 min on the roller apparatus to allow
phagocytosis to occur. After phagocytosis, BAM were sedimented by
centrifugation at 100 g for 5 min at 4°C, washed three times to
remove extracellular bacteria, resuspended in 1 ml of 0.1% Triton
X100 (Sigma) and finally vortexed vigorously to lyse BAM and
release intracellular bacteria. The lysed BAM suspensions were
then titrated in ten-fold dilutions in peptone water (Gibco) and
each dilution plated for retrospective bacterial counting.
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The mean percentage of P. haemolvtica A2 phagocytosed in
duplicate sample tubes was calculated from the formula:
mean % phagocytosis = 100 x (The mean cfu ml ^ in lysed BAM
suspensions / 0.5 x the mean cfu ml ^ in the assay inoculum).
An opsonic index (OpI) was calculated for each suspension using
the formula:
100 x (Cs - Cc / Ct).
Where Cs = the mean counts from phagocytosed bacteria in sample
suspensions opsonised with the standard positive serum, Cc = the
mean counts from phagocytosed bacteria in sample suspensions
opsonised with the standard negative serum and Ct = 0.5 x the mean
counts from the total number of bacteria in the assay inoculum.
The P. haemolvtica inocula gave counts of 2.9 x 10^ and 1.0 x
10^ cfu ml ^ of assay suspension for in vivo grown organisms and
3.9 x 10^ and 1.0 x 10^ cfu ml ^ of assay suspension for in vitro
grown organisms respectively on the two separate assay occasions.
Results (Table 6.1) showed that BAM phagocytosed a mean of 21.8%
and 21.5% of the in vitro grown bacterial inoculum on the two
separate occasions in the presence of the standard positive serum
while a mean of 0.002% and 0.7% of the in vitro grown bacterial
inoculum was phagocytosed in the presence of the standard negative
serum. The levels of opsonophagocytosis of the in vitro grown
bacteria in the presence of the standard positive serum were
similar to those seen in the microtitre-plate phagocytosis assay
(section 5). The mean % phagocytosis of in vivo grown bacteria was
also increased in the presence of the standard positive serum
(9.65% and 8.1%) when compared to the standard negative serum (1.9%
and 4.7%) on the two separate assay occasions, but this was a
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Table 6.1. The mean percentage phagocytosis of P. haemolvtica A2
grown in vivo or in vitro.













2 in vivo standard positive 8.1 3.4
standard negative 4.7 0
in vitro standard positive 21.5 20.8
standard negative 0.7 0
Standard positive serum = a "convalescent" immune specific-pathogen-
free lamb serum.
Standard negative serum = a naive specific-pathogen-free lamb serum
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lower percentage of opsonophagocytosis than was determined for in
vitro grown bacteria and resulted in a mean OpI of 5.6% over the
two assays compared with a mean OpI of 21.3% for in vitro grown
bacteria tested under the same assay conditions.
These results indicated that in vivo grown P. haemolvtica A2
organisms were less susceptible to antibody-mediated
opsonophagocytosis than in vitro grown organisms and suggested that
phenotypic changes occur in organisms grown in vivo which reduce
their susceptibility to opsonophagocytosis.
6.3. The susceptibility of in vivo grown P. haemolvtica A2 to
bactericidal activity.
In vivo grown bacteria were tested on two separate occasions for
their susceptibility to antibody-mediated complement-dependent
bacterial killing by the method described in section 4. In vitro
grown organisms were tested in the same assay and considered to be
known susceptible organisms (section 4). The standard positive and
negative sera and the assay method were as described in section 4.
The inoculum for in vivo grown organisms was prepared by
resuspending organisms in modified barbitol buffer (MBB) and
bacterial counts in the assay inocula were found by retrospective
4 4-1
plate counting to be 1.7 x 10 and 1.1 x 10 cfu ml on the two
separate assay occasions.
The in vitro grown bacteria were from 3 hour cultures and were
prepared as described in section 4. Bacterial counts in the assay
4
inoculum were found by retrospective plate counting to be 1.0 x 10
4 -1
and 1.8 x 10 cfu ml on the two separate assay occassions.
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Results (Table 6.2) showed that the in vitro bacterial inocula
were killed by a mean of 100% and 87% in the presence of the
standard positive serum and 0% by the standard negative serum on
the two separate assay occasions. These results indicated that the
assay procedure was functional and that in vitro bacteria required
the addition of antibody and complement for bacterial killing to
occur. This confirmed the findings of section 4. In contrast, in
vivo grown bacteria were killed by a mean of 97% and 100% in the
presence of the standard positive serum and 91% and 90% in the
presence of the standard negative serum.
These results led to suggestions that either phenotypic changes
in in vivo grown organisms had induced susceptibility of these
organisms to the alternative complement pathway or that in vivo
grown bacteria had cell-surface bound host-derived immunoglobulin.
An examination was therefore made for the presence of cell-surface
bound immunoglobulin.
6.4. Examination of in vivo grown P. haemolvtica A2 for bound,
host-derived immunoglobulin.
Host derived immunoglobulin which was bound to in vivo grown P.
haemolvtica A2 was detected by direct interaction of the
immunoglobulin with donkey anti sheep-immunoglobulin conjugated
with horse radish peroxidase.
6.4.1. Detection of immunoglobulin by dot immunoblotting.
An aliquot (1 ml) of in vivo grown P. haemolvtica A2 cells was
recovered from -70°C storage, thawed, pelleted on a microfuge,
washed twice in 1ml of MBB and resuspended in 1 ml of MBB. A 2 yl
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Table 6.2. The mean percentage killing (%K) of in vitro and in vivo
grown P. haemolvtica A2 in the bactericidal assay
Assay Bacterial growth Serum Mean % K
conditions
1 in vivo standard positive 97
standard negative 91
in vitro standard positive 100
standard negative 0
2 in vivo standard positive 100
standard negative 90
in vitro standard positive 87
standard negative 0
Standard positive serum = a "convalescent" immune specific-pathogen-
free lamb serum.
Standard negative serum = a naive specific-pathogen-free lamb serum
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volume of this suspension was adsorbed onto a nitrocellulose strip
(Millipore, U.K.) and air dried. An 18 hour in vitro culture of P.
haemolvtica was treated in a similar manner and acted as a negative
control for the presence of bound sheep immunoglobulin. A 2 pi
volume of the standard positive serum was also adsorbed onto
nitrocellulose to act as an IgG positive control. Dot
immunoblotting was carried out as described in Materials and
Methods.
The in vivo grown P. haemolvtica A2 organisms were found to have
bound sheep immunoglobulin detectable by dot immunoblotting whereas
the in vitro grown organisms did not (Fig.6.2). Immunoglobulin was
also detectable in the positive control.
6.4.2. Detection of bound IgG by western blotting.
Immunoglobulin bound to in vivo grown P. haemolvtica A2 was
further characterised by western blotting as described in Materials
and Methods. Lyophilised P. haemolvtica A2 organisms (300 pg),
which were from either peritoneal chambers or 18 hour NB cultures
grown in vitro. were resuspended in SDS-PAGE solubilising buffer
and run on 10% gels. Resolved antigens were transferred to
nitrocellulose and reacted with donkey anti-sheep immunoglobulin
conjugated with HRP.
A thick band of 53 kDa was detected by the conjugate on the
track containing in vivo grown organisms. The in vitro grown
organisms did not contain this band (Fig. 6.3). By its molecular
mass and its reaction with the conjugate, the band was identified
as the heavy chain of sheep IgG which was previously identified in
Materials and Methods (part 2.7).
Fig. 6.2. Dot iramunoblot of samples of P. haemolvtica A2
whole cells grown: (1), in vitro: (2), in vivo;
and (3), a "convalescent" immune specific-
pathogen- free lamb serum containing IgG.
Samples were reacted with donkey anti-sheep
immunoglobulin conjugated with horseradish
peroxidase to detect sheep immunoglobulin.
Fig. 6.3. Western blot of P. haemolvtica A2 whole cells
grown: lane 1, in vitro. lane 2, in vivo and
lane 3, molecular mass markers. Samples were
reacted with donkey anti-sheep immunoglobulin














6.5. SDS-PAGE analysis of in vivo grown P. haemolvtica A2
organisms.
Donachie and Gilmour (1988) have recently reported that P.
haemolvtica A2 organisms isolated from the pleuritic fluid of
infected animals expressed envelope-located proteins which were
either not detectable, or present in detectably lesser amounts, in
bacteria grown in NB in vitro. Some of these proteins
(particularly 70 and 100 kDa) could be expressed in vitro when
grown in iron depleted media and were therefore considered to be
IRPs. SDS-PAGE analysis to detect these IRPs was used to confirm
that the bacteria recovered from peritoneal chambers had undergone
phenotypic change during in vivo growth. Kelly et al. (1989) have
recently found that the LPS recovered from in vivo grown P.
aeruginosa organisms had additional polysaccharide bands which they
suggested may enhance the virulence of this organism in vivo. In
vivo grown P. haemolvtica A2 organisms were therefore examined for
their LPS phenotype by SDS-PAGE.
6.5.1. Examination of proteins from in vivo grown P. haemolvtica
A2 by SDS-PAGE.
SDS-PAGE for the detection of proteins was carried out as
described in Materials and Methods. Lyophilised whole bacterial
cells (300 pig) from either peritoneal chambers or in vitro grown 18
hour NB cultures were resuspended in solubilising buffer and loaded
onto 10% SDS-PAGE gels. Gels were stained with Coomassie blue dye
(Morrisey, 1981) to visualise protein bands.
Figure 6.4 shows that protein bands which were additionally
produced or detectably over-produced were identified in in vivo
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grown cells when compared to in vitro grown cells. These bands
were 105, 100, 95, 70, 66, 53 and 25 kDa in molecular mass.
Furthermore, protein bands of 36 and 24 kDa were expressed by in
vitro grown organisms which were not detectable in in vivo grown
organisms.
6.5.2. Examination of LPS from in vivo grown P. haemolytica A2 by
SDS-PAGE.
LPS from both in vivo and in vitro grown cells was examined by
SDS-PAGE of proteinase K digested whole bacterial cells as
described in Materials and Methods. Lyophilised cells (300 pg)
were resuspended in solubilising buffer and proteinase K and loaded
onto 12.5% gels.
Both in vivo and in vitro grown cells were found to possess
rough type LPS (results not shown) which gave an identical profile
to the serotype A2 LPS shown in section 4 (Fig. 4.3). No
phenotypic change in the A2 LPS structure was therefore detectable
after in vivo growth.
6.6. Detection of a cell-wall capsule on in vivo grown P.
haemolvtica A2.
The production of a capsule in aureus has been associated
with avoidance of opsonophagocytosis by prevention of opsonin
phagocyte-receptor interaction (Wilkinson et al., 1979) . Early
log-phase cultures of P. haemolvtica Al have been shown to produce
more capsule than late log-phase cultures (Corstvet et al., 1982)
and it is reported that early log-phase P. haemolvtica Al are less
susceptible to opsonophagocytosis than late log-phase cultures. The
Fig. 6.4. SDS-PAGE of: lane 1, molecular mass standards,
lane 2, in vitro grown and lane 3, in vivo






















size of the P. haemolvtica capsule might therefore be implicated
as a factor in avoidance of phagocytosis. Since in vivo grown P.
haemolvtica A2 organisms were found to be opsonophagocytosed to a
lesser degree than similarly treated in vitro grown organisms, in
vivo grown organisms were compared to early log-phase and late
log-phase in vitro grown organisms for capsule content.
Detection of capsule was carried out retrospectively after the
findings of phagocytosis studies. In vivo grown organisms were
therefore examined for capsule either after storage at -70°C or
upon recovery of organisms from a third chamber implant. Capsule
was detected by the Maneval stain (Maneval, 1941). In vitro grown
P. haemolvtica A2 were recovered from 10 ml volumes of NB grown for
6, 18 or 24 hours. Bacteria were harvested from 1 ml volumes by
centrifugation at 11,000 g for 5 min and pelleted bacteria
resuspended in 1 ml of PBS pH 7.2. Similarly, in vivo grown
bacteria were pelleted from chamber fluid by centrifugation
followed by resuspension in 100 jul of PBS pH 7.2. A loopful of
each bacterial suspension was mixed on a microscope slide with a
loopful of a 1.0% aqueous solution of Congo red stain (BDH
chemicals.), spread thinly and then air dried. The smears were
then counter-stained with a 1.0% aqueous solution of acid fuchsin
suspended in Maneval solution A (30 ml of 5% aqueous phenol, 8 ml
of 20% aqueous glacial acetic acid and 4 ml of 30% aqueous ferric
chloride) for 2 min, drained and blotted dry. Negatively stained
capsules were seen by this method to surround red staining
bacterial bodies presented on a pale blue background.
P. haemolvtica A2 organisms from 6 hour in vitro cultures (Fig.
6.5.1) were found to have thicker capsules when compared to
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bacteria from 18 and 24 hour cultures (Fig. 6.5.2 and 6.5.3
respectively). Both, In vivo grown organisms recovered from -70°C
storage (Fig 6.5.4), and in vivo grown organisms recovered
directly from peritoneal chambers (not shown) did not appear to
have any more capsule than was seen on organisms from 18 hour
cultures. Since 18 hour in vitro grown organisms were used for
comparison with in vivo grown organisms it therefore appeared
unlikely that capsular content was the reason for the differences
in opsonophagocytosis observed between these type of organisms. In
vivo grown organisms were, however, found to be aggregated into
clusters of bacteria (Fig. 6.5.4). This aggregation may have
inhibited the optimal binding and distribution of opsonic
antibodies and/or may have constituted too large a particle for
optimal uptake by phagocytes. Either of these possibilities could
have given rise to the decreased levels of phagocytosis observed
with in vivo grown bacteria.
Fig. 6.5.1. Maneval stain showing the capsule surrounding
P. haemolvtica A2 organisms grown for 6 hours
in vitro.
Magnification x 2,000
Fig. 6.5.2. Maneval stain showing the capsule surrounding




Fig. 6.5.3. Maneval stain showing the capsule surrounding
P. haemolvtica A2 organisms grown for 24
hours in vitro.
Magnification x 2,000
Fig. 6.5.4. Maneval stain showing the capsule surrounding





The method of Day et al. (1980) was used successfully to grow
pure cultures of P. haemoltica A2 organisms in vivo. The bacteria
were viable, in relatively large numbers and free of contaminant
host cells.
Day e_t al. (1980) found that the formation of a fibrinous
capsule around peritoneal implant chambers was associated with
virulent strains of S. aureus and was probably due to chemotaxis,
since the fibrinous capsule was composed mainly of PMNL.
Xmplanted chambers containing P. haemolvtica A2 were also
found in this thesis to promote the formation of a capsule around
the chambers. This may suggest that chemotactic factors are also
produced by P. haemolvtica A2. Areas of ecchymoses were also noted
on the peritoneum adjacent to the chambers and may have suggested
the production of soluble toxin(s) such as proteases by bacteria in
the chambers.
In vivo grown organisms were found to be as susceptible to
antibody-mediated complement-dependent bacterial killing as were in
vitro grown organisms. In vivo grown organisms were also found,
however, to be killed in the absence of added specific antibodies.
The detection of surface adherent (host-derived) antibodies on in
vivo organisms (part 6.4) suggested that this was responsible for
the effect, rather than phenotypic changes causing susceptibility
of in vivo grown P. haemolvtica A2 to killing by the alternative
complement pathway. The finding that in vivo grown organisms had
no detectable structural changes in LPS antigens, when compared
with in vitro grown organisms supported this conclusion, since LPS
was detected as a target antigen for antibodies involved in
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bactericidal mechanisms (section 4). The presence of host-derived
antibodies may also have been responsible for the slightly elevated
levels of phagocytosis observed for in vivo grown organisms in the
presence of the standard negative serum when compared to similar
suspensions of in vitro grown organisms. The binding of IgG to S.
epidermidis grown in peritoneal dialysate has been observed by
others (Williams et al., 1988).
On two separate occasions, in vivo grown organisms were found
to be opsonophagocytosed to a lesser degree than similarly treated
in vitro organisms (part 6.2). In vitro and in vivo grown
organisms were therefore compared for the presence of capsule to
determine if over-production of this factor in vivo may be
resposible for the reduced susceptibility to opsonophagocytosis. In
vivo grown organisms were however found to possess similar amounts
of capsule when compared to in vivo grown organism from 18 hour
cultures, which were employed for phagocytosis studies. Since
large quantities of capsule were not detected in in vivo grown
organisms this was not a reason for the apparent reduction in
susceptibility of these organisms to phagocytosis. In vivo grown
organism were, however found in aggregates and these may have
afforded these organisms some resistance to phagocytosis.
Early log-phase P. haemolvtica A2 (6 hour) cultures were found
to possess larger amounts of capsule than organisms from 18 or 24
hour cultures. This finding is in agreement with that of Corstvet
et al. (1982), who reported similar findings for capsular
production in P. haemolvtica Al.
Donachie and Gilmour (1988) detected the in vivo expression of
outer-membrane proteins from organisms recovered from the pleuritic
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fluid of experimentally infected animals. Similar expression of
these antigens in organisms recovered from peritoneal chambers was
therefore taken as evidence of phenotypic change in the bacterial
chamber inoculum in response to the in vivo environment. Organisms
from chambers were found to express increased amounts of 100 and 70
kDa antigens. These antigens were detected by Donachie and Gilmour
(1988) from in vivo derived organisms and were further proven to be
IRPs which were inducible in vitro by growth in iron depleted
medium. In this thesis, two further proteins were detected as
being produced by in vivo grown organisms. These proteins were of
95 and 105 kDa in molecular mass. It is interesting to note that
recombinant cytotoxin has been found to consist either of a 102
kDa antigen (Lo et al., 1986) or of a 105 kDa antigen which results
in a 95 kDa degradation product in older cultures (Chang et al
1987) . These novel bands in in vivo organisms could therefore be
evidence of increased levels of intracellular cytotoxin. Also,
proteins of 53, 23 and 66 kDa were found in in vivo cells. The 53
kDa protein may have been heavy chain IgG since bound IgG was
detected on in vivo cells as a 53 kDa band (part 6.4.2.) and
purified IgG was found to consist of a 53 KDa heavy chain and a 26
kDa light chain in section 2. The 66 kDa protein may have been
sheep albumin which was bound to in vivo cells.
Attempts to detect the production of cytotoxin by in vivo grown
organisms were not made since substantial indirect evidence of
toxin production in vivo has already been reported. This evidence
consists of reports of CN antibodies being raised in cattle which
have recovered from either natural or experimental infection with
P. haemolvtica (Baluyut et al., 1981; Shewen and Wilkie, 1983a;
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Cho et: al., 1984; Gentry et al. , 1985a), and in this thesis
"convalescent" lambs have been shown to produce CN antibodies after
infection (section 3).
Two proteins (36 kDa and 24 kDa) were found to be produced by in
vitro organisms which were not expressed by in vivo organisms.
These proteins may be useful in distinguishing between animals
which have been vaccinated with in vitro derived products and those
which have undergone natural infection.
The findings that in vivo grown organisms are susceptible to
antibody-mediated bactericidal mechanisms, and to some extent
opsonophagocytosis, lends further support to the suggestion that
these mechanisms may play an important role in immunity and that
the in vitro assays for detecting these mechanisms may therefore
help in analysing the protective potential of vaccines.
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SECTION 7
Protection of Lambs by Passive Transfer of Immune Serum.
Wells et al. (1979) failed to protect lambs by passive
protection with serum from lambs that had been vaccinated against
P. haemolvtica Al. This led these authors to conclude that humoral
immunity alone was incapable of protecting against experimental
pasteurellosis. Serum from "convalescent" lambs however was later
found to passively protective in a mouse infection model (Donachie
et al., 1986b) and in this thesis humoral effector mechanisms of
immunity such as cytotoxin neutralisation by antibody (section 3),
antibody-dependent bacterial killing (section 4) and
opsonophagocytosis (section 5) have been associated with immunity
in "convalescent" SPF lambs.
A re-evaluation of the protection afforded by the transfer of
immune serum to SPF lambs challenged with P. haemolvtica therefore
seemed merited. It was considered that the demonstration of
immunity via passive transfer of immune serum might prove the
importance of humoral immunity. Furthermore, examination of the
sera by in vitro assays may further confirm the role of these
mechanisms of immunity in protection and support the value of these
in vitro tests as correlates of immunity.
7.1. Production of immune sera for passive transfer
experiments.
Immune sera were produced in conventionally reared Cheviot lambs
from the same flock located at New Milton farm, which is part of
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the
Moredun Research Institute research facilities. Sera were obtained
either from "convalescent" or vaccinated lambs.
7.1.1. "Convalescent" lambs.
Chronic ("atypical") pneumonia was reproduced experimentally at
different times in two groups of lambs by minor variations of the
general methodology described previously (Jones et: al. , 1986) .
Homogenised lung lesion suspensions made from naturally occurring
cases of "atypical" pneumonia (LH) were injected intratracheally
(i.t.) in 8 to 10 ml volumes on day 0. Two different suspensions
were used. The first (injected into group Cvl) was treated with 2
mg ml ^ of ampicillin (Penbritin, Beecham Animal Health) and
contained Mycoplasma ovipneumoniae as the only detectable
microorganism, present at 5 x 10^ colour changing units (ecu) ml ^.
The second, which was not treated with antibiotic, was injected
into group Cv2 and contained M. ovipneumoniae (5 x 10^ ecu ml ) ,
Mycoplasma arginini (5 x 10^ ecu ml ^~) and P. haemolvtica A2 (1 x
3 9 -1
10 cfu ml ).
Group Cvl (6 lambs) was injected intramuscularily (i.m.) with 5
mg kg ^ liveweight of ampicillin at the time of LH inoculation. The
same lambs were injected again on days 7, 50, 56 and 93 with 2 ml
i.t. and 2 ml intranasally (i.n.) of 5 hour NB cultures of P.
haemolvtica A2 diluted appropriately in PBS. These inocula
contained 1 x 10^"^, 1 x 10^'^, 1 x 10^'^ and 1 x 10^'^ cfu ml ,
respectively.
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Group Cv2 (6 lambs) was Inoculated in like manner on days 4 and
40 with inocula containing 1 x 10^'^ and 1 x 10^'^ cfu ml ^,
respectively, of P. haemolvtica A2.
7.1.2. Vaccinated lambs.
Individual animals were injected subcutaneously three times, on
each occasion with 2 ml of vaccine prepared by adsorption of
antigen with aluminium hydroxide gel (Alhydrogel, Miles Research
Products) and emulsification with Bayol and Arlacel A. Group VI
(contemporary with Group Cvl) was injected with a mixture of
heat-killed organisms (HKO, 1 mg ml ^) and SSE (2.5 mg ml ^) of P.
haemolytica A2 (Gilmour et al., 1983). Each dose was administered
28 days apart. Group V2 (contemporary with Group Cv2) was injected
with a vaccine containing SSE only (2.5 mg ml "*") given 21 and 22
days apart.
7.1.3. Collection of serum and formation of immune serum pools.
Blood in 200 to 300 ml volumes was taken on four occasions
between Weeks 9 and 14, and the animals were exsanguinated in
Weeks 14 or 15. Serum pools were formed from all bleedings of the
three or four animals in each group that were serologically
negative before the experiment.
7.1.4. Production of control serum
Two batches of control sera were used for experiment 1. One
(CtSl) was made up of sera taken from 3 to 6 week-old (w.o.) SPF
lambs; the other (CtS2) was made up of sera taken over 2 weeks
from 20 to 25 conventionally reared lambs aged 4 to 6 weeks.
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For experiment 2, a serum pool (CtS3) was formed from four
peers of those used to produce CvS2 and VS2. These donors were
serologically negative when first screened, but low transient
titres to P. haemolvtica were detected by anti-SSE ELISA in three
of them during later bleeds.
7.1.5. Preparation of semi-purified immunoglobulin-rich fractions.
For experiment 1, immunoglobulin-rich fractions (IRF) were
prepared from 3 1 volumes of CvSl, VS1 and CtS2 by cold ethanol
extraction (Cohn et al.. 1946; Oncley et al. , 1949). These
fractions (Cvlgl, VIgl and Ctlg2, respectively) were resuspended
in 200 ml normal saline solution (0.85%) and sterilised by passing
through filters of 0.22 jum average pore diameter.
IRF for subsequent experiments were prepared by precipitation
with 40% (v/v) saturated ammonium sulphate (Garvey et al., 1977)
from 1.8 1 volumes of CvS2 and VS2 for Experiment 3 (Cvlg2 and
VIg2i, respectively) and from 1.9 1 of VS2 for Experiment 4
(VIg2ii). The precipitates were resuspended in normal saline and
2-
dialysed exhaustively against normal saline until free of SO^
ions as determined by the addition of 10% barium chloride (Garvey
et al., 1977). After filtration through 0.45 jjm membranes, the
suspensions were concentrated using either polyethylene glycol
(Breox 20M PEG, Chemical Services and Distribution, Crewe) or
lyophilisation followed by resuspension in a minimum volume of
distilled water. The suspensions were further dialysed against
normal saline, adjusted with saline to a volume considered
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appropriate for the experiment and sterilised by filtration. Total
volumes produced were 250 ml each of Cvlg2 and VIg2i, and 380 ml of
VIg2ii.
7.2. Characterisation of serum pools and IRF (Table 7.1).
IgG was estimated turbidimetrically (Seneviratne and Moores,
1980) and IgM nephelometrically by an adaptation of the method of
Buffone et al. (1975) using an IL Multistat III microcentrifugal
analyser (Instrumentation Laboratory U.K.). Albumin was determined
by the bromocresol- green dye binding method of Doumas et al.
(1971).
Antibodies to P. haemolvtica A2 were assayed by indirect
haemagglutination (IHA) (Fraser et al., 1983) , ELISA using SSE
(Donachie and Jones, 1982) or lipopolysaccharide (LPS) bound to
assay plates by the method of Fodor and Donachie (1988) , cytotoxin
neutralizing (CN) assay (Section 3), bactericidal assay (Section
4) and opsonophagocytosis assay (section 5).
IgG:albumin ratios were 0.56 to 1.20 in whole serum (Table 7.1).
They were increased 9.9 to 11.0 fold by cold ethanol extraction and
6.7 to 8.2 fold by ammonium sulphate precipitation. IgM:albumin
ratios were increased 8.5 to 8.7 fold by cold ethanol extraction
and 3.0 to 4.8 fold by ammonium sulphate precipitation.
All sera and IRF pools from vaccinated or convalescent animals
were positive and those from control animals negative by anti-SSE
ELISA; IRF generally demonstrated higher titres than their parent
serum pools. All pools tested by anti-LPS ELISA were positive,
including CtS3 which had a low titre. The CN assay produced very
similar findings, except that VS1 was negative. The bactericidal
Table7.1.Ch racterisationofs umpoolsndimmunoglobulin-richfra t s Content(g/1)Titrea
Bactopsonophagocytosis
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assay distinguished immune from control serum and IRF, although
some bactericidal activity was detected in Ctlg2 and none was
detected in Cvlg2 or VIg2(i). The IHA test distinguished immune
from control serum, except in experiment 1, where three immune
products yielded insignificant titres. The opsonophagocytosis
assay gave similar results to the IHA test, and the three sera
which gave low IHA titres in experiment 1 also gave low OpI. In
general, the highest titres in the IHA test were produced by
convalescent sera and IRF.
7.3. Passive protection experiments
The design of these experiments is shown in Table 7.2.
Infective inocula: P13 virus, produced as described previously
(Sharp et al, 1978), was injected i.t. and i.n. in 8 ml and 2 ml
volumes respectively. Two preparations of virus inoculum were used
which contained 1 x 10^'^ and 1 x 10^'^ of a 50% tissue culture
infective dose (TCID^q) per 0.2 ml.
P. haemolvtica was administered by aerosol as described
elsewhere (Gilmour ej: al., 1975). Titres of P. haemolvtica from
particles <3.3 um in diameter, as indicated by the growth from
the bottom stage of a 3-stage Porton impinger (May, 1966) , ranged
_ , 1A6.98 n 1A8.43 ..-1from 1 x 10 to 1 x 10 cfu ml
Virus, when used, was given 7 days before P. haemolvtica. Day
0 was the day of first exposure to either agent.
Large volumes (60 to 430 ml) of serum were administered 24 h
before P. haemolvtica infection by intraperitoneal (i.p.)
injection into the right sublumbar fossa using a flutter valve.
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Experiment 3) were given by intravenous ( iv.) injection 3 to 4
hours before exposure to aerosol. In Experiment 4, where i.v.
doses were particularly large, the animals were pre-sedated with
Saffan (Glaxovet). Serum or IRF was warmed to 37°C before
inj ection.
7.4. Clinical, microbiological, histopathological and serological
examinations and necropsy
A disease index was employed, based on four components, in
which the maximum score per lamb was 60.
(i) Clinical score. Animals were examined from Days 1 to 6
inclusive and necropsied on Day 7. One point was allotted for each
observation of raised rectal temperature (>40.5°C), dyspnoea or
coughing, severe depression, and death or euthanasia on
humanitarian grounds. The maximum daily score was 4 and the
experiment score 24. Animals which died prematurely were scored 4
for each day remaining in the experiment.
(ii) Pneumonia score. The mean area of consolidated lung tissue
on dorsal and ventral surfaces was assessed by computer-aided
measurement from lung diagram charts completed at necropsy. This
area, expressed as a percentage of the total lung area, was
halved to give the pneumonia score (maximum 22). Animals which
died rapidly, without development of consolidated lung tissue,
were scored maximum if isolations of P. haemolytica indicated lung
infection and a generalised septicaemia (one or more of heart
blood, spleen and liver positive).
(iii) P. haemolvtica isolation index. Lung tissue samples from
eight different sites were combined to give four pools as follows:
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right apical and cardiac lobes; left apical and cardiac lobes;
right diaphragmatic and intermediate lobes; and either side of the
left diaphragmatic lobe. These samples were titrated and cultured,
and the counts of viable P. haemolvtica estimated. The mean log
titre of the four pools was taken as the isolation index figure
(maximum 8).
(iv) Pleurisy. Fibrinous pleuritic adhesions were scored 1 for
each lobe affected, the apical and cardiac lobes of each side
being regarded as one lobe for this purpose (maximum 4).
Gelatinous fibro-cellular pleurisy with excess pleuritic fluid was
scored 3 for each side affected (maximum 6).
Surviving lambs were killed at Day 7 by barbiturate overdosage.
Lung tissue pools were examined for bacteria and viruses as
described previously (Sharp et al., 1978), and representative lung
blocks were fixed in 10% formol saline for histopathological
examination. Sera were examined for antibodies to P. haemolvtica.
7.5. Experimental results of passive protection experiments.
Experiments 1 and 2: virtually no evidence of pneumonia was
detected in the 19 animals treated with immune material and only
one (from experiment 2) yielded P. haemolvtica from the lungs, in
low numbers (Table 7.3). In contrast, three of the six control
lambs in experiment 1 died rapidly and four had consolidated
lesions in the lungs.
All six control lambs in experiment 2 yielded P. haemolvtica
from the lungs (P<0.01 compared with Group 1), but marked evidence
of pneumonia was apparent in only two, of which one died and one
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had extensive lung consolidation.
Experiment 3: three lambs died of PI3 virus infection on Days 5
and 6. The remainder were then randomised on pre-experiment
weights into three groups of seven and one ((Group 4) of eight
lambs for challenge with P. haemolvtica.
No deaths occurred in any of the treated lambs and evidence of
disease in them was minor (Table 7.3). Mean isolation titres were
2 -1
less than 1 x 10 cfu g in all six of the 21 animals treated with
immune serum which yielded P. haemolvtica from the lungs. In
contrast, seven control lambs died, all with evidence of
septicaemia. The sole survivor yielded a mean titre of only 1 x
2.4 -1
10 cfu P. haemolvtica g of lung tissue, but had consolidation
involving 94% of the lung surface area.
Experiment 4: clinical signs of disease were virtually absent in
the group treated with immune Ig, although three lambs showed 5-8%
consolidation of the lung surface area; two of these yielded low
numbers of P. haemolvtica (Table 7.3). All but one control animal
died of septicaemia, most on Day 3. P. haemolvtica was isolated
from a shoulder joint, but not the lungs of the sole survivor.
Histopathologically, the majority of animals in experiments 3
and 4 showed interstitial pneumonia with or without a
non-suppurative exudate. A small proportion, represented in every
group, showed mild to moderate neutrophil presence with or without
lung consolidation. Changes typical of pasteurellosis were found in
only one animal of Group 3, experiment 3. Fibro-cellular pleurisy
was observed only in untreated animals, with four positive in both
experiments 3 and 4.
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Discussion
These studies have demonstrated that serum or IRF administered
i.v. or i.p. can provide virtually total protection against
experimental pasteurellosis. Protection was produced by two
separate batches of convalescent serum, by post-vaccinal serum
produced with two forms of vaccine and by IRF produced from these
convalescent and post-vaccinal sera. These findings thus support
other work indicating that protection against respiratory disease
can be mediated by humoral elements alone (Lam and Switzer, 1971;
Masiga et al., 1975), in contrast to the conclusion of Wells et
al. (1979) that humoral immunity per se is incapable of
preventing pneumonia, specifically ovine pasteurellosis.
Gilmour et al. (1983) found that Serotype A2 SSE/HKO vaccines
similar to those used in this study gave only 40 to 50% protection
in SPF lambs, whereas Donachie e_t al. (1986a) observed that SPF
lambs convalescent from experimental infection with P. haemolvtica
A2 were completely resistant to subsequent challenge with the
homologous serotype. However, in this study similar levels of
passive protection (between 94 and 100%) were afforded by serum
both from vaccinated and convalescent animals. This anomaly may
have been due to several reasons: (i) Excessive dosages of serum
and IRF may have obscured differences in levels of protective
antibodies raised by these two protocols. Generally, convalescent
serum and IRF pools had higher bactericidal assay (%K), CN and IHA
titres than did vaccinate serum and IRF pools. (ii) A considerable
boost in antibody titre was invariably seen in these studies by
anti-SSE ELISA following the third vaccination. Gilmour et al.
(1983) used only a double-vaccination schedule. (iii) Prior
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exposure of donor animals to P. haemolvtica may have supplemented
the smaller range of antibodies stimulated by the SSE vaccine,
thereby raising the protective efficacy of post-vaccinal serum to
equivalence with the convalescent serum. Pre-screening indicated
that donor animals were negative for antibodies to P. haemolvtica
A2 by the anti-SSE ELISA, but some of their peers were positive by
this test and two yielded P. haemolvtica from nasal swabs. In
experiment 2 also, control serum from untreated peers of immune
serum donors appeared to offer some protection (Table 7.3) and
antibodies to LPS were present at low titre (Table 7.1). This
indicates that the anti-SSE ELISA lacked the ability and/or
sensitivity to detect low levels of protective antibodies.
IRF preparations were as effective as their parent serum pools
in these studies. Being no more than semi-purified, the precise
nature of their protective components cannot be deduced, although
compared with serum their proportional contents of IgG and IgM were
increased at the expense of albumin and, presumably, other serum
components. Since dosages used were equilibrated by IgG content,
this suggests that immunoglobulin was responsible for the
protection engendered.
The use of a P. haemolvtica-only infection in experiment 4 was
designed to ascertain whether prior infection with PI3 virus was
responsible, wholly or in part, for the protective effects of
injected materials seen previously. PI3 virus can cause epithelial
damage and oedema (Rushton et al., 1979), effects which could have
promoted the exudation and accumulation in the lungs of blood
constituents, including the injected materials. The 95% protection
observed in Group 1, experiment 4, indicates
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that viral pre-infection was not essential for efficacy of
treatment and that either normal immunoglobulin transudation into
the bronchoalveolar tree was sufficient or that protection was
provided mainly or exclusively intravascularly.
Death after acute or hyperacute septicaemia occurred in some
control animals of all experiments, but the 3 to 4.5 w.o. lambs
of experiments 3 and 4 had virtually no pulmonary phagocytic cell
response, compared with the extensive neutrophil and macrophage
exudate present in the lungs of three 9.5 w.o. control lambs of
experiment 1. This difference suggests that phagocytic cell
function and responses in the young lamb are deficient and mature
only after 5 weeks of age. Naturally-occurring field cases of
pasteurellosis in lambs 2 months old are generally of septicaemic
form (Gilmour, 1978). In the absence of severe respiratory
disablement, the cause of death in such cases is presumably
endotoxaemia. The ability of immune serum and IRF to protect the
immunologically immature lambs of experiments 3 and 4 suggests that
protection was independent of phagocytes, i.e. non-opsonic.
Instead, the injected immunoglobulins may have been bactericidal,
prevented bacterial adherence, enhanced clearance by the
muco-ciliary blanket and/or neutralized bacterial metabolic
function or products, such as endotoxin or cytotoxin.
The immune sera used for passive protection experiments varied
in their abilitites to stimulate activity in in vitro assays
measuring bactericidal activity, CN and opsonophagocytosis. These
sera were however invariably capable of inducing passive protection
against P. haemolvtica A2. This perhaps indicates the
multifactorial nature of protective immunity. Further demonstration
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of whether any of these functional mechanisms of immmunity can
alone provide adequate protection would (if it were possible)
require the use of vaccines containing single antigens which
stimulate the individual immune mechanisms.
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SECTION 8
Protection of Lambs by Vaccination with a Crude Cvtotoxin
Preparation
Serotype A2 was the least immunogenic of P. haemolvtica
serotypes when SSE vaccines were evaluated against homologous
challenge in lambs, and significant protection was obtained only
when heat-killed organisms were included (Gilmour e_t al. , 1983) .
However, Donachie et al. (1986a) subsequently showed that
"convalescent" lambs were completely protected against a further
homologous A2 challenge. This suggested that effective
immunisation against the A2 serotype was possible and that the
antigens involved in protection were either absent from or present
in insufficient amounts in the SSE vaccines tested.
Isolates of P. haemolvtica produce an extracellular cytotoxin
which is lethal for ovine leucocytes (Sutherland et al., 1983;
Sutherland, 1985) and which may be an important pathogenic
determinant in ovine pneumonic pasteurellosis. This extracellular
toxin was unlikely to have been a component of SSE vaccines which
failed to adequately protect against P. haemolvtica A2 (Gilmour et
al., 1983). It was considered, therefore, that a toxoid might
provide protection against P. haemolvtica A2, although,
toxin-neutralising activity in itself may not be sufficient.
Vaccines based on cholera toxoid were found to be more protective
when additionally including somatic antigens which stimulated the
clearance of organisms (Svennerholm and Holmgren, 1976). Therefore,
two vaccines were prepared, one of which contained a crude form of
cytotoxin, the other the crude cytotoxin plus SSE. These
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toxin-based vaccines were compared with an SSE vaccine simnilar to
that described previously (Gilmour et al.. 1983).
Serum antibody responses were measured by an enzyme-linked
immunosorbent assay (ELISA) for antibodies to SSE cell surface
antigens (Donachie et al., 1986a), an IHA test to measure
anti-capsular antibodies (Donachie and Jones, 1982), a
cytotoxin-neutralisation (CN) test (section 3), a bactericidal
test (section 4) and an opsonophagocytosis assay (section 5).
Results from these tests were compared for correlation with
protection against P. haemolvtica A2 infection, and significance
testing between grouped serological data was carried out using the
Mann Whitney test for non-parametric data.
8.1. Production of a cytotoxin preparation
Crude cytotoxin was prepared as described in Materials and
Methods. P. haemolvtica A2 cultures in dialysis sacs submerged in
500 ml volumes of nutrient broth were incubated for 24 h at 37°C.
Sac contents were centrifuged at 10,000 g for 20 min to pellet
bacteria and the culture supernatant fluid, containing cytotoxin,
was filter-sterilised and lyophilised after exhaustive dialysis
against distilled water.
The toxicity end-point (section 3) of the crude cytotoxin used
for vaccination was at a concentration of 2.5 mg ml .
8.2. Production of SSE
The SSE was prepared as described in Materials and Methods with
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the additional step that bacterial cell pellets were washed once in
PBS to minimise contamination of the extracts with extracellular
cytotoxin.
8.3. Formulation of vaccines
Three vaccines, which consisted of 0.27% Alhydrogel adjuvant
(Miles Laboratories) adsorbed to lyophilised antigen resuspended in
distilled water and were formulated as follows: (i) 10 mg ml ^ of
crude cytotoxin; (ii) 2.5 mg ml ^ of SSE; (iii) 10 mg ml ^ of
crude cytotoxin plus 2.5 mg ml ^ of SSE.
8.4. Experimental procedure.
Vaccine studies were carried out on lambs which were
caesarian-derived, colostrum-deprived and maintained in isolation.
They were fed sterilised cows' milk, hay and concentrates, and
designated specific pathogen-free (SPF) lambs.
8.4.1. Experimental infections
The experimental infection of lambs with P. haemolvtica A2 was
3
preceded by infection with PI virus, a method which consistently
induces severe pneumonia in SPF lambs (Sharp et al., 1978). The
virus was administered intratracheally (8 ml) and intranasally (2
ml) at a titre of 1 x 10^ TCID^ ml . Infection with P.
haemolvtica A2 was achieved by exposure for 15 min to an aerosol of
strain X205A at approximately 4 x 10^ colony forming units 1 ^ and
was administered 7 days after infection with PI3 virus.
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8.4.2. Experimental design
Three-week-old SPF lambs were allocated randomly into four
groups. The crude cytotoxin vaccine group and the control group
were allotted eight animals. Groups treated with the SSE and
cytotoxin plus SSE vaccines were allotted 14 animals each to ensure
that sufficient animals were available for statistical comparison
between these vaccine groups. One animal in each of the cytotoxin,
SSE and control groups died prior to experimental infection with
PI3 virus. Three groups were vaccinated on Days 0 and 28 with 1 ml
doses of each vaccine, while one group remained unvaccinated. All
animals were given PI3 virus on Day 35 and an aerosol of P.
haemolvtica A2 on Day 42. Lambs were bled for serum on Day 42.
Clinical examinations (section 7) were carried out for 6 days after
P. haemolvtica infection and surviving animals were necropsied on
Day 49.
8.5. Clinical and pathological findings.
Clinical, microbiological and pathological assessments of the
response of each lamb were made according to the methods described
in section 7.
A high degree of protection was afforded to animals vaccinated
with crude cytotoxin both with and without the addition of SSE,
while SSE-vaccinated animals were protected significantly less (P<
0.01) than the cytotoxin plus SSE group (Table 8.1).
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Table 8.1. Group mean experimental disease indices and percentage
protection.
sl b
Vaccine N Deaths Disease index % Protection
group
Cytotoxin 71 7 86
SSE 13 6 26 47
Cytotoxin/SSE 14 0 1 98
Unvaccinated 7 7 50 0
Disease index - the sum of the clinical, consolidated lesion,
P. haemolvtica isolation index and pleurisy scores (section 7, this
thesis)
Protection =/ disease index of treated group




All vaccinated animals had serum antibodies to P. haemolvtica
when measured by SSE-ELISA, while unvaccinated animals had none
(Table 8.2). None of the animals had IHA titres indicating that
none of the vaccines had induced an antibody response to capsular
antigens. The mean CN titres and bactericidal capacities of sera
from the cytotoxin and cytotoxin/SSE vaccine groups were
significantly (PC0.001) greater than those of the SSE vaccine and
unvaccinated control groups. Only two animals of the SSE vaccine
group had serum CN activity, both of low titre, indicating that the
SSE antigen contained negligible amounts of cytotoxin. None of the
vaccinated or untreated control animals had serum OpI > 1.0.
Antibodies involved in opsonophagocytosis were therefore not
stimulated by any vaccine.
Serum CN titres and bactericidal capacities of experimental
lambs correlated inversely (P<0.001) with the severity of disease
measured by an index taking account of clinical, pathological and
microbiological parameters (section 7) .
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Table 8.2. Assay findings for post-vaccinal sera as measured







Group mean antibody titre





















In this study, a vaccine containing crude cytotoxin plus SSE was
98% protective against experimental infection of lambs with P.
haemolvtica A2 and the protection afforded by the cytotoxin alone
(86%) was only slightly (not significantly) less. However, the
protection (47%) given by the SSE vaccine was significantly
(P<0.01) poorer and similar to values found previously (Gilmour et
al., 1983). Serological analysis revealed no significant
difference in the mean %K of groups given crude cytotoxin or crude
cytotoxin plus SSE vaccines, whereas the SSE vaccine group had a
significantly lower mean %K. The antigens in the crude cytotoxin
thus stimulated bactericidal activity more effectively than SSE.
Similar ELISA titres in all groups showed there was no significant
difference in levels of antibodies to SSE cell surface antigens.
Therefore, it was concluded that SSE was not an additional
requirement for protective cytotoxin-based vaccines. This is in
contrast to vaccines based on Cholera toxoid which show improved
protection with the addition of somatic antigens (Svennerholm and
Holmgren, 1976). With the crude cytotoxin vaccines used in this
thesis, bactericidal acitivity was probably induced by contaminant
lipopolysaccharide (LPS), since antibodies involved in the
bactericidal activity of immune serum can be absorbed by the
addition of LPS (section 4). The presence of LPS in crude
cytotoxin has been detected by SDS-PAGE and a sensitive Limulus
amoebocyte lysate assay (section 3).
Since the partially protective SSE vaccine produced negligible
CN titres and low bactericidal activity, either CN antibodies or
high bactericidal capacity, or both, are probably required for
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significant protection. Both these variables were significant
correlates of immunity (P<0.001) and were stimulated by the crude
cytotoxin vaccine.
Whether protection can be ascribed to either CN or bactericidal
antibodies alone can only be determined if different antigens are
responsible for inducing these antibodies and separation and
identification of these can be achieved. However, the most
efficient vaccine formulation for P. haemolvtica may include those
antigens that induce both CN and bactericidal antibodies as found
in the crude cytotoxin preparation. In addition, inclusion of
antigens that stimulate opsonising antibodies for phagocytosis (if
these can be found and presented in the correct manner) may be
beneficial for protection since this mechanism of immunity
correlated in animals convalescent to P. haemolvtica A2 (Donachie
et al.. 1986a; section 5, this thesis)
None of the vaccines used in this section of the thesis induced
opsonophagocytic antibodies or IHA titres in SPF lambs. The IHA
test detects capsular specific antibodies. If the capsule of P.
haemolvtica A2 is a target for opsonins as it is for other bacteria
(Giebink et al., 1977; Van Dijk et al., 1979; Penaredondo et al.,
1988) , then the lack of specific anticapsular antibodies may





The aim of this thesis was to examine those humoral effector
mechanisms involved in immunity to P. haemolvtica A2 infection.
This involved the development of in vitro assays, for investigating
the influence which effector mechanisms had on P. haemolvtica.
Studies included the use of "convalescent" sera to characterise
these assays and correlate them with immunity. Characterisation
also involved the detection of P. haemolvtica antigens which
stimulated specific antibodies involved in the immune mechanisms
described.These methods allowed antigen preparations to be selected
for the production of a novel vaccine. This vaccine was found to be
capable of stimulating protective immunity against experimental P.
haemolvtica A2 infection.
From the outset, the cytotoxin of P. haemolvtica was considered
to be potentially of prime importance as a protective antigen,
assuming that its toxic activity could be neutralised by specific
antibodies. The supposed importance of the toxin stemmed from the
evidence given of its lethal effects on ovine leucocytes
(Sutherland et al.,1983; Sutherland, 1985; Sutherland and
Donachie, 1985), which gave rise to the suggestion that the
cytotoxin was a major virulence factor in ovine pneumonic
pasteurellosis. Cytotoxin antigens had not previously been included
in vaccines for P. haemolvtica and, as such, represented possible
novel protective antigens for inclusion in experimental vaccines.
The development of a protective vaccine against the A2 serotype of
P. haemolvtica was of particular importance since attempts to
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protect against this serotype had been unsuccessful with a previous
experimental vaccine formulation. This was despite the fact that
this vaccine had proven protection agaist other P. haemolvtica
serotypes (Gilmour et al. . 1979; Gilmour et al. , 1983). Further
evidence was therefore sought that the cytotoxin was an important
virulence factor of P. haemolvtica A2 and that cytotoxin
neutralising (CN) antibodies might be involved in protection.
A crude cytotoxin preparation from the A2 serotype was produced
in the same manner as, and compared with, that produced by the Al
serotype, as previously described by Sutherland and Redmond (1986).
The crude cytotoxin from the A2 serotype produced potent levels of
toxic activity which were detectable by a chromium-51 release
assay. It was found, however, that the A2 crude cytotoxin was
noticeably less toxic than the Al toxin preparation. Also,
comparison of SDS-PAGE profiles showed lesser amounts of 95 and 105
kDa antigens in the A2 crude cytotoxin compared to those in the Al
preparation. These antigens have recently been identified as
cytotoxin antigens by Chang et al. (1987). These findings therefore
suggested that the A2 serotype produced lesser amounts of
extracellular cytotoxin than the Al serotype. This observation is
in agreement with that of Gentry et al. (1988) , who also showed
that the extracellular A2 cytotoxin was present in less detectable
amounts than toxin from other serotypes. These results were of
interest when compared with previous reports in which Sutherland
and Donachie (1985) showed that live P. haemolvtica A2 organisms
were as toxic for sheep bronchoalveolar macrophage (BAM) as were Al
organisms. Combined, these findings might suggest that serotype A2
either has larger amounts of intracellular cytotoxin than the Al
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serotype, or that the Al serotype multiplies faster than the A2
srotype, therefore producing more toxin in the growth medium.
Neither of these possibilities was examined in this thesis and
studies on this aspect would perhaps benefit from the availability
of monoclonal antibodies against the cytotoxin.
In considering the extracellular production of cytotoxin by P.
haemolvtica further, it is worthwhile comparing the export of
proteins by other Gram-negative bacteria. It has been debated
whether proteins, including exotoxins, can be truly secreted from
the cytoplasm across both inner and outer membranes into the
medium. Rather, it seems that most proteins may be exported from
the cytoplasm into the periplasmic space and released from there on
cell lysis or by secretion in outer membrane vesicles (Schwartz,
1984). Colicins , for example, appear to be released after
cell-lysis which is produced by a lysis protein (Mock and Schwartz,
1978; Jakes and Model, 1979). E. coli heat-labile toxin (LT) is
mostly located in the cytoplasm, and the smaller amounts found in
the medium are mainly associated with outer membrane vesicles
(Gankema et al., 1980). It is interesting to note, however, that
cholera toxin, which is antigenically cross-reactive with, and
chemically similar to, LT is found in abundance in the medium
(Germanier et al., 1976). This, at least, indicates that two
similar toxins can be secreted in different manners by two
different species of bacteria. The outer membrane vesicles with
which LT is associated may also be functional in the mode of action
of the toxin, being implicated in the interaction of LT with target
cell membranes (Gankema et al., 1980; Middledorp and Witholt,
1981) .
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Examination of crude cytotoxin preparations by SDS-PAGE showed
that both LPS and outer membrane proteins were released into the
culture medium. Added to this, previous work by Chang et al.
(1984) has shown that toxic activity is susceptible to periodate
and amylase treatment, suggesting a role for carbohydrate moities
in the cytotoxin. Also, Sutherland and Redmond (1986) found that
the native form of the active toxin was very large in size, as
determined by its elution profile from gel-filtration columns. The
toxic fraction was also shown to contain LPS and outer membrane
proteins. With this evidence it could therefore be speculated that
P. haemolvtica cytotoxin is secreted in association with membrane
vesicles. Differences in extracellular cytotoxic activity between
the Al and A2 serotypes of P. haemolvtica might therefore be
associated with differences in mechanisms of secretion between
these two serotypes.
In possible contrast to this suggestion, however, are the
findings of Lo et al. (1986) , who showed a large degree of
homology between P. haemolvtica Al cytotoxin and E. coli alpha
haemolysin. Alpha haemolysin is an actively secreted protein
(Springer and Goebel, 1980) which has cistron-encoded components
involved in export. This finding might suggest that the Al
cytotoxin is actively secreted from the cell and not released in
outer membrane blebs. Recent work A. Lainson (personal
communication) indicates that differences in sequence analysis and
restriction enzyme digestion-profiles exist between Al and A2
cytotoxin genes. It would therefore be of interest to determine if
these differences are associated with mechanisms of secretion and
the different levels of extracellular activity observed between the
two serotypes.
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Besides outer membrane proteins, LPS and capsular antigens
being identified in crude cytotoxin preparations by SDS-PAGE,
proteases were also identified in these preparations. The Al
serotype was found to produce a large (Rf 0.05) protease on
SDS-PAGE gels incorporating casein (section 3). The size and
activity of this protease was unaffected by heating in the presence
of mercaptoethanol, suggesting that the size, conformation and
activity of the protease were not dependant upon disulphide
bridges. The A2 serotype produced an extracellular protease which
was much smaller (Rf 0.99) than that produced by the Al serotype
and sensitive to heat treatment with mercaptoethanol (section 3).
Otulakowski et al. (1983) speculated that protease activity
detected in cytotoxin preparations may be involved in toxin
activity. If this were so, the differences in the proteases
produced by the Al and A2 serotypes could also be associated with
the lower levels of activity found in the A2 cytotoxin
preparations. Proteases have been found to be involved in the
activation of toxins produced by other species. Clostridium
botulinum type A toxin and E. coli LT are both produced as
protoxins which require cleavage by a protease for activation
(Thorne and Gorbach, 1981).
The proteases could also be virulence factors. Some proteases,
such as those found in N. meningitidis. N. gonorrhoea and E.
coli. have been found to split IgA and may help these organisms to
evade mucosal immunity (Plaut et al. , 1975). Inclusion of P.
haemolvtica proteases in vaccines may therefore be beneficial in
protection if they are antigenic. Other antigens found in the crude
cytotoxin, such as LPS, capsular polysaccharide and outer membrane
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proteins, are also of potential importance as vaccine constituents
and are discussed later.
The main emphasis of the work on the cytotoxin in this thesis
was to produce detectable amounts of toxin from the A2 serotype and
assess the potential of the product as a vaccine constituent. In
the absence of purified, active toxin, detection of the cytotoxin
is still based on evidence of its biological activity.
Neutralisation of the toxin is also best demonstrated by inhibition
of biological activity. The serotype A2 cytotoxin was standardised
by the chromium-51 release assay, and rabbit antibodies raised
against the crude cytotoxin were found to neutralise the toxic
activity. The rabbit serum did not, however, have a high CN titre
(compared to titres from "convalescent" lambs), despite the use of
large amounts of crude cytotoxin (10 mg per dose) in the vaccine.
This indicated either that only small amounts of the cytotoxin
component were present in the crude cytotoxin or that the toxin was
not particularly immunogenic. The raising of CN antibodies with the
crude cytotoxin indicated, however, that this preparation may be a
valuable constituent in an experimental vaccine.
Further evidence for the potential protective effects of
cytotoxin neutralising antibodies was given by the demonstration
that "convalescent" lamb sera and lung washings had significant CN
antibody titres. In contrast, control lamb sera had negligible CN
titres, although control lambs which survived to necropsy did have
CN antibody titres in lung washings. These were probably due to a
local response to challenge and may have been associated with the
survival of these lambs. Generally, these findings indicated a
correlation for CN antibodies with immunity.
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Although CN antibodies were therefore considered potentially
important in immunity to P. haemolvtica A2, it was also considered
that for complete protection vaccines would need to induce
antibodies that stimulated mechanisms involved in the clearance of
the live organism from the host. Complement-dependent bacterial
killing of Gram-negative organisms and opsonin-mediated
phagocytosis are both effector mechanisms of immunity that can be
stimulated by specific antibodies in the immune host to induce
clearance of organisms during infection. The susceptibility of P.
haemolvtica A2 to these mechanisms of immunity was therefore
investigated with a view to determining their importance in
protection against pneumonic pasteurellosis.
P. haemolvtica Al was reported by MacDonald et al. (1983) to be
susceptible to antibody-mediated bactericidal activity operating
via the classical pathway of complement. The role of this
mechanism of immunity in protection against P. haemolvtica Al was
however not established. In this thesis an in vitro microtitre
plate assay was developed to determine whether this mechanism of
immunity may be important in combating disease caused by P.
haemolvtica A2 infection in lambs. The assay measured the capacity
of specific antibody to activate bacterial killing mechanisms. The
assay was rapid, used small sample volumes and could deal with
large numbers of samples in one day. As such, the assay may have
application to studies on other organisms.
P. haemolvtica A2 organisms were found to be susceptible to
antibody-dependent bactericidal killing mechanisms and LPS was
determined as a target antigen for antibodies by absorption
studies. Evidence that this mechanism of immunity may be involved
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in protection against pneumonic pasteurellosis caused by P.
haemolvtica A2 was given by the finding that sera and lung washings
from "convalescent" lambs were significantly bactericidal for P.
haemolvtica A2 whereas similar samples from control animals were
not.
Since LPS was shown to be a target antigen involved in
bactericidal activity against serotype A2 organisms, this suggested
that inclusion of LPS in experimental vaccines could be important
in stimulating mechanisms for the clearance of biotype A organisms
during infection.
Serotype T10 organisms were, however, found to be resistant to
bactericidal mechanisms and this resistance appeared to be due to
the presence of "smooth" type LPS, which was demonstrated by
SDS-PAGE in this and other T serotypes. This was in contrast to
the A serotypes which had "rough" type LPS. The resistance of the
T10 serotype indicated that bactericidal mechanisms may not be able
to combat the systemic type of disease caused by T serotypes and
may, in fact, be a reason why the T serotypes are able to cause
systemic disease in adult sheep. Septicaemic strains of other
bacterial species are often found to be resistant to bactericidal
activity and to possess "smooth" type LPS (Turk, 1959; Chedid et
al. , 1968; Rowley, 1968; Taylor, 1975; Madonna and Allen, 1981).
Another mechanism of immunity which may be important in the
clearance of bacteria during infection is opsonin-mediated
phagocytosis. In respiratory infections in particular, the
resident BAM has been considered to be the first line of defence
against infection (Reynolds and Newball, 1976). The sheep BAM may
be compromised by P. haemolvtica cytotoxin once infection is
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established. However, in the early stages of infection, the
immune animal may be able to neutralise the cytotoxin with CN
antibodies and opsonic antibodies may effect rapid clearance of the
organism. As such, opsonophagocytosis may be an important
mechanism of immunity to stimulate by vaccination. Evidence to
support this assumption was given by Donachie et al. (1986a), who
found that opsonophagocytic indices in "convalescent" lambs
correlated with immunity.
In this thesis, a microfiltration assay was employed for
measuring the opsonic potential of sera. The filtration process
was demonstrated to retain phagocytes whilst excluding
extracellular bacteria. The assay was rapid, economic in reagents
and capable of dealing with large numbers of samples in a day. The
assay was firstly employed to characterise the role of opsonins in
the phagocytosis of P. haemolvtica (section 5) and later (section
8) to determine the role of opsonin-mediated phagocytosis in the
protection given by an experimental vaccine against P. haemolvtica
A2 infection.
Both complement and antibody were found to be significantly
opsonic for P. haemolvtica A2. The opsonic potential of
immunoglobulin was considered to be of greater importance in
respect of acquired immunity, since this opsonin could potentially
be stimulated by vaccination. Absorption studies indicated that
LPS was not a target antigen for opsonic antibody, but antigens
present in SSE preparations did absorb opsonins. Whilst anti-LPS
antibodies have been implicated as opsonins for P. aeruginosa
(Young, 1972), capsular antigens have been shown to be of prime
importance in opsonisation of other bacteria such as S. pneumoniae
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(Giebink et al., 1977) and E. coli (Van Dijk et al., 1979).
Capsular antigens are a major constituent of SSE (Donachie et al.,
1984b) and this may have been the antigen involved in absorption of
opsonins by the SSE preparation. Outer membrane proteins are also
present in SSE (fig 3.1) and whether these have a role in
opsonisation is worthy of further investigation. Monoclonal
antibodies against these antigens would undoubtedly help in the
elucidation of their role as target antigens for opsonins.
Monoclonal antibodies have been used for such purposes recently
with P. haemolvtica Al (Penaredondo et al., 1988).
The phagocytic potential of PMNL was not examined because of the
considerable difficulties involved in isolating sheep PMNL
(Sutherland, 1985). These cells are generally considered to be
capable of augmenting the phagocytic potential of resident BAM and
have been implicated in the clearance of P. haemolvtica A2 from
infected sheep lungs (Davies and Penwarden, 1981). PMNL are
usually recruited to an inflammatory site by chemotactic stimuli.
The presence of P. haemolvtica cytotoxin in vitro has been shown
to inhibit the release of chemotaxins by bovine BAM (Markham et
al. , 1982) indicating another perturbing aspect of this toxin
against host defence mechanisms. It is not known whether P.
haemolvtica antigens are chemotaxins or chemotaxinogens, but LPS,
for example, has been shown to be a chemotaxinogen for other
Gram-negative species (Morrison and Ulevitch, 1978).
Intracellular killing of P. haemolvtica A2 by phagocytes was
also not examined, but others have shown that BAM and PMNL are
bactericidal for internalised P. haemolvtica Al (Maheswaran et
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al.. 1980; Czuprynski et al., 1987). Extracellular killing of
bacteria can also be mediated by the secretion of antibacterial
factors such as lysozyme (Gordon et al., 1974) and catalytic
proteases and hydrogen peroxide from activated macrophages (Nathan
et al., 1979).
Chemotaxis, intracellular killing and complement-dependent
opsonisation are unlikely to be modifiable by vaccination but may
play an important role in innate immunity against P. haemolvtica
infection.
In vitro grown P. haemolvtica A2 organisms were found to be
susceptible to antibody-mediated bacterial killing and
opsonophagocytosis, and indications that these mechanisms of
immunity may be important in protection were given by studies with
"convalescent" lamb sera. However, bacteria are known to undergo
phenotypic changes in vivo. and these changes can alter
susceptibility to immune mechanisms (Penn et al., 1976). P.
haemolvtica A2 organisms were therefore grown in vivo in peritoneal
chamber implants and these organisms were compared with in vitro
grown organisms for their susceptibility to opsonophagocytosis and
bacterial killing.
Donachie and Gilmour (1988) have recently detected changes in
outer membrane protein profiles of in vivo grown organisms and in
particular demonstrated the production of iron restricted proteins
(IRPs) of 70 and 100 kDa. These proteins were demonstrated in
organisms recovered from peritoneal chambers and this was
considered as proof that these organisms expressed a different
phenotype when grown in vivo.
S.. epidermidis grown in peritoneal dialysate was also found to
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express additional cell-surface proteins of 27, 39, 45, 54 and 98
kDa. The 16, 35 and 39 kDa proteins were depressed under
iron-replete growth conditions in vitro, suggesting that growth of
these proteins was iron-regulated (Williams et al. , 1988).
In vivo grown P. haemolvtica A2 were found to be as susceptible
to killing by antibody and complement as were in vitro grown
organisms. The LPS profile of in vivo grown organisms was similar
to that found for in vitro grown organisms (section 4). This
indicated that phenotypic changes had not occurred in the LPS
structure in vivo. and since LPS was found to be a target antigen
for such antibodies, this complemented the finding that no change
in the susceptibility to antibody-mediated bacterial killing
occurred. In vivo grown organisms were, however, found to be
additionally susceptible to killing in the absence of exogenous
antibody. The demonstration, by immunoblotting methods, that in
vivo organisms had host immunoglobulin bound to them suggested an
explanation for this observed additional susceptibility. The bound
IgG may also have been responsible for the slightly elevated levels
of phagocytosis found in the presence of the standard negative
serum when compared with in vitro grown organisms under the same
conditions. Bound IgG has also been detected on S. epidermidis
organisms grown in peritoneal dialysate (Williams et al. , 1988) .
In vivo grown P. haemolvtica A2 organisms were found to be
susceptible to antibody-mediated phagocytosis, but to a lesser
degree than in vitro grown (18 hour culture) organisms. In vivo
and in vitro grown organisms were therefore compared for the
amounts of capsular polysaccharide they possessed. Capsules were
detected by Maneval stain but no differences were observed in the
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thickness of capsule between in vivo and in vitro grown (18 and 24
hour cultured) organisms. An increase in capsule size was
therefore not an explanation for the reduced susceptibility of in
vivo organisms to opsonophagocytosis. Interestingly though, 6
hour in vitro grown organisms did have thicker capsules than
organisms from 18 hour cultures. This is in agreement with the
findings of Corstvet et al. (1982) who had similar findings with P.
haemolvtica Al organisms from 6 and 18 hour cultures. The thicker
capsule found on organisms from earlier cultures of P. haemolvtica
Al may explain why these organisms were found to be less
susceptible to phagocytosis (Berrgren et al., 1981) .
This thesis has concentrated on examining humoral mechanisms of
immunity to P. haemolvtica A2 despite the suggestion by Wells e_t
al. (1979) that humoral immunity was unimportant in protection
against ovine pasteurellosis, and their suggestion as a result that
CMI may be the most important mechanism of defence in this disease.
More recently, and in contrast, Donachie et al. (1986a) found
humoral immunity to be important in the immunity of "convalescent"
lambs, whereas no CMI response was detectable, at least by the
lymphocyte transformation test.
To determine further whether humoral mechanisms were of prime
importance in immunity to P. haemolvtiaca A2 infection, passive
protection experiments were carried out with immune sera. These
sera were shown to be highly protective against experimental
infection and variously stimulated the effector mechanisms of
immunity studied in this thesis. This demonstrated that humoral
immunity was of prime importance in immunity. These studies also
indicated that parenteral humoral immunity could be transudated
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into the lung and protect against respiratory infection, suggesting
that serum antibody levels should correlate with immunity, and
that the ability to monitor these antibody levels with in vitro
assays may be an important means by which the efficacy of vaccines
can be assessed.
Since the crude cytotoxin preparation from P. haemolvtica A2
was found to stimulate CN antibodies, and these antibodies had
been correlated with protection in "convalescent" lambs, it was
decided to test the protective capacity of this preparation in the
form of a novel vaccine against experimental P. haemolvtica A2
infection in lambs. In designing a vaccine based on the cytotoxin
it was however decided to take into account the findings of others
who had developed toxin based vaccines. Protective vaccines
against cholera were shown to be most efficacious when both cholera
toxoid and the main protective somatic antigens of V. cholerae were
included in the vaccine. Svennerholm and Holmgren (1976) found
that antitoxin and anti-LPS antibodies combined synergistically to
give optimal protection in a rabbit infection model. This strategy
of combining toxoids with somatic antigens has apparently also been
adopted in the past for vaccines against clostridial diseases of
sheep (Outteridge, 1985). It was therefore considered that the
combination of P. haemolvtica cell-surface antigens, in the form
of SSE, with the crude cytotoxin preparation might constitute the
most efficacious vaccine against P. haemolvtica A2. By
vaccination with this formulation, the CN antibodies induced would
conceivably combat the leucocytic effects of the cytotoxin, whilst
antibodies produced against cell-surface antigens may promote
antibody-mediated complement-dependent bactericidal activity and/or
opsonise bacteria to enhance phagocytosis.
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As the results indicated however, the crude cytotoxin was highly
protective even without the addition of SSE. The SSE alone was
poorly protective, confirming the previous findings of Gilmour et
al. (1983). The crude cytotoxin preparation probably contained
sufficient cell-surface antigens for it not to require the addition
of SSE. The presence of cell-surface antigens in the crude
cytotoxin was detected in section 3 of this thesis. The presence
of these antigens probably explains why the crude cytotoxin
promoted both cytotoxin neutralisation and bactericidal activity,
both of which correlated with immunity. It was particularly
interesting that the crude cytotoxin preparation stimulated higher
levels of bactericidal activity than the SSE vaccine. Both of
these preparations contained LPS, but perhaps these results
indicate that the LPS is presented in a more immunogenic form in
the crude cytotoxin. The crude cytotoxin possibly presented a more
natural form of LPS since, unlike the SSE preparation it is not
treated by chemicals. The poor immunogenicity of Westphal-purified
LPS for mice and rabbits has made it of questionable value as a
vaccine antigen against organisms such as P. multocida (Rebers et
al., 1980). LPS from P. multocida was found to be most
immunogenic when presented in a more native form: as a complex
with proteins (Ganfield et al., 1976), or when complexed with
ribosomes (Phillips and Rimler, 1984).
The finding that the crude cytotoxin was highly protective
without the addition of cell-surface antigen extracts is perhaps of
particular importance in the manufacture of vaccines, in that
production is much simplified.
Vaccines comprising crude cytotoxin, crude cytotoxin plus SSE
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or SSE alone failed to stimulate opsonic antibodies or IHA titres.
This is in contrast to the response of immune, "convalescent"
lambs which did produce opsonic antibodies (Donachie et aj_. , 1986a;
section 5 this thesis) and IHA titres (Donachie, personal
communication). An explanation for the inability of
sub-particulate vaccines to induce opsonic antibodies may lie in
the findings of Adlam et al. (1987). These authors have
characterised the chemical composition of the £• haemolvtica A2
capsular polysaccharide and found it to be ane< -2-8-linked polymer
of N-acetylneuraminic acid. Traces of o<-l-4-linked dextran were
also found. Both of these polymers are poorly immunogenic and if
the capsule of P. haemolvtica is an important target for opsonic
antibodies (discussed in section 5), this may explain the inability
of sub-particulate vaccines to induce opsonophagocytosis of P.
haemolvtica A2. The N-acetylneuraminic acid polymer of P.
haemolvtica A2 is identical to the capsular polymers of N.
meningitidis group B (Bhattacharjee et al., 1975) and E. coli K1
(McGuire and Binkley, 1964), and it has been noted that the N.
meningitidis group B capsule is poorly immunogenic when included in
sub-particulate vaccines used against meningitis in children (Wyle
et al., 1972). A possible explanation for this poor immunogenicity
came from Finne (1982) and Hoffman et al. (1982) who found a
glycoprotein in neuronal cell membranes with a sialic acid polymer
which was similar to the E. coli K1 capsular polysaccharide. This
suggests a mechanism of immune avoidance by host mimicry (Jann and
Jann, 1985) .
Some similarities in the protective response following
vaccination to N. meningitidis group B in children and P.
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haemolvtica in lambs can also be seen. Capsular extracts were found
to be highly protective against meningitis caused by N.
meningitidis groups other than group B. In P. haemolvtica
infections of lambs, SSE vaccines, which include capsular
antigens, were protective against serotypes A1, A6 and A9 and
raised IHA antibody titres, which are a measure of the immune
response to capsule (Gilmour et al., 1983). In contrast, SSE
vaccines did not protect well against serotype A2 infection and IHA
titres were not induced.
Protection against N. meningitidis group B now seems likely to
depend upon the use of protective cell-surface proteins (Frasch,
1983). In this thesis protective antigens which were an
alternative to the capsule of P. haemolvtica A2 were found to be
in a crude cytotoxin preparation. This preparation induced CN
antibodies which an SSE preparation did not, and further,
stimulated significantly higher bactericidal activity than did SSE
antigens. These immune mechanisms appear therefore to represent
alternative means of protection against the A2 serotype, and they
compare in terms of efficacy with the capsular-based immunity which
is satisfactory for other serotypes of P. haemolvtica. A
cytotoxin-based vaccine may, however, protect against other
serotypes equally well, and since the cytotoxin is cross-reactive
amongst P. haemolvtica serotypes (Shewen and Wilkie, 1983b),
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ABSTRACT
Sutherland, A.D., 1988. A rapid micro-method for the study of antibody-mediated killing of bac¬
teria, with specific application to infection of sheep with Pasteurella haemolytica. Vet. Micro¬
biol, 16: 263-271.
A micro-titration plate bactericidal assay was developed to measure complement-dependent
antibody-mediated killing of Pasteurella haemolytica. Sera and lung washings from specific path¬
ogen-free (SPF) lambs convalescent from a challenge with live, virulent P. haemolytica were
bactericidal in the presence of complement. Similar samples from naive SPF lambs had no such
activity. Purified IgG derived from a convalescent lamb serum was as bactericidal as the whole
serum. Absorption of convalescent serum with lipopolysaccharide from P. haemolytica abolished
bactericidal activity, suggesting that this antigen may be a target for antibody in the bactericidal
complex.
INTRODUCTION
In the U.K., Pasteurella haemolytica is the organism most commonly asso¬
ciated with acute pneumonia in sheep (Gilmour, 1980). P. haemolytica can be
divided into two biotypes, A and T (Smith, 1961), and within these biotypes
15 serotypes have been identified (Fraser et al., 1982b). Of 1198 isolates from
cases of ovine pasteurellosis (Fraser et al., 1982a) 38% were serotyped as Bio-
type A Serotype 2 (A2), which therefore constitutes the predominant serotype
implicated in ovine pasteurellosis in Britain.
Experimental vaccines based on sodium salicylate extracts (SSE) of the P.
haemolytica cell wall have been developed (Donachie et al., 1984). These were
generally of good efficacy, but those prepared from Serotype A2 were less pro¬
tective against homologous experimental challenge than those from other ser¬
otypes, and offered no protection against heterologous challenge (Gilmour et
0378-1135/88/$03.50 © 1988 Elsevier Science Publishers B.V.
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al., 1983). However, strong immunity to the A2 serotype is possible, as was
demonstrated recently when specific pathogen-free (SPF) lambs, convales¬
cent from a virulent A2 serotype challenge, were shown to be completely re¬
fractory to a subsequent homologous challenge (Donachie et ah, 1986).
In studies relating to protection against pneumonic disease, it is important
to define the functional mechanisms of immunity which operate both system¬
atically and in the lung. It is also desirable to determine which antigen(s)
stimulate those mechanisms of immunity after vaccination. P. haemolytica Al
was shown to be susceptible to the bactericidal activity of antibodies in adult
cattle sera when these antibodies were combined with complement (Macdon-
ald et al., 1983). Antibody- and complement-mediated bacterial killing may,
therefore, be a mechanism contributing to the prevention or suppression of P.
haemolytica infection in the sheep.
This paper describes an improved, rapid micro-method which enables large
numbers of samples to be screened for antibody- and complement-mediated
bactericidal activity. The method was used to assay bactericidal antibodies in
sera and lung washings of lambs which were either resistant or susceptible to
experimental challenge with P. haemolytica. Finally, a standard convalescent
serum was absorbed with selected antigen preparations in an attempt to iden¬
tify target antigen(s) involved in the bactericidal complex.
MATERIALS AND METHODS
Bacterial suspension
A few separate colonies from a cloned isolate (T884) of P. haemolytica A2
were removed from a 7% sheep blood agar (SBA) plate culture and inoculated
into 10 ml of nutrient broth (NB). After incubation at 37= C overnight, 200 p\
of culture were transferred to 50 ml of NB and grown at 37 = C for 3-4 h to
obtain a log-phase culture, which was then centrifuged at 11 OOOxg for 5 min
at room temperature (Taylor, 1983). The resultant bacterial pellet was washed
once in modified barbitol buffer (MBB) (Oxoid, U.K.) to remove residual
NB, which has been shown to be anti-complementary (Muschel and Treffers,
1956). The bacterial inoculum was finally adjusted with MBB to the required
number of colony-forming units per millilitre (cfu ml-1) by comparing its op¬
tical density at 420-nm wavelength with a standard curve of cfu ml-1 against
optical density. The actual bacterial number was confirmed by retrospective
plate counting on SBA.
Sera and lung washings
These samples wre collected as previously described (Donachie et al., 1986)
from two groups of animals which, in brief, were treated as follows. Seven SPF
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lambs were immunised by challenge (DayO) with a virulent strain (T884) of
P. haemolytica A2, followed by antibiotic treatment to prevent death. These
animals ("convalescent" group) were infected with parainfluenza type 3 virus
(P13 virus) at Day 27 and re-challenged with the homologous strain of P.
haemolytica A2 at Day 34. Seven naive lambs (control group) were challenged
on the second occasion only with P13 virus and P. haemolytica A2 (Days 27
and 34, respectively). Only 3 animals survived until necropsy and these pro¬
vided control samples for the assay. All animals were necropsied on Day 41.
Serum from a convalescent lamb was included in each asay as a standard
positive control. The negative control was fetal bovine serum (FBS).^Stan¬
dards and test samples were heat inactivated at 56 °C for 30 min before assay
to destroy endogenous complement.
Purified Immunoglobulin G (IgG) was prepared from aliquots of the stan¬
dard positive serum by immunoaffinity chromatography. A column consisting
of a 9-ml bed-volume of cyanogen bromide-activated sepharose 4B (Pharma¬
cia Ltd., Uppsala, Sweden) ligated with 50 mg of pig IgG anti-sheep IgG (Fc
fraction) was used for purification. The purity of the recovered IgG was con¬
firmed by immunoelectrophoresis against rabbit anti-whole-sheep serum. The
IgG concentration was determined by centrifugal analyser (Allied Instrumen¬
tation Laboratories, Warrington, U.K.) and adjusted to correspond to the orig¬
inal serum IgG concentration.
Other 1-ml aliquots of the standard positive serum were absorbed with 1 mg
of either SSE or lipopolysaccharide (LPS) of P. haemolytica A2 cell wall. The
LPS was purified by the method of Westphal et al. (1952) from cells grown in
nutrient broth at 37 °C for 18 h.
Sources of standard complement
Sera from naive SPF lambs or fetal calves were collected and stored in ali¬
quots at — 70 cC until used. Each batch of serum was tested before use for the
absence of bactericidal antibodies and the presence of sufficient complement
to cause 100% bactericidal activity when used in conjunction with the standard
positive control serum.
Assay procedure
Initially, optimal conditions for the demonstration of antibody and comple¬
ment activity were determined with respect to bacterial concentration and in¬
cubation period.
The assay was performed in 96-well, tissue culture-grade, flat-bottomed mi-
cro-titre plates (NUNC, Denmark) into which reactants were simultaneously
delivered to 12 wells with a multi-channel pipette. Triplicate assay wells re¬
ceived 20 pi of each standard serum or test sample followed by 100 /d of bac-
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terial inoculum. Assay suspensions were incubated for 15 min at room
temperature to allow antibody-bacterium interaction to occur. Standardised
serum complement was then added in 80-/d volumes to each assay well, except
when evaluating the effect of antibody on P. haemolytica in the absence of
complement, when 80 jA of heat-inactivated FBS was added.
Assay plates were covered with a sterile adhesive plastic film (Flow Labo¬
ratories, Irvine, U.K.) and incubated at 37cC for the required period. Gener¬
ally, after incubation, 10-/d samples of each triplicate suspension were removed
with a multi-channel pipette and inoculated onto a 12xl2-cm SBA plate
(Sterilin Ltd., Feltham, U.K.). All 96 wells could be inoculated onto one SBA
plate When bacterial counts were too high for direct plate counting, as when
the assay was being evaluated, sequential logarithmic dilutions ofeach suspen¬
sion were made in MBB diluent in microtitre plates before counting. After
incubation of SBA plates at 370 C overnight, the mean number of cfu ml-1 was
calculated from each triplicate.
The mean percent of bacterial inoculum which was killed (%K) in each
suspension was calculated from the formula %K = 100 X1 — (the mean number
of cfu ml-1 after incubation/the mean number of cfu ml-1 before incubation).
The %K for each lung washing was adjusted by a correction factor (Dona-
chie et al., 1986) to take account of the extent to which each sample had been
concentrated before assay.
RESULTS
Optimisation of the bactericidal assay
The micro-titre plate assay could be performed rapidly with little variation
in counts between sample triplicates. The standard positive and negative sera
gave repeatable results (100 and 0%K, respectively) from day to day.
The standard positive serum killed 100% of a bacterial suspension contain¬
ing 3.4 X 103cfu ml-1, but only in the presence of complement. No killing oc¬
curred when complement was replaced with heat-inactivated FBS. This
bactericidal capacity rapidly diminished with dilution of the standard positive
serum, and was abolished at 1/32 (Fig. 1). The standard negative serum was
not bactericidal at any dilution (Fig. 1).
The standard positive serum ws tested with various concentrations of P.
haemolytica (Fig. 2). The activity of the serum remained >85% for P. hae-
molytica concentrations between 3.4 X103 and 3.4 X 105cfu ml-1, but thereafter
decreased rapidly with increasing bacterial concentration. A bacterial concen¬
tration of 3xl03cfuml-1 (equivalent to an inoculum of 6.0X 103cfu ml-1)
was therefore selected.
Bacterial killing by the standard positive serum was apparent after 2 min of
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Fig. 1. Titration of the bactericidal activity of a convalescent ( X — X ) and a naive (O—O)
specific pathogen-free lamb serum.
incubation (97%K) and had increased to 100%K by 15 min. An incubation
period of 30 min was therefore selected.
Fresh FBS was as effective a source of complement as naive SPF lamb serum,
but less convenient to obtain. Complement source sera were used undiluted
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since the bactericidal capacity of sera decreased rapidly in the presence of a
diluted complement source, e.g., 100% killing by one serum in the presence of
a neat concentration of the complement source was reduced to 86% when the
complement source was diluted 1 in 2. Heat inactivation of the complement
source completely abolished bactericidal activity, demonstrating that comple¬
ment was essential. The complement source was not bactericidal in the pres¬
ence of the standard negative serum, indicating that specific antibody was also
essential for bacterial killing. That antibody was the essential component in
the standard positive serum was confirmed by the use of immunoaffmity-pur-
ified IgG isolated from this serum. This proved to be as bactericidal (100%K)
as the complete serum when used at an equivalent copcentration (2.27 g 1_1).
1
The bactericidal capacity of convalescent and naive SPF lamb sera and lung
washings
Sera taken from the "convalescent" group lambs on Day 0 (pre-immunising
challenge) had no bactericidal activity, but when collected on Days 34 and 41
had group mean activities of 92.1 and 89.8%K, respectively (Table I). Further,
all but one lung washing obtained at necropsy (Day 41) from these "convales-
TABLEI
The bactericidal activity (%K) of sera and lung washings from "convalescent" lambs"




challenge (Day 34) (necropsy, Day
(DayO) 41)
1 0 97.6 95.5 13.2
2 0 NAd 98.5 18.0
3 0 93.2 94.5 0
4 0 99.5 99.2 27.0
5 0 99.0 99.6 9.8
6 0 98.0 98.4 11.6
7 0 65.5 42.7 11.3
Groupmean (±S.E.) 0 92.1 (±5.4) 89.8 (±7.9) 12.99 (±3.1)
"Bactericidal activity was not detectable in sera or lung washings of control lambs.
bThe bactericidal activity of lung washings taken at necropsy was adjusted by a correction factor
to return all samples to a unit volume of the original harvest.
cBy challenge with live organisms, followed by prevention of fulminating disease by antibiotic
therapy.
dNA = not available.
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cent" group lambs also contained bactericidal activity, although this was less
than in their sera (Table I). Conversely, no activity was detected in sera or
lung washes of 3 control group lambs nor were these lambs protected against
P. haemolytica A2.
Target antigens implicated in the bactericidal assay
Aliquots of the standard positive serum were absorbed with either SSE of P.
haemolytica A2 cell wall or LPS. Absorption with LPS completely abolished
bactericidal activity. The SSE reduced activity to 21%K.
<■
DISCUSSION
The bactericidal assay described in this paper was rapid, gave little variation
amongst replicates and was comparable on a day-to-day basis. Titration of the
immune serum and bacterial inoculum indicated that assay results were de¬
pendent upon both antigen and antibody titre. The most suitable conditions
for assay of SPF lamb sera or lung washings were 20 pi of neat serum and
3 X 103cfu ml-1 of P. haemolytica.
Serum complement was not bactericidal for P. haemolytica in the absence of
antibody, indicating that P. haemolytica could not activate the alternative
complement pathway. This result is in agreement with the findings of Mac-
donald et al. (1983) who showed that P. haemolytica was not killed in the
absence of a functional classical complement pathway. Also, the standard po¬
sitive serum was not bactericidal unless in combination with complement,
indicating that bactericidal activity was due to an antibody-complement
complex.
Purification proved that IgG was the bactericidal component in the standard
positive serum. The bactericidal activities of IgA and IgM against P. haemo¬
lytica remain to be investigated in this system. Previous studies have shown
that IgM is more active than IgG in bactericidal assays (Robbins et al., 1S65;
Bjornson and Michael 1970; Schulkind et al., 1972), although the activity of
IgG has been found in rabbit serum to increase during sequential immunisa¬
tion (Pike and Chandler, 1971). Also, IgG is predominantly produced in an
anamnestic response and is the major antibody class found in the lower res¬
piratory tract of sheep (Gorin et al., 1979). It is doubtful whether IgA can
activate bactericidal activity via the classical pathway (Sirotak et al., 1976)
and it has even been suggested that IgA may block bactericidal activity against
P. haemolytica (Macdonald et al., 1983). The immunoglobulin class meriting
most attention following vaccination or development of pneumonia would,
therefore, seem to be IgG.
SPF lambs convalescent from P. haemolytica A2 infection were recently
shown to be immune to subsequent challenge with the homologous serotype
270
(Donachie et al., 1986). In this report, the sera and all but one of the lung
washings of those convalescent animals were found to exhibit bactericidal ac¬
tivity against P. haemolytica A2. In contrast, samples from untreated control
animals which were susceptible to the P. haemolytica challenge had no bacte¬
ricidal activity. The presence of bactericidal antibodies in the sera and lung
washings of the convalescent lambs, therefore, correlated with resistance to P.
haeomolytica. Whether sufficient complement is available in the lung for bac¬
tericidal activity to occur is uncertain, but Burrells (1986) has shown that the
C3 component of complement increases in the sheep lung during PI3 virus/P.
haemolytica infection. The possibility that complement behaves asj an acute-
phase reactant in disease has been sugggested elsewhere (Atkinson and Frank,
1980). Because the recovery of lung washings involved dilution of the lung
fluids, bactericidal activities of sera and lung washings were not comparable,
therefore, although the bactericidal capacity of the lung washings was lower
than their respective sera, this may not necessarily reflect the situation in vivo.
The lungs of these convalescent lambs may have constituted as bactericidal an
environment for P. haemolytica as their blood. It is perhaps more relevant to
note that control lambs had no detectable bactericidal antibody in their lung
washings at necropsy.
In attempts to determine which antigen was the target for antibodies in¬
volved in the bactericidal assay, absorption with LPS was found to abolish the
bactericidal activity of the standard positive serum. Previous authors have de¬
scribed LPS as being the antigen receptor for the bactericidal antibodies di¬
rected against other gram-negative bacteria (Glynn and Ward, 1970; Tramont
et al., 1974). An SSE preparation of P. haemolytica A2 also reduced the activity
of bactericidal antibodies. This crude extract contained small amounts of LPS
and this was probably responsible for the reduction in bactericidal activity,
although other cell-surface antigens such as outer membrane proteins (Tra¬
mont et al., 1974) and phage receptors (Gabay, 1977), have been implicated
as targets for bactericidal antibodies. Separation of SSE into its components
may, therefore, reveal additional target antigens. The bactericidal assay de¬
scribed here will be useful in the understanding of the mechanisms of immu¬
nity agaisnt P. haemolytica and in monitoring the ability ofvaccines to produce
bactericidal activity both systematically and in the lung. This asay may have
similar applications for the study of bactericidal activity against other gram-
negative bacteria.
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ABSTRACT
Sutherland, A.D., Donachie, W., Jones, G.E. and Quirie. M., 1989. A crude cytotoxin vaccine
protects sheep against experimental Pasteurella haemolytica Serotype A2 infection. Vet. Mi¬
crobiol., 19: 175-181.
Three vaccines containing Pasteurella haemolytica serotype A2 antigens were tested for their
ability to protect sheep against a homologous challenge. A crude cytotoxin preparation in com¬
bination with a sodium salicylate extract (SSE) or crude cytotoxin alone were highly protective
(98 and 86%, respectively), whereas SSE alone was poorly (47%) protective. These findings
indicated that the crude cytotoxin was an essential component of a protective vaccine. Protection
correlated with serum cytotoxin-neutralising (CN) titres and bactericidal activity, which were
stimulated by antigens in the crude cytotoxin preparation.
INTRODUCTION
Pasteurella haemolytica is the causative organism of ovine pneumonic pas-
teurellosis in Britain (Gilmour, 1980) and biotype A serotype 2 (A2) is the
most frequently isolated serotype (Fraser et ah, 1982). However, A2 was the
least immunogenic serotype of P. haemolytica when sodium salicylate extract
(SSE) vaccines were evaluated against homologous challenge in lambs and
significant protection was obtained only when heat-killed organisms were in¬
cluded (Gilmour et ah, 1983). Subsequently, Donachie et al. (1986) showed
that convalescent lambs were completely protected against a further homolo¬
gous A2 challenge, which suggested that effective immunisation against the A2
serotype was possible and that the protective antigens were either absent from
or present in insufficient amounts in the SSE vaccines tested.
Ovine isolates of P. haemolytica produce an extracellular cytotoxin which is
lethal for ovine leucocytes (Sutherland et ah, 1983; Sutherland, 1985) and
which may be an important pathogenic determinant in ovine pneumonic pas-
teurellosis. It was considered, therefore, that a toxoid might provide protection
against P. haemolytica A2. Toxin-neutralising activity in itself may not, how-
0378-1135/89/$03.50 © 1989 Elsevier Science Publishers B.V.
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ever, be sufficient. Clostridial toxoid vaccines were poorly protective in sheep
unless they additionally included somatic antigens which stimulated the clear¬
ance or organisms (Outteridge. 1985); therefore two vaccines were prepared,
one of which contained a crude form of cytotoxin, the other the crude cytotoxin
plus SSE. These toxin-based vaccines were compared with an SSE vaccine
similar to that described previously (Gilmour et al., 1983). Serum antibody
responses were measured by an enzyme-linked immunosorbent assay (ELISA)
for antibodies to SSE cell surface antigens (Donachie et al., 1986), a cytotoxin-
neutralisation (CN) test and a bactericidal test (Sutherland, 1988), and re¬
sults from these tests were compared for correlation with protection against P.
haemolytica A2 infection. f
MATERIALS AND METHODS
Production of a cytotoxin preparation
Crude cytotoxin was prepared as described previously (Sutherland and Red¬
mond, 1986). P. haemolytica A2 cultures in dialysis sacs submerged in 500-ml
volumes of nutrient broth were incubated for 24 h at 37 :C. Sac contents were
centrifuged at 10 000 Xg for 20 min to pellet bacteria and the culture super¬
natant fluid, containing cytotoxin, was filter sterilised and lyophilised after
exhaustive dialysis against distilled water.
Production of SSE
The SSE was prepared by the method of Gilmour et al. (1983) with the
additional step that bacterial cell pellets were washed once in phosphate-buff¬
ered saline (pH 7.2) to minimise contamination of the extracts with extracel¬
lular cytotoxin.
Formulation of vaccines
Vaccines consisted of 9% alhydrogel adjuvant (Miles Laboratories) contain¬
ing lyophilised antigen resuspended in distilled water and were formulated as
follows: (i) 10 mg ml"1 of crude cytotoxin; (ii) 2.5 mg ml-1 of SSE; (iii) 10
mg ml-1 of crude cytotoxin plus 2.5 mg ml-1 of SSE.
Experimental animals
Lambs were caesarian derived, colostrum deprived and maintained in iso¬
lation. They were fed sterilised cows' milk, hay and concentrates, and desig¬
nated specific pathogen-free (SPF) lambs.
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Experimental infections
The experimental infection of lambs with P. haemolytica A2 was preceded
by infection with parainfluenza virus Type 3, a method which consistently
induces severe pneumonia in SPF lambs (Sharp et al., 1978). PI3 virus was
administered intratracheally (8 ml) and intranasally (2 ml). The titre of the
virus was 1X 10s TCID50ml~ h Infection with P. haemolytica A2 was achieved
by exposure for 15 min to an aerosol of strain X205A at ~ 4 X107 colony-form¬
ing units 1_1 and was administered 7 days after infection with PI3 virus.
Experimental design s
Three-week-old SPF lambs were allocated randomly into four groups. The
SSE vaccine which had been previously tested for efficacy (Gilmour et al.,
1983) and the control group were allotted eight animals. The untested cyto-
toxin and cytotoxin plus SSE vaccines were allotted 14 animals to ensure that
sufficient animals were available for statistical comparison between the vac¬
cine groups. One animal in each of the cytotoxin. SSE and control groups died
prior to experimental infection with PI3 virus. Three groups were vaccinated
on Day 0 and Day 28 with 1-ml doses of each vaccine, while one group remained
unvaccinated. All animals were given PI3 virus on Day 35 and an aerosol of P.
haemolytica A2 on Day 42. Lambs were bled for serum on Day 42. Clinical
examinations were carried out for 6 days after P. haemolytica infection and
surviving animals were necropsied on Day 49.
Clinical and pathological examinations
A clinical, microbiological and pathological assessment of the response of
each lamb was made according to the method of Jones et al. (1989).
Measurement of cytotoxin potency and serum CN antibody titres
The 0lCr-release cytotoxicity assay was a modification of that described by
Shewen and Wilkie (1982) and results were calculated by a modification of
the method of Gentry et al. (1985). Briefly, sheep bronchoalveolar macro¬
phages (BAM) were isolated, as described previously by Burrells (1985), and
resuspended at 4X10' viable BAM ml-1 in RPMI1640 medium supplemented
with 10% heat-inactivated fetal bovine serum (FBS), 1% glutamine, 3 mM
Hepes buffer, 2% sodium bicarbonate, adjusted to pH 7.4 with 1 M NaOH
(complete RPMI medium). BAM counts and viability were assessed by trypan
blue exclusion in an improved Neubauer haemocytometer. Sodium chromate
51Cr isotope was added to the BAM suspension at 50 pCi ml-1 and incubated
at 37 °C for 1 h, after which cells were sedimented and washed three times in
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Hanks basic salt solution by centrifugation at 100 for 10 min at room tem¬
perature. The BAM suspension was finally resuspended in complete RPMI
medium at 2x 10® viable BAM ml-1.
The potency of the crude cytotoxin preparation used for vaccination and
serology was assessed by titration. Lyophilised cytotoxin was resuspended at
20 mg ml-1 in complete RPMI medium and duplicate 100-/d volumes were
titrated by doubling dilution in sterile, tissue culture grade flat-bottomed mi-
crotitre plates (Nunc, Denmark). Complete RPMI medium (100 /d) was added
to the titrated cytotoxin to replace the volume of test serum added when de¬
termining CN titres. Finally, BAM (100 /d) were added to each well, including
spontaneous release control wells containing 200 /d of complete RPMI me¬
dium and total release control wells containing 200 /d of 0.1%"Tritoji X-100
(Sigma). Plates were sealed with sterile plastic film (Flow Laboratories, Ir¬
vine, Scotland) and incubated at 37°C for 3 h. BAM were then sedimentedby
centrifugation of the plates at 100 Xg for 10 min, after which 100 ul of super¬
natant fluid was removed from each well for counting in a gamma counter. The
percent specific cytotoxicity for each supernatant was calculated from the
formula:
Percent specific cytotoxicity = 100
counts in sample —counts in spontaneous release control
counts in total release control —counts in spontaneous release control
The end-point titre of the cytotoxin sample was taken as the final concentra¬
tion of toxin which gave a percent specific cytotoxicity> 10%.
The CN titre was taken as the highest serum dilution neutralising cytotoxic
activity by > 80% and was calculated by the formula:
the percent specific toxicity of the cytotoxin —the percent specific tox¬
icity of the cytotoxin in the presence of test serum
ioo x
the percent mean toxicity of the cytotoxin in the presence of a negative
control serum
Bactericidal assay and ELISA
These assays were performed as previously described [Sutherland (1988)
and Donachie et al. (1986), respectively]. The bactericidal capacity of serum
samples was calculated as the mean percentage of bacterial inoculum killed
(%K) in triplicate assay suspensions.
Statistical analysis
The Mann-Whitney ranking test was used to determine the significance of
differences between group data. Correlation tests were performed by the
Spearman ranking test for non-parametric data.
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RESULTS
The end-point titre of the crude cytotoxin used for vaccination was at a
concentration of 2.5 mg ml-1.
A high degree of protection was afforded to animals vaccinated with crude
cytotoxin both with and without the addition of SSE, while SSE-vaccinated
animals were protected significantly less (PcO.Ol) than the cytotoxin plus
SSE group (Table 1).
All vaccinated animals had serum antibodies to P. haemolytica when mea¬
sured by SSE-ELISA, while unvaccinated animals had none (Table 2)- The
mean CN titres and bactericidal capacities of sera from the cytotoxin and cy-
totoxin/SSE vaccine groups were significantly (P< 0.001) greater than those
of the SSE vaccine and unvaccinated control groups. Only two animals of the
SSE vaccine group had serum CN activity, both of low titre, indicating that
the SSE antigen contained negligible amounts of cytotoxin.
Serum CN titres and bactericidal capacities of experimental lambs corre-
TABLE 1




Deaths Disease index1 Percent protection2
Cytotoxin (7) 1 7 86
SSE (13) 6 26 47
Cytotoxin/SSE (14) 0 1 98
Unvaccinated (V) 7 50 0
'Disease index = the sum of the clinical, consolidated lesion, P. haemolytica isolation index and
pleurisy scores (Jones et al., 1989).
"Percent protection = [1 —disease index of treated group/disease index of unvaccinated
group] X 100.
TABLE 2
Group means of the reciprocal antibody titres in post-vaccinal sera measured by SSE-ELISA, CN
and bactericidal assay
Vaccine group SSE-ELISA CN assay Bactericidal assay
(%K)
Cytotoxin 5360 (±3452) 15.1 (± 4.3) 100 (±0.3)
SSE 7171 (±4179) 0.1 (± 0.1) 77 (±4.0)
Cytotoxin/SSE 3819 (±6624) 38.7 (±10.6) 96 (±2.5)
Unvaccinated 0 0.0 38 (±5.8)
Figures in parentheses are the standard error of the mean.
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lated inversely (P< 0.001) with the severity of disease measured by an index
taking account of clinical, pathological and microbiological parameters.
DISCUSSION
In this study, a vaccine containing crude cytotoxin plus SSE was 98% pro¬
tective against experimental infection of lambs with P. haemolytica A2 and the
protection afforded by the cytotoxin alone (86%) was only slightly les^. How¬
ever, the protection (47%) given by the SSE vaccine was- significantly
(P < 0.01) poorer and similar to values found previously (Gilmour et al., 1983).
Serological analysis revealed no significant difference in the mean %K of groups
given crude cytotoxin or crude cytotoxin plus SSE vaccines, whereas the SSE
vaccine group had a significantly lower mean %K. The antigens in the crude
cytotoxin thus stimulated bactericidal activity more effectively than SSE.
Similar ELISA titres in all groups showed there was no significant difference
in levels of antibodies to SSE cell surface antigens. Therefore, it was concluded
that SSE was not an additional requirement for protective cytotoxin-based
vaccines. This is in contrast to clostridial toxoid vaccines (Outteridge, 1985)
which require the addition of somatic antigens, usually in the form ofbacterins.
With crude cytotoxin vaccines, bactericidal activity is probably induced by
contaminant lipopolysaccharide (LPS) since antibodies involved in the bac¬
tericidal activity of immune serum can be absorbed by the addition of LPS
(Sutherland, 1988). The presence of LPS in crude cytotoxin has been detected
by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (Sutherland,
1986) and the limulus amoebocyte lysate assay (A.D. Sutherland, unpublished
results, 1987).
Since the partially protective SSE vaccine produced negligible CN titres and
low bactericidal activity, either CN antibodies or high bactericidal capacity, or
both, are probably required for significant protection. Both these variables
were significant correlates of immunity (P< 0.001) and were stimulated by
the crude cytotoxin vaccine.
Whether protection can be ascribed to either CN or bactericidal antibodies
alone can only be determined if different antigens are responsible for inducing
these antibodies, and separation and identification of these can be achieved.
However, the most efficient vaccine formulation for P. haemolytica may in¬
clude those antigens that induce both CN and bactericidal antibodies as found
in the crude cytotoxin preparation. In addition, inclusion of antigens that stim¬
ulate opsonising antibodies for phagocytosis may be beneficial for protection
since these correlate with immunity in animals convalescent to P. haemolytica
A2 (Donachie et al., 1986).
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ABSTRACT
Jones, G.E., Donachie, W., Sutherland, A.D., Knox, D.P. and Gilmour, J.S., 1989. Protection of
lambs against experimental pneumonic pasteurellosis by transfer of immune serum. Vet.
Microbiol., 20: 59-71.
Passive protection of specific pathogen-free lambs against experimental pasteurellosis was
achieved using antisera from conventionally reared sheep which were either convalescent from
experimental pneumonia or inoculated with Pasteurella haemolytica A2 vaccines. The complete
immune sera, or immunoglobulin-rich fractions prepared from them, when administered sepa¬
rately or together provided 94-100% protection of recipients compared to control lambs.
Antibodies to P. haemolytica in donor sera were quantified by anti-sodium salicylate extract
(SSE) and anti-lipopolysaccharide (LPS) ELISA, bactericidal assay, cytotoxin neutralization
and indirect haemagglutination. The anti-SSE ELISA titres correlated best with protective effi¬
cacy and could be used to measure antibody in recipient lambs immediately before challenge. The
degree of protection was unaffected by prior infection with parainfluenza virus Type 3, suggesting
that such exposure did not enhance exudation of circulating immunoglobulin into the respiratory
tract. It was concluded that systemic humoral immunity alone can prevent pasteurellosis.
INTRODUCTION
Pneumonic pasteurellosis of sheep generally involves Pasteurella haemo¬
lytica Biotype A, though predisposing factors may also be significant (Gilmour,
1978). Disease indistinguishable from the natural condition has been repro¬
duced experimentally in specific pathogen-free (SPF) lambs using aerosols of
P. haemolytica, either alone or preceded by parainfluenza virus Type 3 (PI3)
(Gilmour et al., 1975; Sharp et al., 1978).
Several vaccines incorporating bacterial cell extracts have been shown to be
protective against homologous serotype challenge (Gilmour et al., 1982; Wells
et al., 1984), but the A2 serotype was poorly immunogenic in lambs (Gilmour
etal., 1983),mice (Evans and Wells, 1979) andrabbits (Donachie etal., 1986a).
0378-1135/89/$03.50 © 1989 Elsevier Science Publishers B.V.
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The reasons for the lower immunogenicity of the A2 serotype are unknown,
but the practical implications are considerable: A2 constituted 55% of biotype
A isolates in one survey of pneumonia in British sheep (Fraser et ah, 1982).
The mechanisms by which the efficacious vaccines protect sheep are not yet
understood. Wells et al. (1979) failed to protect SPF lambs with serum from
lambs that had been vaccinated against Serotype Al, which led them to con¬
clude that humoral immunity alone was incapable of protecting against exper¬
imental pasteurellosis.
Serum from sheep convalescent from experimental pneumonia involving P.
haemolytica A2 and Mycoplasma ovipneumoniae (Jones et ah, 1986) passively
protected mice against experimental pasteurella infection (Donachie''et al.,
1986b), whereas antiserum to inactivated antigens did not. A re-evalilation of
the protection afforded by transferred serum to ovine pasteurellosis using serum





All animals used were conventionally reared Cheviot lambs from the same
flock. Though the flock was virtually free of respiratory disease during more
than 9 years of close observation, P. haemolytica had been found occasionally
in nasal swabs.
While under experiment, the convalescent groups (Cvl and Cv2) were
maintained indoors in isolation. The vaccinated animals (Groups VI and V2)
were maintained outdoors throughout as distinct, separate groups. Each group
contained six lambs of 3.5-4 months old (m.o.) at experiment initiation.
In pre-experimental screening, P. haemolytica was isolated from nasal swabs
from two sheep in Group VI and titres of antibody to P. haemolytica were
detected by anti-sodium salicylate extract (SSE) ELISA ( > 1 in 500; Dona-
chie and Jones, 1982) in two lambs in each of Cvl, VI and V2, and in three
lambs of Cv2.
Serum recipients
Crossbred SPF lambs, produced and maintained as described previously
(Hart et al., 1971), were randomised into groups on the basis of liveweight,
with restriction on siblings.
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Production of immune serum
Convalescent groups
Chronic ("atypical") pneumonia was reproduced experimentally at differ¬
ent times in two groups of lambs by minor variations of the general method¬
ology described elsewhere (Jones et al., 1986). Briefly, homogenised lung le¬
sion suspensions made from naturally occurring cases of atypical pneumonia
(LH) were injected intratracheally (i.t.) in 8-10-ml volumes on Day 0. Two
different suspensions were used. The first (injected into Group Cvl) was treated
with 2 mg ml-1 of ampicillin (Penbritin, Beecham Animal Health) apd con¬
tained M. ouipneumoniae as the only detectable microorganism-, present at 106
colour-changing units (ecu) per 0.2 ml. The second, which was not treated with
antibiotic, was injected into Group Cv2 and contained M. ovipneumoniae (106
ecu per 0.2 ml), Mycoplasma arginini (105 ecu per 0.2 ml) and P. haemolytica
A2 [103'9 colony-forming units (cfu) ml-1].
Group Cvl was injected intramuscularly (i.m.) with 5 mg kg-1 liveweight of
ampicillin at the time of LH inoculation. The same lambs were injected again
on Days 7, 50, 56 and 93 with 2 ml i.t. and 2 ml intranasally (i.n.) of 5-h broth
cultures of P. haemolytica A2 diluted appropriately in phosphate-buffered sa¬
line, pH 7.2. These inocula contained 1045, 1045, 106'3 and 108° cfu ml-1,
respectively.
Group Cv2 was inoculated in like manner on Days 4 and 40 with inocula
containing 10' 2 and 10°'6 cfu ml-1, respectively, of P. haemolytica A2.
Vaccinated groups
Individual animals were injected subcutaneously three times, on each occa¬
sion with 2 ml of vaccine prepared by adsorption of antigen with aluminium
hydroxide gel (Alhydrogel, Miles Research Products) and emulsification with
Bayol and Arlacel A. Group VI (contemporary with Group Cvl) was injected
with a mixture of heat-killed organisms (HKO, 1 mg ml-1) and SSE (2.5 mg
ml-1) of P. haemolytica A2 (Gilmour et al., 1983). Each dose was administered
28 days apart. Group V2 (contemporary with Group Cv2) was injected with a
vaccine containing SSE only (2.5 mg ml-1) given 21 and 22 days apart.
Collection of serum and formation of immune serum pools
Blood in 200-300-ml volumes was taken on four occasions between Weeks 9
and 14, and the animals were exsanguinated in Weeks 14 or 15. Serum pools
were formed from all bleedings of the three or four animals in each group that
were serologically negative before the experiment.
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Production of control serum
Two batches of control sera were used for Experiment 1. One (CtSl) was
made up of sera taken from 3-6-week-old (w.o.) SPF lambs; the other (CtS2)
was made up of sera taken over 2 weeks from 20-25 conventionally reared
lambs aged 4-6 weeks.
For Experiment 2, a serum pool (CtS3) was formed from four peers of those
used to produce CvS2 and VS2. These donors were serologically negative when
first screened, but low transient titres to P. haemolytica were detected by anti-
SSE ELISA in three of them during later bleeds.
Preparation of semi-purified immunoglobulin-rich fractions
For Experiment 1, immunoglobulin-rich fractions (IRF) were prepared from
~ 3-1 volumes of CvSl, VSl and CtS2 by cold ethanol extraction (Cohn et al.,
1946; Oncley et al., 1949). These fractions (Cvlgl, VIgl and Ctlg2, respec¬
tively) were resuspended in 200 ml distilled water and sterilised by passing
through filters of 0.22 pm average pore diameter.
IRF for subsequent experiments were prepared by precipitation with 40%
(v/v) saturated ammonium sulphate (Garvey et al., 1977) from 1.8-1 volumes
of CvS2 and VS2 for Experiment 3 (Cvlg2 and VIg2i, respectively), and from
1.9 1 of VS2 for Experiment 4 (VIg2ii). The precipitates were resuspended in
normal saline and dialysed exhaustively against normal saline until free of
SO|~ ions as determined by the addition of 10% barium chloride (Garvey et
al., 1977). After filtration through 0.45-/tm membranes, the suspensions were
concentrated using either polyethylene glycol (Breox 20M PEG, Chemical
Services and Distribution, Crewe) or lyophilisation followed by resuspension
in a minimum volume of distilled water. The suspensions were further dialysed
against normal saline, adjusted with saline to a volume considered appropriate
for the experiment and sterilised by filtration. Total volumes produced were
250 ml each of Cvlg2 and VIg2i, and 380 ml of VIg2ii.
Characterisation of serum pools and IRF
IgG was estimated turbidimetrically (Seneviratne and Moores, 1980) and
IgM nephelometrically by an adaptation of the methods of Buffone et al. (1975)
using an IL Multistat III microcentrifugal analyser (Instrumentation Labo¬
ratory U.K.). Albumin was determined by the bromocresol-green dye binding
method of Doumas et al. (1971).
Antibodies to P. haemolytica A2 were assayed by indirect haemagglutination
(IHA) (Fraser et al., 1983), ELISA using SSE (Donachie and Jones, 1982) or
lipopolysaccharide (LPS) bound to assay plates by the method of Fodor and
63
Donachie (1988), cytotoxin neutralizing (CN) assay (Sutherlandet al., 1989)
and bactericidal assay (Sutherland, 1988).
Passive protection experiments
The design of these experiments is shown in Table 1.
Infective inocula: administration and dosage
PI3 virus produced as described previously (Sharp et ah, 1978) was injected
i.t. and i.n. in 8- and 2-ml volumes, respectively. Two preparations of virus
inoculum were used which contained 10625 and 10617 TCID50 per 0.2 rpl.
P. haemolytica was administered by aerosol as described elsewhere (Gilmour
et al., 1975). Titres of P. haemolytica from particles <3.3 pm in diameter, as
indicated by the growth from the bottom stage of a 3-stage Porton impinger
(May, 1966), ranged from 106-98 to 108'43 cfu ml-1.
Virus, when used, was given 7 days before the pasteurella. Day 0 was the day
of first exposure to either agent.
TABLE l
Design of experiments
Experi- Lambs at Day 0 Challenge Treatment of Group
ment method
Age Weight 1 2 3
(days) (kg)
1 67-69 12.5-19.5 PI3 + PhA2 CvSl+ VS1+ CtSl+CtS2 22 1.4
Cvlgl VIgl +Ctlg2
(614)* (628) (444)
2 25-26 5.7-13.9 PI3 + PhA2 CvS2 CtS3 20
(542) (624)
3 20-21 5.9-11.2 PI3 + PhA2 Cvlg2 VIg2i VS2 None 11.4 31
(451) (664) (365)
(S i.v. and i.p.)2
4 30-31 5.2-14.1 PhA2 only VIg2ii None 4.1
(606)
Cv = convalescent; V = post-vaccinal; Ct = control; S = serum; Ig = immunoglobulin-rich fraction;
i.p. = intraperitoneal injection given 24 h before challenge with P. haemolytica; i.v. = intravenous
injection given 3-4 h before P. haemolytica; PI3 = parainfluenza 3 virus; PhA2 = P. haemolytica
A2.
*Figures in parentheses indicate total IgG administered as mg kg-1 liveweight.
'Groups 1 and 2.
2Group 3 was given 11.4 ml serum kg-1, 30 ml i.v. and the remainder i.p.
Dose (ml kg )
4 i.p.(S) i.v.(Ig)
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Large volumes (60-430 ml) of serum were administered 24 h before P. hae-
molytica infection by intraperitoneal (i.p.) injection into the right sublumbar
fossa using a flutter valve. Small volumes of IRF (18-59 ml) or serum (30 ml,
Group 3, Experiment 3) were given by intravenous (i.v.) injection 3-4 h before
exposure to aerosol. In Experiment 4, where i.v. doses were particularly large,
the animals were pre-sedated with Saffan (Glaxovet). Serum or IRF was
warmed to 37 °C before injection.
Clinical, microbiological, histopathological and serological examinations and
necropsy
A combined scoring (CS) system was employed, based on four components,
in which the maximum score per lamb was 60. ' ,
(i) Clinical score. Animals were examined from Days 1 to 6 inclusive and
necropsied on Day 7. One point was allotted for each observation of raised
rectal temperature ( ^40.5°C), dyspnoea or coughing, severe depression, and
death or euthanasia on humanitarian grounds. The maximum daily score was
4 and the experiment score 24. Animals which died prematurely were scored 4
for each day remaining in the experiment.
(ii) Pneumonia score. The mean area of consolidated lung tissue on dorsal
and ventral surfaces was assessed by computer-aided measurement from lung
diagram charts completed at necropsy. This area, expressed as a percentage of
the total lung area, was halved to give the pneumonia score (maximum 22).
Animals which died rapidly, without development of consolidated lung tissue,
were scored maximum if isolations of P. haemolytica indicated lung infection
and a generalised septicaemia (one or more of heart blood, spleen and liver
positive).
(iii) P. haemolytica isolation index. Lung tissue samples from eight different
sites were combined to give four pools as follows: right apical and cardiac lobes;
left apical and cardiac lobes; right diaphragmatic and intermediate lobes; and
either side of the left diaphragmatic lobe. These samples were titrated and
cultured, and the counts of viable P. haemolytica estimated. Representative
colonies were identified by methods described elsewhere (Fraser et al., 1983).
The mean log10 titre of the four pools was taken as the isolation index figure
(maximum 8).
(iv) Pleurisy. Fibrinous pleuritic adhesions were scored 1 for each lobe af¬
fected, the apical and cardiac lobes of each side being regarded as one lobe for
this purpose (maximum 4). Gelatinous fibro-cellular pleurisy with excess
pleuritic fluid was scored 3 for each side affected (maximum 6).
Surviving lambs were killed at Day 7 by barbiturate overdosage. Lung tissue
pools were examined for bacteria and viruses as described previously (Sharp
et al., 1978), and representative lung blocks were fixed in 10% formol saline




Characteristics of the serum pools and IRF (Table 2)
IgG:albumin ratios were 0.56-1.20 in whole serum. They were increased 9.9-
11.0-fold by cold ethanol extraction and 6.7-8.2-fold by ammonium sulphate
precipitation. IgM:albumin ratios were increased 8.5-8.7-fold by cold ethanol
extraction and 3.0-4.8-fold by ammonium sulphate precipitation.
All sera and IRF pools from vaccinated or convalescent animals were posi¬
tive and those from control animals negative by anti-SSE ELISA; IF?E dem¬
onstrated higher titres than their parent serum pools. All pools tested by anti-
LPS ELISA were positive, including CtS3 which had a low titre. The CN assay
produced very similar findings, except that VSl was negative. The bactericidal
assay distinguished immune from control serum and IRF, although some bac¬
tericidal activity was detected in Ctlg2 and none was detected in Cvlg2 or
VIg2(i). The IHA test distinguished immune from control serum, except in
Experiment 1, where three immune products yielded insignificant titres. In
TABLE 2
Characterisation of serum pools and immunoglobulin-rich fractions
Experi- Group Inoculum Content (g 1_1) Reciprocal of titre* Bacteri-
ment






1 1 CvSl + 26.0 0.7 27.1 16 1172 6500 200 100
Cvlgl 30.3 0.7 3.2 2 5434 3111 800 100
2 VS1 + 26.7 0.7 35.6 0 2597 12091 <100 86
vigl 29.1 0.6 3.5 2 9060 10292 100 100
3 CtSl + 2 17.6 0.2 31.7 2 0 NA <100 0
+ Ctlg2 40.5 1.2 4.1 0 0 NA <100 36
2 1 CvS2 27.1 0.7 30.2 32 1046 3183 200 91
2 CtS3 31.2 0.7 31.1 2 0 2615 <100 0
3 1 Cvlg2 150.2 1.5 21.8 128 2748 NA 1600 0
2 VIg2(i) 221.3 1.6 22.4 32 62502 24369 1600 0
3 VS2 32.0 0.4 26.7 8 9060 6697 100 90
4 1 VIg2 (ii) 147.9 1.0 18.5 32 41996 8342 400 88
*Mean of duplicate tests using P. haemolytica A2 as antigen. IHA = indirect haemagglutination
test; ELISA = enzyme-linked immunosorbent assay; CN = cytotoxin neutralisation assay;
SSE = sodium salicylate extract; LPS = lipopolysaccharide; %K = percent killed; NA = not avail¬
able. Otherwise, abbreviations as in Table 1.
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general, the highest titres in the IHA test were produced by convalescent sera
and IRF.
Experiments 1 and 2
Virtually no evidence of pneumonia was detected in the 19 animals treated
with immune material and only one (from Experiment 2) yielded P. haemo-
lytica from the lungs, in low numbers (Table 3). In contrast, three of the six
control lambs in Experiment 1 died rapidly and four had consolidated lesions
in the lungs.
All six control lambs in Experiment 2 yielded P. haemolytica from the lungs
(PcO.Ol compared with Group 1), but marked evidence of pneumonia was
apparent in only two, of which one died and one had extensive lung
consolidation.
Experiment 3
Three lambs died of PI3 virus infection on Days 5 and 6. The remainder
were then randomised on pre-experiment weights into three groups of seven
and one (Group 4) of eight lambs for challenge with P. haemolytica.
No deaths occurred in any of the treated lambs and evidence of disease in
them was minor (Table 3). Mean isolation titres were < 102 cfu g-1 in all six
of the 21 animals treated with immune serum which yielded P. haemolytica
from the lungs. In contrast, seven control lambs died, all with evidence of sep¬
ticaemia. The sole survivor yielded a mean titre of only 1024 cfu P. haemolytica
g~1 of lung tissue, but had consolidation involving 94% of the lung surface area.
Experiment 4
Clinical signs of disease were virtually absent in the group treated with im¬
mune Ig, although three lambs showed 5-8% consolidation of the lung surface
area; two of these yielded low numbers of P. haemolytica (Table 3). All but one
control animal died of septicaemia, most on Day 3. P. haemolytica was isolated
from a shoulder joint, but not the lungs of the sole survivor.
Histopathologically, the majority of animals in Experiments 3 and 4 showed
interstitial pneumonia with or without a non-suppurative exudate. A small
proportion, represented in every group, showed mild to moderate neutrophil
presence with or without lung consolidation. Changes typical of pasteurellosis
were found in only one animal of Group 3, Experiment 3. Fibro-cellular pleu¬
risy was observed only in untreated animals, with four positive in both Exper¬
iments 3 and 4.
Sera of lambs in Experiments 3 and 4 taken after treatment, immediately
before challenge with P. haemolytica, were assayed by anti-SSE ELISA (Table
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TABLE 4
ELISA titres to P. haemolytica in the sera of lambs in Experiments 3 and 4 following treatment,
immediately before challenge with P. haemolytica





3 1 Cvlg2 i.v. 0/7 0
2 VIg2i i.v. 6/7 3.1 ±0.06
3 VS2 i.p. + i.v. 1/7 2.8
4 None 0/8 0 '
4 1 VIg2ii i.v. 5/8 3.1 ±0.10
2 None 0/9 0
'Titres > 1 in 500.
2As log10, positive animals only.
4). Most lambs treated with VIg2 were positive, but none injected with Cvlg2
and only one given VS2 had detectable antibody.
DISCUSSION
These studies have demonstrated that serum or IRF administered i.v. or i.p.
can provide virtually total protection against experimental pasteurellosis. Pro¬
tection was produced by two separate batches of convalescent serum, by post¬
vaccinal serum produced with two forms of vaccine and by IRF produced from
these convalescent and post-vaccinal sera. These findings thus support other
work indicating that protection against respiratory disease can be mediated by
humoral elements alone (Lam and Switzer, 1971; Masiga et al., 1975), in con¬
trast to the conclusion of Wells et al. (1979) that humoral immunity per se is
incapable of preventing pneumonia, specifically ovine pasteurellosis.
Gilmour et al. (1983) found that Serotype A2 SSE/HKO vaccines similar
to those used in this study gave only 40-50% protection in SPF lambs, whereas
Donachie et al. (1986a) observed that SPF lambs convalescent from experi¬
mental infection with P. haemolytica A2 were completely resistant to subse¬
quent challenge with the homologous serotype. However, in this study similar
levels of passive protection (between 94 and 100%) were afforded by serum
both from vaccinated and convalescent animals. This anomaly may have been
due to several reasons, (i) Excessive dosages of serum and IRF may have ob¬
scured differences in levels of protective antibodies raised by these two proto¬
cols. Generally, convalescent serum and IRF pools had higher bactericidal as-
69
say (%K), CN and IHA titres than did vaccinate serum and IRF pools, (ii) A
considerable boost in antibody titre was invariably seen in these studies by
anti-SSE ELISA following the third vaccination. Gilmour et al. (1983) used
only a double-vaccination schedule, (iii) Prior exposure of donor animals to
P. haemolytica may have supplemented the smaller range of antibodies stim¬
ulated by the SSE vaccine, thereby raising the protective efficacy of post-vac-
cinal serum to equivalence with the convalescent serum. Pre-screening indi¬
cated that donor animals were negative for antibodies to P. haemolytica A2 by
the anti-SSE ELISA, but some of their peers were positive by this test and two
yielded P. haemolytica from nasal swabs. In Experiment 2 also, control serum
from untreated peers of immune serum donors appeared to offer some protec¬
tion (Table 3) and antibodies were present at low titre to LPS (Tablfe 2). This
indicates that the anti-SSE ELISA, probably the most sensitive test employed,
lacked the ability and/or sensitivity to detect low levels of protective antibod¬
ies. The same test detected circulating antibodies in only 12 of 29 recipient
lambs in Experiments 3 and 4 immediately before challenge.
IRF preparations were as effective as their parent serum pools in these stud¬
ies. Being no more than semi-purified, the precise nature of their protective
components cannot be deduced, although compared with serum their propor¬
tional contents of IgG and IgM were increased at the expense of albumin and,
presumably, other serum components. Since dosages used were equilibrated by
IgG content, this suggests that immunoglobulin was responsible for the pro¬
tection engendered.
The use of a P. haemolytica-only infection in Experiment 4 was designed to
ascertain whether prior infection with PI3 virus was responsible, wholly or in
part, for the protective effects of injected materials seen previously. PI3 virus
can cause epithelial damage and oedema (Rushton et al., 1979; Davies et al.,
1981), effects which could have promoted the exudation and accumulation in
the lungs of blood constituents, including the injected materials. The 95% pro¬
tection observed in Group 1, Experiment 4, indicates that viral pre-infection
was not essential for efficacy of treatment and that either normal immuno¬
globulin transudation into the broncho-alveolar tree was sufficient or that pro¬
tection was provided mainly or exclusively intravascularly.
Death after acute or hyperacute septicaemia occurred in some control ani¬
mals of all experiments, but the 3-4.5-w.o. lambs of Experiments 3 and 4 had
virtually no pulmonary phagocytic cell response, compared with the extensive
neutrophil and macrophage exudate present in the lungs of three 9.5-w.o. con¬
trol lambs of Experiment 1. This difference suggests that phagocytic cell func¬
tion and responses in the young lamb are deficient and mature only after 5
weeks of age. Naturally occurring field cases of pasteurellosis in lambs <2
months old are generally of septicaemic form (Gilmour, 1978). In the absence
of severe respiratory disablement, the cause of death in such cases is presum¬
ably endotoxaemia. The ability of immune serum and IRF to protect the im¬
munologically immature lambs of Experiments 3 and 4 suggests that protec-
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tion was independent of phagocytes, i.e., non-opsonic. Instead, the injected
immunoglobulins may have been bactericidal, prevented bacterial adherence,
enhanced clearance by the muco-ciliary blanket and/or neutralized bacterial
metabolic function or products, such as endotoxin or cytotoxin (Pennington,
1979; Shewen and Wilkie, 1983), by steric hindrance.
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